419eae9a的个人主页 - 老虎社区

419eae9a

暂无个人介绍

IP属地：未知

9关注

15粉丝

0主题

0勋章

2022-01-01

Ok

4 Biggest Price Target Changes For Friday

2021-12-31

Ok

SenseTime shares surged more than 30% in Hong Kong market

2021-12-30

Ok

Dow, S&P Close at Record Highs as Omicron Worries Ease

2021-12-28

Ok

Think Lucid and Rivian Are Overvalued? Buy These Alternative Energy Growth Stocks Instead

2021-12-27

Ok

Grab stock climbed more than 3% in premarket trading

2021-12-26

Ok

A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State

2021-12-25

Ok

3 Best Buffett Stocks to Buy for the Long Haul

2021-12-24

Ok

Is Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates

2021-12-23

Ok

Cathie Wood Loads Up Another $800K In This Chinese Tesla Rival Ahead Of Its Overseas Expansion

2021-12-22

Ok

Biden Says He’s Considering Lifting U.S. Omicron Travel Ban

2021-12-21

Ok

Wall Street skids on Omicron worry, obstacle to Biden social-spending package

2021-12-21

Ok

Oil prices edge higher but investor worries on Omicron spread remain

2021-12-20

Ok

抱歉，原内容已删除

2021-12-19

Ok

Watch these five electric vehicle models in 2022

2021-12-18

Ok

Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list

2021-12-16

Ok

Adobe tumbled over 7% in premarket trading as its financial report missed estimate

2021-12-15

Ok

Toplines Before US Market Open on Wednesday

2021-12-14

Ok

4 Stocks Insiders Are Selling

2021-12-13

Ok

Charlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd

2021-12-12

Ok

Ford expects to triple electric Mustang output by 2023

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3583487187442003,"uuid":"3583487187442003","gmtCreate":1620393353061,"gmtModify":1620393353061,"name":"419eae9a","pinyin":"kalpana","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":15,"headSize":9,"tweetSize":145,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692285036,"gmtCreate":1640993498730,"gmtModify":1640993498922,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692285036","repostId":"1150283067","repostType":4,"repost":{"id":"1150283067","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640962811,"share":"https://www.laohu8.com/m/news/1150283067?lang=&edition=full","pubTime":"2021-12-31 23:00","market":"us","language":"en","title":"4 Biggest Price Target Changes For Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1150283067","media":"Benzinga","summary":"SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. X","content":"<html><head></head><body><p>SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.</p><p>Rosenblatt lifted Synaptics Incorporated SYNA +0.75%  price target from $290 to $345. Synaptics shares fell 1.6% to close at $287.70 on Thursday.</p><p>HC Wainwright &amp; Co. raised the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $4.25 to $5.4. Xeris Biopharma shares gained 18.9% to $2.89 in pre-market trading.</p><p>Barclays raised Constellation Brands, Inc. STZ +0.19% price target from $268 to $271. Constellation shares fell 0.2% to $249.00 in pre-market trading.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Biggest Price Target Changes For Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Biggest Price Target Changes For Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-31 23:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.</p><p>Rosenblatt lifted Synaptics Incorporated SYNA +0.75%  price target from $290 to $345. Synaptics shares fell 1.6% to close at $287.70 on Thursday.</p><p>HC Wainwright &amp; Co. raised the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $4.25 to $5.4. Xeris Biopharma shares gained 18.9% to $2.89 in pre-market trading.</p><p>Barclays raised Constellation Brands, Inc. STZ +0.19% price target from $268 to $271. Constellation shares fell 0.2% to $249.00 in pre-market trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STZ":"星座品牌","SYNA":"Synaptics Incorporated","XERS":"Xeris制药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150283067","content_text":"SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.Rosenblatt lifted Synaptics Incorporated SYNA +0.75%  price target from $290 to $345. Synaptics shares fell 1.6% to close at $287.70 on Thursday.HC Wainwright & Co. raised the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $4.25 to $5.4. Xeris Biopharma shares gained 18.9% to $2.89 in pre-market trading.Barclays raised Constellation Brands, Inc. STZ +0.19% price target from $268 to $271. Constellation shares fell 0.2% to $249.00 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":760,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692845738,"gmtCreate":1640924197041,"gmtModify":1640924197279,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692845738","repostId":"1165020011","repostType":4,"repost":{"id":"1165020011","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640920697,"share":"https://www.laohu8.com/m/news/1165020011?lang=&edition=full","pubTime":"2021-12-31 11:18","market":"hk","language":"en","title":"SenseTime shares surged more than 30% in Hong Kong market","url":"https://stock-news.laohu8.com/highlight/detail?id=1165020011","media":"Tiger Newspress","summary":"SenseTime shares surged more than 30% in Hong Kong market.","content":"<html><head></head><body><p>SenseTime shares surged more than 30% in Hong Kong market.<img src=\"https://static.tigerbbs.com/97b25aff276c5db83cf8732631a18cc0\" tg-width=\"710\" tg-height=\"624\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SenseTime shares surged more than 30% in Hong Kong market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSenseTime shares surged more than 30% in Hong Kong market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-31 11:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>SenseTime shares surged more than 30% in Hong Kong market.<img src=\"https://static.tigerbbs.com/97b25aff276c5db83cf8732631a18cc0\" tg-width=\"710\" tg-height=\"624\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00020":"商汤-W"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165020011","content_text":"SenseTime shares surged more than 30% in Hong Kong market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692336463,"gmtCreate":1640844176377,"gmtModify":1640844176622,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692336463","repostId":"2195466435","repostType":4,"repost":{"id":"2195466435","pubTimestamp":1640814752,"share":"https://www.laohu8.com/m/news/2195466435?lang=&edition=full","pubTime":"2021-12-30 05:52","market":"us","language":"en","title":"Dow, S&P Close at Record Highs as Omicron Worries Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=2195466435","media":"Reuters","summary":"Dec 29 (Reuters) - The Dow and S&P 500 closed at all-time highs on Wednesday on a boost from retaile","content":"<html><head></head><body><p>Dec 29 (Reuters) - The Dow and S&amp;P 500 closed at all-time highs on Wednesday on a boost from retailers including Walgreens and Nike, as investors shrugged off concerns on the spreading Omicron variant.</p><p>The Dow has now risen six straight trading days, marking the longest streak of gains since a seven-session run from March 5 to March 15 this year.</p><p><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> and Nike Inc rose 1.59% and 1.42% respectively against the backdrop of recent reports suggesting holiday sales were strong for U.S. retailers.</p><p>Data on Wednesday showed the U.S. trade deficit in goods mushroomed to the widest ever in November as imports of consumer goods shot to a record, as the coronavirus pandemic has limited spending by Americans on services.</p><p>Some early studies pointing to a reduced risk of hospitalization in Omicron cases have eased some investors concerns over the travel disruptions and powered the S&amp;P 500 to record highs this week.</p><p>&#34;The market started to recognize that the Omicron variant was in a strange way good news, because it will burn itself out more rapidly because it&#39;s easily transmissible, but it&#39;s less likely to overwhelm hospitals,&#34; said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York. Still, he said Omicron arguably is going to be a headwind for at least the next month.</p><p>Meanwhile, the S&amp;P 1500 airlines index dipped. Delta Air Lines and Alaska Air Group canceled hundreds of flights again on Tuesday as the daily tally of infections in the United States surged.</p><p>Three of the 11 major S&amp;P sector indexes declined, the energy index, the consumer services sector .SPLRCL and the financial sector are in the red.</p><p>Typically, the final five trading days of the year and the first two of the subsequent year are seasonally strong for U.S. stocks, known as the &#34;Santa Claus Rally.&#34; However, market participants warned against reading too much into daily moves as the holiday season tends to record some of the lowest volume turnovers that can cause exaggerated price action.</p><p>The Dow Jones Industrial Average rose 90.42 points, or 0.25%, to 36,488.63, the S&amp;P 500 gained 6.71 points, or 0.14%, to 4,793.06 and the Nasdaq Composite dropped 15.51 points, or 0.1%, to 15,766.22.</p><p>The S&amp;P 500 dipped on Tuesday in the lowest trading volume session of 2021, snapping a four-day winning streak.</p><p>As 2021 draws to a close, the main U.S. stock indexes are on pace for their third straight year of stunning annual returns, boosted by historic fiscal and monetary stimulus. The S&amp;P 500 is looking at its strongest three-year performance since 1999.</p><p>The focus next year will shift to the U.S. Federal Reserve&#39;s path of interest rate hikes amid a surge in prices caused by supply chain bottlenecks and a strong economic rebound.</p><p>Among other stocks, shares of Victoria’s Secret &amp; Co rose more than 12% after the intimate apparel retailer announced a $250 million accelerated share repurchase program. The retailer also said they had strong sales over the holidays.</p><p>Tesla&#39;s CEO Elon Musk exercised all of his options expiring next year, signaling an end to his stock sales. Its shares dropped 0.21% but were still on course to end about 54% for the year.</p><p>Volume on U.S. exchanges was 7.89 billion shares, compared with the 11.15 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.20-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 76 new 52-week highs and no new lows; the Nasdaq Composite recorded 77 new highs and 374 new lows.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow, S&P Close at Record Highs as Omicron Worries Ease</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow, S&P Close at Record Highs as Omicron Worries Ease\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 05:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-dow-p-close-215232570.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 29 (Reuters) - The Dow and S&P 500 closed at all-time highs on Wednesday on a boost from retailers including Walgreens and Nike, as investors shrugged off concerns on the spreading Omicron variant...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-dow-p-close-215232570.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SH":"标普500反向ETF","UPRO":"三倍做多标普500ETF","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","SSO":"两倍做多标普500ETF","BK4079":"房地产服务","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","BK4539":"次新股","OEX":"标普100","SPXU":"三倍做空标普500ETF","BK4550":"红杉资本持仓","BK4504":"桥水持仓"},"source_url":"https://finance.yahoo.com/news/us-stocks-dow-p-close-215232570.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2195466435","content_text":"Dec 29 (Reuters) - The Dow and S&P 500 closed at all-time highs on Wednesday on a boost from retailers including Walgreens and Nike, as investors shrugged off concerns on the spreading Omicron variant.The Dow has now risen six straight trading days, marking the longest streak of gains since a seven-session run from March 5 to March 15 this year.Walgreens Boots Alliance and Nike Inc rose 1.59% and 1.42% respectively against the backdrop of recent reports suggesting holiday sales were strong for U.S. retailers.Data on Wednesday showed the U.S. trade deficit in goods mushroomed to the widest ever in November as imports of consumer goods shot to a record, as the coronavirus pandemic has limited spending by Americans on services.Some early studies pointing to a reduced risk of hospitalization in Omicron cases have eased some investors concerns over the travel disruptions and powered the S&P 500 to record highs this week.\"The market started to recognize that the Omicron variant was in a strange way good news, because it will burn itself out more rapidly because it's easily transmissible, but it's less likely to overwhelm hospitals,\" said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York. Still, he said Omicron arguably is going to be a headwind for at least the next month.Meanwhile, the S&P 1500 airlines index dipped. Delta Air Lines and Alaska Air Group canceled hundreds of flights again on Tuesday as the daily tally of infections in the United States surged.Three of the 11 major S&P sector indexes declined, the energy index, the consumer services sector .SPLRCL and the financial sector are in the red.Typically, the final five trading days of the year and the first two of the subsequent year are seasonally strong for U.S. stocks, known as the \"Santa Claus Rally.\" However, market participants warned against reading too much into daily moves as the holiday season tends to record some of the lowest volume turnovers that can cause exaggerated price action.The Dow Jones Industrial Average rose 90.42 points, or 0.25%, to 36,488.63, the S&P 500 gained 6.71 points, or 0.14%, to 4,793.06 and the Nasdaq Composite dropped 15.51 points, or 0.1%, to 15,766.22.The S&P 500 dipped on Tuesday in the lowest trading volume session of 2021, snapping a four-day winning streak.As 2021 draws to a close, the main U.S. stock indexes are on pace for their third straight year of stunning annual returns, boosted by historic fiscal and monetary stimulus. The S&P 500 is looking at its strongest three-year performance since 1999.The focus next year will shift to the U.S. Federal Reserve's path of interest rate hikes amid a surge in prices caused by supply chain bottlenecks and a strong economic rebound.Among other stocks, shares of Victoria’s Secret & Co rose more than 12% after the intimate apparel retailer announced a $250 million accelerated share repurchase program. The retailer also said they had strong sales over the holidays.Tesla's CEO Elon Musk exercised all of his options expiring next year, signaling an end to his stock sales. Its shares dropped 0.21% but were still on course to end about 54% for the year.Volume on U.S. exchanges was 7.89 billion shares, compared with the 11.15 billion average for the full session over the last 20 trading days.Advancing issues outnumbered declining ones on the NYSE by a 1.20-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored decliners.The S&P 500 posted 76 new 52-week highs and no new lows; the Nasdaq Composite recorded 77 new highs and 374 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696820193,"gmtCreate":1640665464340,"gmtModify":1640665466317,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696820193","repostId":"2194047961","repostType":4,"repost":{"id":"2194047961","pubTimestamp":1640662800,"share":"https://www.laohu8.com/m/news/2194047961?lang=&edition=full","pubTime":"2021-12-28 11:40","market":"us","language":"en","title":"Think Lucid and Rivian Are Overvalued? Buy These Alternative Energy Growth Stocks Instead","url":"https://stock-news.laohu8.com/highlight/detail?id=2194047961","media":"Motley Fool","summary":"Not all alternative energy values are stretched. Here are three great picks for investors.","content":"<p>The alternative energy industry has been a hot topic over the last two years with electric vehicle stocks taking a lot of the attention. But valuations for companies like <b>Lucid Group</b> (NASDAQ:LCID) and <b>Rivian Automotive</b> (NASDAQ:RIVN) have gotten so high that they will have to perform perfectly to live up to expectations.</p>\n<p>If you're looking for great alternative energy stocks that have more history and growth behind them, three of our Fool.com contributors think <b>First Solar</b> (NASDAQ:FSLR), <b><a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a></b> (NASDAQ:ENPH), and <b>Brookfield Renewable</b> <b>Corporation</b> (NYSE:BEPC)&nbsp;are well positioned heading into 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/507feebce526e6920a5fe442d936cf3b\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Solar energy's rock</h2>\n<p><b>Travis Hoium (First Solar):</b> The global solar industry continues to grow by double digits each year and in 2022 it will reach over 200 gigawatts (GW) and $170 billion of investment, according to IHS <a href=\"https://laohu8.com/S/MRKT\">Markit</a>. That's a massive tailwind for solar manufacturers who can make product profitably, and no <a href=\"https://laohu8.com/S/AONE.U\">one</a> has as long a history of profitable manufacturing as First Solar.</p>\n<p>You can see below that First Solar is solidly profitable and has over $1 billion in cash on the balance sheet. And with demand up and supply tight in the solar market we should see strong economics given First Solar's integrated manufacturing and thin-film technology that isn't reliant on typical industry silicon supply chains.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/37846107aae8b4cd066a1fef25334668\" tg-width=\"720\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>FSLR Revenue (TTM) data by YCharts</span></p>\n<p>What makes this a great growth stock is the company's plans to double production over the next three years. We should see improved economies of scale and better net margins overall as manufacturing expands. Management expects $4 to $4.60 per share in earnings this year, which at the midpoint puts the stock at a price-to-2021-earnings ratio of 20. Given the growth expected over the next three years, this could be a breakout stock in alternative energy.</p>\n<h2>Branching out while still in growth mode</h2>\n<p><b>Howard Smith (Enphase Energy):</b> Residential and commercial solar system technology company Enphase Energy fits into the growth stock category by several measures. The more than $350 million in revenue in its recently reported third quarter was 250% above its sales from just three years ago. And that growth hasn't plateaued yet. The midpoint of its fourth-quarter revenue guidance range would represent an increase of over 50% year over year.</p>\n<p>Enphase also isn't sitting on its laurels. The company looks to be hitting its stride at the same time the solar industry is gaining tailwinds from both public and private investment. Until recently, Enphase's growth has been tied to selling its microinverters and associated system software and communication technology. Microinverters convert the DC power generated by solar panels into the AC power used in homes and businesses. Enphase has recently introduced the IQ8, its eighth-generation system.</p>\n<p>But the company has also moved into battery storage systems, and is expanding those sales globally. Most recently, Enphase announced it is acquiring electric vehicle charging solutions company ClipperCreek. That makes sense as EV buyers, as well as businesses supporting sustainability solutions, want those vehicles to be charged using 100% renewable energy. The company also plans to integrate its new charging technology to provide the capability for \"vehicle-to-home and vehicle-to-grid applications.\"</p>\n<p>Even with the expectation of strong revenue growth in the fourth quarter, it will take some time for Enphase to grow into its valuation. Its current price-to-earnings ratio is above 180. But as long as its pace of growth continues, it will justify its recent price. With the company branching into the EV charging space, it might even do it sooner than some investors think, making Enphase a quality growth name for investors looking at the alternative energy sector.</p>\n<h2>A great blend of value, income, and growth</h2>\n<p><b>Daniel Foelber (Brookfield Renewable Corporation):</b> Share prices of Brookfield Renewable are hovering around a 52-week low despite massive gains in the energy sector and the <b>S&amp;P 500</b>. However, renewable energy investors know that it hasn't exactly been a great year for solar and wind energy stocks. In fact, both the <b>Invesco Solar ETF</b>&nbsp;and the <b>First Trust Global Wind Energy ETF</b>&nbsp;are negative for the year. However, it's worth mentioning that the average stock in the Invesco Solar ETF returned 14 times more than the market in 2020.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5d184ccbf4b67fc00483dd2d500d85e2\" tg-width=\"720\" tg-height=\"533\" width=\"100%\" height=\"auto\"><span>BEPC Total Return Level data by YCharts</span></p>\n<p>In Brookfield's case, the company has suffered a few analyst downgrades and faces skepticism over whether or not it can grow its earnings and dividend at the rate it previously guided for. Brookfield increased its dividend by just 5% in 2021 and is due for an increase next quarter. That's at the low end of management's target range of 5% to 9% a year. Yet because Brookfield's stock price has fallen, it now yields an impressive 3.5%. What's more, Brookfield reiterated its goal to drive shareholder value with a total annual return of 12% to 15% for investors over the long term. Brookfield is able to make this impressive commitment due to its top-tier portfolio of renewable energy assets, which consists of a global development backlog of 36 gigawatts (GW) and an existing capacity of 20 GW. All told, Brookfield's business is doing well and is set up nicely for growth and income.</p>\n<p>For investors who don't want to bother with hyper-growth stocks like Lucid and Rivian, Brookfield Renewable could just be the ideal antidote for an electric vehicle euphoria migraine.</p>\n<h2>Opportunities abound</h2>\n<p>Not all alternative energy stocks have wild valuations today. First Solar, Enphase Energy, and Brookfield Renewable have strong growth and decent value, which is a great combination in today's market.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Think Lucid and Rivian Are Overvalued? Buy These Alternative Energy Growth Stocks Instead</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThink Lucid and Rivian Are Overvalued? Buy These Alternative Energy Growth Stocks Instead\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/tired-of-lucid-and-rivian-ev-euphoria-try-these-3/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The alternative energy industry has been a hot topic over the last two years with electric vehicle stocks taking a lot of the attention. But valuations for companies like Lucid Group (NASDAQ:LCID) and...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/tired-of-lucid-and-rivian-ev-euphoria-try-these-3/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","RIVN":"Rivian Automotive, Inc.","FSLR":"第一太阳能","ENPH":"Enphase Energy","BEPC":"Brookfield Renewable Corp."},"source_url":"https://www.fool.com/investing/2021/12/27/tired-of-lucid-and-rivian-ev-euphoria-try-these-3/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194047961","content_text":"The alternative energy industry has been a hot topic over the last two years with electric vehicle stocks taking a lot of the attention. But valuations for companies like Lucid Group (NASDAQ:LCID) and Rivian Automotive (NASDAQ:RIVN) have gotten so high that they will have to perform perfectly to live up to expectations.\nIf you're looking for great alternative energy stocks that have more history and growth behind them, three of our Fool.com contributors think First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), and Brookfield Renewable Corporation (NYSE:BEPC) are well positioned heading into 2022.\nImage source: Getty Images.\nSolar energy's rock\nTravis Hoium (First Solar): The global solar industry continues to grow by double digits each year and in 2022 it will reach over 200 gigawatts (GW) and $170 billion of investment, according to IHS Markit. That's a massive tailwind for solar manufacturers who can make product profitably, and no one has as long a history of profitable manufacturing as First Solar.\nYou can see below that First Solar is solidly profitable and has over $1 billion in cash on the balance sheet. And with demand up and supply tight in the solar market we should see strong economics given First Solar's integrated manufacturing and thin-film technology that isn't reliant on typical industry silicon supply chains.\nFSLR Revenue (TTM) data by YCharts\nWhat makes this a great growth stock is the company's plans to double production over the next three years. We should see improved economies of scale and better net margins overall as manufacturing expands. Management expects $4 to $4.60 per share in earnings this year, which at the midpoint puts the stock at a price-to-2021-earnings ratio of 20. Given the growth expected over the next three years, this could be a breakout stock in alternative energy.\nBranching out while still in growth mode\nHoward Smith (Enphase Energy): Residential and commercial solar system technology company Enphase Energy fits into the growth stock category by several measures. The more than $350 million in revenue in its recently reported third quarter was 250% above its sales from just three years ago. And that growth hasn't plateaued yet. The midpoint of its fourth-quarter revenue guidance range would represent an increase of over 50% year over year.\nEnphase also isn't sitting on its laurels. The company looks to be hitting its stride at the same time the solar industry is gaining tailwinds from both public and private investment. Until recently, Enphase's growth has been tied to selling its microinverters and associated system software and communication technology. Microinverters convert the DC power generated by solar panels into the AC power used in homes and businesses. Enphase has recently introduced the IQ8, its eighth-generation system.\nBut the company has also moved into battery storage systems, and is expanding those sales globally. Most recently, Enphase announced it is acquiring electric vehicle charging solutions company ClipperCreek. That makes sense as EV buyers, as well as businesses supporting sustainability solutions, want those vehicles to be charged using 100% renewable energy. The company also plans to integrate its new charging technology to provide the capability for \"vehicle-to-home and vehicle-to-grid applications.\"\nEven with the expectation of strong revenue growth in the fourth quarter, it will take some time for Enphase to grow into its valuation. Its current price-to-earnings ratio is above 180. But as long as its pace of growth continues, it will justify its recent price. With the company branching into the EV charging space, it might even do it sooner than some investors think, making Enphase a quality growth name for investors looking at the alternative energy sector.\nA great blend of value, income, and growth\nDaniel Foelber (Brookfield Renewable Corporation): Share prices of Brookfield Renewable are hovering around a 52-week low despite massive gains in the energy sector and the S&P 500. However, renewable energy investors know that it hasn't exactly been a great year for solar and wind energy stocks. In fact, both the Invesco Solar ETF and the First Trust Global Wind Energy ETF are negative for the year. However, it's worth mentioning that the average stock in the Invesco Solar ETF returned 14 times more than the market in 2020.\nBEPC Total Return Level data by YCharts\nIn Brookfield's case, the company has suffered a few analyst downgrades and faces skepticism over whether or not it can grow its earnings and dividend at the rate it previously guided for. Brookfield increased its dividend by just 5% in 2021 and is due for an increase next quarter. That's at the low end of management's target range of 5% to 9% a year. Yet because Brookfield's stock price has fallen, it now yields an impressive 3.5%. What's more, Brookfield reiterated its goal to drive shareholder value with a total annual return of 12% to 15% for investors over the long term. Brookfield is able to make this impressive commitment due to its top-tier portfolio of renewable energy assets, which consists of a global development backlog of 36 gigawatts (GW) and an existing capacity of 20 GW. All told, Brookfield's business is doing well and is set up nicely for growth and income.\nFor investors who don't want to bother with hyper-growth stocks like Lucid and Rivian, Brookfield Renewable could just be the ideal antidote for an electric vehicle euphoria migraine.\nOpportunities abound\nNot all alternative energy stocks have wild valuations today. First Solar, Enphase Energy, and Brookfield Renewable have strong growth and decent value, which is a great combination in today's market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":708,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696976213,"gmtCreate":1640612015110,"gmtModify":1640612015319,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696976213","repostId":"1122290660","repostType":4,"repost":{"id":"1122290660","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640608857,"share":"https://www.laohu8.com/m/news/1122290660?lang=&edition=full","pubTime":"2021-12-27 20:40","market":"us","language":"en","title":"Grab stock climbed more than 3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1122290660","media":"Tiger Newspress","summary":"Grab stock climbed more than 3% in premarket trading as Wall Street saw massive upside for Asian tec","content":"<p>Grab stock climbed more than 3% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p><img src=\"https://static.tigerbbs.com/722d12abbd9fc66fd8ccd5576d98e63c\" tg-width=\"841\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock climbed more than 3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock climbed more than 3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 20:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab stock climbed more than 3% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p><img src=\"https://static.tigerbbs.com/722d12abbd9fc66fd8ccd5576d98e63c\" tg-width=\"841\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122290660","content_text":"Grab stock climbed more than 3% in premarket trading as Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.\n\nGrab debuted on the Nasdaq following a deal with blank-check company Altimeter Growth Corp., which valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.\nBut shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.\nStill, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.\n“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”\nHere are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:\nJPMorgan\nJPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.\nBased on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.\nThe analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”\nGMV is a metric often used in e-commerce to measure the total dollar value of goods sold over a certain period of time.\nThe investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.\nWhile the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.\nThe analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.\nCiti\nCiti initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.\nCompared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.\nThe analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.\nCiti said, however, spending per transaction and per user is lower for Grab than other regional players like Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.\n“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.\nEvercore\nEvercore initiated coverage with an outperform rating and a price target of $10.\nThe firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.\n“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.\n“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.\nIn the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.\nStill, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698422321,"gmtCreate":1640502303877,"gmtModify":1640502591533,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698422321","repostId":"1144001147","repostType":4,"repost":{"id":"1144001147","pubTimestamp":1640485026,"share":"https://www.laohu8.com/m/news/1144001147?lang=&edition=full","pubTime":"2021-12-26 10:17","market":"us","language":"en","title":"A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State","url":"https://stock-news.laohu8.com/highlight/detail?id=1144001147","media":"InvestorPlace","summary":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, t","content":"<p>In the last year,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.</p>\n<p>However, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with&nbsp;<b>Bharat Biotech</b>. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.</p>\n<p>Beyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.</p>\n<p>Ocugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.</p>\n<p>Let’s talk about the reasons to be bearish.</p>\n<p>FDA Approval Remains Elusive</p>\n<p><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>) and&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.</p>\n<p>Back in June, the biotech company’s&nbsp;application for emergency use authorization&nbsp;was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.</p>\n<p>In November, Ocugen announced that the FDA has “issued a clinical hold&nbsp;on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.</p>\n<p>The key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.</p>\n<p>In July, Ocugen had also initiated a&nbsp;rolling submission to Health Canada&nbsp;for the vaccine. There is no positive news on that front either.</p>\n<p>Let’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.</p>\n<p>Can Omicron Provide a Lifeline for OCGN Stock?</p>\n<p>The omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are&nbsp;currently studying the effectiveness&nbsp;of the vaccine against the variant.</p>\n<p>If the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.</p>\n<p>First and foremost, Moderna has announced that its Covid-19 booster&nbsp;increases neutralizing antibodies 37-fold&nbsp;against Omicron variant.</p>\n<p>Furthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold&nbsp;compared to two doses against the Omicron variant.”</p>\n<p>Clearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.</p>\n<p>People who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.</p>\n<p>It’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.</p>\n<p>OCGN Stock Will Trend Lower</p>\n<p>OCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.</p>\n<p>The company is&nbsp;building a pipeline of drugs&nbsp;for various indications. However, the pipeline for various indications is still at a pre-clinical stage.</p>\n<p>The stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.</p>\n<p>It also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Year After Announcing a Big Partnership, Ocugen Is in a Sorry State\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there...</p>\n\n<a href=\"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144001147","content_text":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.\nHowever, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with Bharat Biotech. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.\nBeyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.\nOcugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.\nLet’s talk about the reasons to be bearish.\nFDA Approval Remains Elusive\nPfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.\nBack in June, the biotech company’s application for emergency use authorization was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.\nIn November, Ocugen announced that the FDA has “issued a clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.\nThe key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.\nIn July, Ocugen had also initiated a rolling submission to Health Canada for the vaccine. There is no positive news on that front either.\nLet’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.\nCan Omicron Provide a Lifeline for OCGN Stock?\nThe omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are currently studying the effectiveness of the vaccine against the variant.\nIf the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.\nFirst and foremost, Moderna has announced that its Covid-19 booster increases neutralizing antibodies 37-fold against Omicron variant.\nFurthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold compared to two doses against the Omicron variant.”\nClearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.\nPeople who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.\nIt’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.\nOCGN Stock Will Trend Lower\nOCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.\nThe company is building a pipeline of drugs for various indications. However, the pipeline for various indications is still at a pre-clinical stage.\nThe stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.\nIt also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698594888,"gmtCreate":1640439041190,"gmtModify":1640439041417,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698594888","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝","JNJ":"强生","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698846888,"gmtCreate":1640351644280,"gmtModify":1640351644473,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698846888","repostId":"1175608113","repostType":4,"repost":{"id":"1175608113","pubTimestamp":1640342686,"share":"https://www.laohu8.com/m/news/1175608113?lang=&edition=full","pubTime":"2021-12-24 18:44","market":"us","language":"en","title":"Is Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates","url":"https://stock-news.laohu8.com/highlight/detail?id=1175608113","media":"Investors","summary":"Amazon(AMZN) plans to build its first large-format retail stores, making a new foray into physical o","content":"<p><b>Amazon</b>(AMZN) plans to build its first large-format retail stores, making a new foray into physical outlets and stepping up its battle against&nbsp;<b>Walmart</b>(WMT). Is Amazon stock a buy?</p>\n<p>Amazon's 30,000-square-foot stores, which will&nbsp;debut in California and Ohio, are less than one-third the size of Walmart's conventional outlets. They're about one-sixth the size of Walmart Supercenter stores.</p>\n<p>Walmart, the behemoth of brick-and-mortar discount stores, is dueling Amazon, the giant of online shopping, in a battle over the future of retail, e-commerce and grocery shopping.</p>\n<p>Much work remains for either company to win theAmazon vs. Walmart battle. Walmart needs to expand online operations while also managing 11,500 stores across 28 countries, of which 4,743 are in the U.S. It's in the process of redesigning 1,000 stores by the end of 2021. Its goal is to create a more streamlined and faster shopping experience for customers.</p>\n<p>At the same time, Amazon must continue its aggressive rollout of warehouse distribution centers and figure out its strategy for building physical stores.</p>\n<p>Amazon Is Making Critical Investments</p>\n<p>\"The key question from here is when/if does the current investment cycle drive evidence of share gains and margin leverage,\" RBC Capital Markets analyst Brad Erickson said in a note. \"Only time will tell, but in our view AMZN stock is making critical investments as consumers increasingly demand faster shipping which should at least maintain share gains while, importantly, growing gross profit dollars.\"</p>\n<p>Amazon reported&nbsp;third-quarter results&nbsp;on Oct. 28. Adjusted earnings fell 51% from the year-ago period to $6.12 a share. Analysts expected $8.92 a share. Revenue climbed 15% to $110.8 billion, below expectations of $111.6 billion.</p>\n<p>For its fourth quarter, Amazon forecast revenue in the range of $130 billion to $140 billion. That missed analyst estimates for $142 billion. Amazon forecast earnings before interest and taxes, called EBIT, of $1.5 billion, versus estimates of $8.1 billion.</p>\n<p>The company's cloud-computing unit, Amazon Web Services, reported revenue growth of 39% to $11.6 billion. That topped estimates for 35% cloud-computing growth.</p>\n<p>Cowen analyst John Blackledge recently raised his price target on Amazon stock to 4,500, from 4,300. He listed Amazon as one of the \"best ideas\" for 2022, in the mega-cap category.</p>\n<p><b>Amazon Introduces Numerous New Gadgets</b></p>\n<p>On Sept. 28, Amazon introduced aplethora of consumer electronics gadgets, including smart displays and a home robot, at a fall product launch event.</p>\n<p>The Seattle-based e-commerce giant unveiled several devices that leverage its Alexa voice assistant technology. They include theEcho Show 15smart display, which is designed to keep families organized, connected and entertained.</p>\n<p>Another Alexa-enabled device is Amazon's first robot, which is named&nbsp;Astro. The robot will act as a security guard, companion and mobile smart display. It brings together new advancements in artificial intelligence, computer vision, sensor technology, and voice and edge computing, the company said.</p>\n<p>Earlier this month, Amazon moved deeper into the television market with an&nbsp;all-new lineup of devices&nbsp;and its first Amazon-branded 4K smart TVs. The Amazon TV products go on sale in October. Amazon also introduced a 4K version of its Fire TV stick.</p>\n<p><b>Plenty Of Growth Opportunities</b></p>\n<p>Amazon entered 2021 with plenty of big growth opportunities. This included plans to expand its virtual health care program across the U.S. It is also expanding its prescription drug business.</p>\n<p>On March 17, Amazon announced that its telehealth pilot program, called Amazon Care, would expand to all of its U.S. employees and their families as well as other firms this summer. The program first launched at its Seattle headquarters 18 months ago.</p>\n<p>If Amazon can deliver more efficient health care services, the potential is enormous for fueling its growth engine — and by extension Amazon stock. Health care now comprises nearly a fifth of the U.S. economy.</p>\n<p>Amazon said the program enables workers to connect with medical professionals via chat or video conference, and connect patients with medical professionals. In addition, Amazon Care can dispatch a medical professional to a patient's home for additional care.</p>\n<p>Analysts at Jefferies give Amazon a buy rating and price target or 4,000.</p>\n<p>\"We believe low expectations following two consecutive guide-downs better positions AMZN for upside in the core retail business,\" according to a Jefferies report.</p>\n<p>\"We also see attractive growth at AWS and advertising, AMZN's two highest margin businesses, serving to more than offset near-term cost headwinds from labor shortages and supply chain disruption,\" it said.</p>\n<p><b>Tapping The Market For Prescription Drugs</b></p>\n<p>In addition, Amazon is tapping into the $350 billion market for prescription drugs. The company fired a big shot across the bow of drugstores and prescription drug wholesalers late last year when it&nbsp;launched Amazon Pharmacy. The new unit will offer Amazon Prime members discounts of up to 80% on generic drugs and 40% on brand medications.</p>\n<p>On May 26, Amazon announced it is acquiring&nbsp;iconic film studio Metro-Goldwyn-Mayer&nbsp;for $8.45 billion, looking broadly expand its position in streaming video and increase the value of its Prime rewards program. The acquisition is Amazon's largest since buying Whole Foods for $13.7 billion in 2017.</p>\n<p>To get Amazon Prime, users pay an annual or monthly fee for the service and receive multiple perks. This includes free access to Amazon Video and Amazon Music. Amazon has invested billions of dollars in its film and TV operations as well as live sports.</p>\n<p>Another growth vehicle for Amazon in 2021 is advertising.&nbsp;When looking for a product, about half of U.S. adults start their search with Amazon. More searches draw more advertisers.&nbsp;And as Covid-19 has caused more consumers to shop online that will keep Amazon's ad growth humming.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 18:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/amazon-stock-buy-now/?src=A00220><strong>Investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon(AMZN) plans to build its first large-format retail stores, making a new foray into physical outlets and stepping up its battle against Walmart(WMT). Is Amazon stock a buy?\nAmazon's 30,000-...</p>\n\n<a href=\"https://www.investors.com/news/technology/amazon-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛","AMZN":"亚马逊"},"source_url":"https://www.investors.com/news/technology/amazon-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175608113","content_text":"Amazon(AMZN) plans to build its first large-format retail stores, making a new foray into physical outlets and stepping up its battle against Walmart(WMT). Is Amazon stock a buy?\nAmazon's 30,000-square-foot stores, which will debut in California and Ohio, are less than one-third the size of Walmart's conventional outlets. They're about one-sixth the size of Walmart Supercenter stores.\nWalmart, the behemoth of brick-and-mortar discount stores, is dueling Amazon, the giant of online shopping, in a battle over the future of retail, e-commerce and grocery shopping.\nMuch work remains for either company to win theAmazon vs. Walmart battle. Walmart needs to expand online operations while also managing 11,500 stores across 28 countries, of which 4,743 are in the U.S. It's in the process of redesigning 1,000 stores by the end of 2021. Its goal is to create a more streamlined and faster shopping experience for customers.\nAt the same time, Amazon must continue its aggressive rollout of warehouse distribution centers and figure out its strategy for building physical stores.\nAmazon Is Making Critical Investments\n\"The key question from here is when/if does the current investment cycle drive evidence of share gains and margin leverage,\" RBC Capital Markets analyst Brad Erickson said in a note. \"Only time will tell, but in our view AMZN stock is making critical investments as consumers increasingly demand faster shipping which should at least maintain share gains while, importantly, growing gross profit dollars.\"\nAmazon reported third-quarter results on Oct. 28. Adjusted earnings fell 51% from the year-ago period to $6.12 a share. Analysts expected $8.92 a share. Revenue climbed 15% to $110.8 billion, below expectations of $111.6 billion.\nFor its fourth quarter, Amazon forecast revenue in the range of $130 billion to $140 billion. That missed analyst estimates for $142 billion. Amazon forecast earnings before interest and taxes, called EBIT, of $1.5 billion, versus estimates of $8.1 billion.\nThe company's cloud-computing unit, Amazon Web Services, reported revenue growth of 39% to $11.6 billion. That topped estimates for 35% cloud-computing growth.\nCowen analyst John Blackledge recently raised his price target on Amazon stock to 4,500, from 4,300. He listed Amazon as one of the \"best ideas\" for 2022, in the mega-cap category.\nAmazon Introduces Numerous New Gadgets\nOn Sept. 28, Amazon introduced aplethora of consumer electronics gadgets, including smart displays and a home robot, at a fall product launch event.\nThe Seattle-based e-commerce giant unveiled several devices that leverage its Alexa voice assistant technology. They include theEcho Show 15smart display, which is designed to keep families organized, connected and entertained.\nAnother Alexa-enabled device is Amazon's first robot, which is named Astro. The robot will act as a security guard, companion and mobile smart display. It brings together new advancements in artificial intelligence, computer vision, sensor technology, and voice and edge computing, the company said.\nEarlier this month, Amazon moved deeper into the television market with an all-new lineup of devices and its first Amazon-branded 4K smart TVs. The Amazon TV products go on sale in October. Amazon also introduced a 4K version of its Fire TV stick.\nPlenty Of Growth Opportunities\nAmazon entered 2021 with plenty of big growth opportunities. This included plans to expand its virtual health care program across the U.S. It is also expanding its prescription drug business.\nOn March 17, Amazon announced that its telehealth pilot program, called Amazon Care, would expand to all of its U.S. employees and their families as well as other firms this summer. The program first launched at its Seattle headquarters 18 months ago.\nIf Amazon can deliver more efficient health care services, the potential is enormous for fueling its growth engine — and by extension Amazon stock. Health care now comprises nearly a fifth of the U.S. economy.\nAmazon said the program enables workers to connect with medical professionals via chat or video conference, and connect patients with medical professionals. In addition, Amazon Care can dispatch a medical professional to a patient's home for additional care.\nAnalysts at Jefferies give Amazon a buy rating and price target or 4,000.\n\"We believe low expectations following two consecutive guide-downs better positions AMZN for upside in the core retail business,\" according to a Jefferies report.\n\"We also see attractive growth at AWS and advertising, AMZN's two highest margin businesses, serving to more than offset near-term cost headwinds from labor shortages and supply chain disruption,\" it said.\nTapping The Market For Prescription Drugs\nIn addition, Amazon is tapping into the $350 billion market for prescription drugs. The company fired a big shot across the bow of drugstores and prescription drug wholesalers late last year when it launched Amazon Pharmacy. The new unit will offer Amazon Prime members discounts of up to 80% on generic drugs and 40% on brand medications.\nOn May 26, Amazon announced it is acquiring iconic film studio Metro-Goldwyn-Mayer for $8.45 billion, looking broadly expand its position in streaming video and increase the value of its Prime rewards program. The acquisition is Amazon's largest since buying Whole Foods for $13.7 billion in 2017.\nTo get Amazon Prime, users pay an annual or monthly fee for the service and receive multiple perks. This includes free access to Amazon Video and Amazon Music. Amazon has invested billions of dollars in its film and TV operations as well as live sports.\nAnother growth vehicle for Amazon in 2021 is advertising. When looking for a product, about half of U.S. adults start their search with Amazon. More searches draw more advertisers. And as Covid-19 has caused more consumers to shop online that will keep Amazon's ad growth humming.","news_type":1},"isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698085066,"gmtCreate":1640262833238,"gmtModify":1640262833452,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698085066","repostId":"1187215359","repostType":4,"repost":{"id":"1187215359","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640260771,"share":"https://www.laohu8.com/m/news/1187215359?lang=&edition=full","pubTime":"2021-12-23 19:59","market":"us","language":"en","title":" Cathie Wood Loads Up Another $800K In This Chinese Tesla Rival Ahead Of Its Overseas Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1187215359","media":"Benzinga","summary":"Cathie Wood’s Ark Investment Management on Friday loaded up another 18,000 shares — worth about $823","content":"<p><b>Cathie Wood</b>’s&nbsp;<b>Ark Investment Management</b>&nbsp;on Friday loaded up&nbsp;another 18,000 shares — worth about $823,320 — in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV).</p>\n<p>Xpeng’s stock closed 4.5% higher at $44.47 a share on Wednesday. The stock is up about 3.7% fp or the year.</p>\n<p>The Guangzhou, China-based company bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) last month with deliveries.</p>\n<p>Each of the three players delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman<b>Brian Gu</b>said last month the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>The Shanghai-based Nio has similar plans and said last week it plans to foray into Germany, the Netherlands, Sweden and Denmark in 2022 and aims to have a presence&nbsp;in 25 countries by 2025.</p>\n<p>Ark Invest first bought shares in Xpeng on Dec. 3 and has since piled up shares in the electric vehicle company’s stock on six days, all&nbsp;via the&nbsp;<b>Ark</b>&nbsp;<b>Autonomous Technology &amp; Robotics ETF</b>(BATS:ARKQ).</p>\n<p>ARKQ held 637,042 shares — worth $27.88 million in Xpeng, prior to Thursday’s trade.</p>\n<p>Besides Xpeng, the Elon Musk-led Tesla is the only all-electric vehicle maker in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Ark also sold 2,273 shares — estimated to be worth $6.68 million — in&nbsp;<b>Alphabet Inc Class C</b>(NASDAQ:GOOG). The stock closed 1.89% higher at $2,938.9 a share on Wednesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> Cathie Wood Loads Up Another $800K In This Chinese Tesla Rival Ahead Of Its Overseas Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n Cathie Wood Loads Up Another $800K In This Chinese Tesla Rival Ahead Of Its Overseas Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-23 19:59</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s&nbsp;<b>Ark Investment Management</b>&nbsp;on Friday loaded up&nbsp;another 18,000 shares — worth about $823,320 — in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV).</p>\n<p>Xpeng’s stock closed 4.5% higher at $44.47 a share on Wednesday. The stock is up about 3.7% fp or the year.</p>\n<p>The Guangzhou, China-based company bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) last month with deliveries.</p>\n<p>Each of the three players delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman<b>Brian Gu</b>said last month the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>The Shanghai-based Nio has similar plans and said last week it plans to foray into Germany, the Netherlands, Sweden and Denmark in 2022 and aims to have a presence&nbsp;in 25 countries by 2025.</p>\n<p>Ark Invest first bought shares in Xpeng on Dec. 3 and has since piled up shares in the electric vehicle company’s stock on six days, all&nbsp;via the&nbsp;<b>Ark</b>&nbsp;<b>Autonomous Technology &amp; Robotics ETF</b>(BATS:ARKQ).</p>\n<p>ARKQ held 637,042 shares — worth $27.88 million in Xpeng, prior to Thursday’s trade.</p>\n<p>Besides Xpeng, the Elon Musk-led Tesla is the only all-electric vehicle maker in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Ark also sold 2,273 shares — estimated to be worth $6.68 million — in&nbsp;<b>Alphabet Inc Class C</b>(NASDAQ:GOOG). The stock closed 1.89% higher at $2,938.9 a share on Wednesday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","09868":"小鹏汽车-W"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187215359","content_text":"Cathie Wood’s Ark Investment Management on Friday loaded up another 18,000 shares — worth about $823,320 — in the U.S. listed Chinese electric vehicle maker Xpeng Inc(NYSE:XPEV).\nXpeng’s stock closed 4.5% higher at $44.47 a share on Wednesday. The stock is up about 3.7% fp or the year.\nThe Guangzhou, China-based company bolted ahead of local rivals Nio and Li Auto Inc(NASDAQ:LI) last month with deliveries.\nEach of the three players delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.\nXpeng ChairmanBrian Gusaid last month the company aims to sell half of its electric vehicles outside of China.\nThe maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.\nThe Shanghai-based Nio has similar plans and said last week it plans to foray into Germany, the Netherlands, Sweden and Denmark in 2022 and aims to have a presence in 25 countries by 2025.\nArk Invest first bought shares in Xpeng on Dec. 3 and has since piled up shares in the electric vehicle company’s stock on six days, all via the Ark Autonomous Technology & Robotics ETF(BATS:ARKQ).\nARKQ held 637,042 shares — worth $27.88 million in Xpeng, prior to Thursday’s trade.\nBesides Xpeng, the Elon Musk-led Tesla is the only all-electric vehicle maker in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.\nThe investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.\nArk also sold 2,273 shares — estimated to be worth $6.68 million — in Alphabet Inc Class C(NASDAQ:GOOG). The stock closed 1.89% higher at $2,938.9 a share on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691366083,"gmtCreate":1640138249892,"gmtModify":1640138658023,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691366083","repostId":"1169166013","repostType":4,"repost":{"id":"1169166013","pubTimestamp":1640136588,"share":"https://www.laohu8.com/m/news/1169166013?lang=&edition=full","pubTime":"2021-12-22 09:29","market":"us","language":"en","title":"Biden Says He’s Considering Lifting U.S. Omicron Travel Ban","url":"https://stock-news.laohu8.com/highlight/detail?id=1169166013","media":"Bloomberg","summary":"Travel restrictions had been imposed starting Nov. 29\nOmicron, first identified in Africa, now domin","content":"<ul>\n <li>Travel restrictions had been imposed starting Nov. 29</li>\n <li>Omicron, first identified in Africa, now dominates U.S. cases</li>\n</ul>\n<p>President Joe Biden said he’s considering lifting travel restrictions on people arriving from southern African countries where the omicron variant of coronavirus was first identified, after it became the dominant strain in the U.S.</p>\n<p>“I’m considering reversing, I’m going to talk with my team in the next couple days,” Biden told reporters at the White House on Tuesday. He said his health advisers had suggested he reconsider the ban.</p>\n<p>The Centers for Disease Control and Prevention said on Monday that omicron now accounts for more than 70% of new U.S. cases of Covid-19.</p>\n<p>The U.S. government&nbsp;imposed restrictions&nbsp;on people traveling from South Africa and seven other nearby nations on Nov. 29 after the discovery of the new variant. The CDC the next day&nbsp;notified&nbsp;airlines they must provide the names of passengers who had traveled in southern Africa in recent days so that local health agencies could conduct contact tracing.</p>\n<p>However successful the travel restrictions may have been in stopping people infected with the omicron variant from entering the U.S., it hasn’t prevented the Covid-19 mutation from rapidly becoming the dominant strain.</p>\n<p>Asked about Biden’s comments, Airlines for America, a trade group that represents large carriers, said in an emailed statement that “as the administration has said, the recent omicron-related country-based restrictions were intended to be temporary, not long-term, and will be updated as more data becomes available.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden Says He’s Considering Lifting U.S. Omicron Travel Ban</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden Says He’s Considering Lifting U.S. Omicron Travel Ban\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 09:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-21/biden-says-he-s-considering-lifting-u-s-omicron-travel-ban><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Travel restrictions had been imposed starting Nov. 29\nOmicron, first identified in Africa, now dominates U.S. cases\n\nPresident Joe Biden said he’s considering lifting travel restrictions on people ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-21/biden-says-he-s-considering-lifting-u-s-omicron-travel-ban\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-21/biden-says-he-s-considering-lifting-u-s-omicron-travel-ban","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169166013","content_text":"Travel restrictions had been imposed starting Nov. 29\nOmicron, first identified in Africa, now dominates U.S. cases\n\nPresident Joe Biden said he’s considering lifting travel restrictions on people arriving from southern African countries where the omicron variant of coronavirus was first identified, after it became the dominant strain in the U.S.\n“I’m considering reversing, I’m going to talk with my team in the next couple days,” Biden told reporters at the White House on Tuesday. He said his health advisers had suggested he reconsider the ban.\nThe Centers for Disease Control and Prevention said on Monday that omicron now accounts for more than 70% of new U.S. cases of Covid-19.\nThe U.S. government imposed restrictions on people traveling from South Africa and seven other nearby nations on Nov. 29 after the discovery of the new variant. The CDC the next day notified airlines they must provide the names of passengers who had traveled in southern Africa in recent days so that local health agencies could conduct contact tracing.\nHowever successful the travel restrictions may have been in stopping people infected with the omicron variant from entering the U.S., it hasn’t prevented the Covid-19 mutation from rapidly becoming the dominant strain.\nAsked about Biden’s comments, Airlines for America, a trade group that represents large carriers, said in an emailed statement that “as the administration has said, the recent omicron-related country-based restrictions were intended to be temporary, not long-term, and will be updated as more data becomes available.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":776,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693529461,"gmtCreate":1640051425615,"gmtModify":1640051425807,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693529461","repostId":"2193761136","repostType":4,"repost":{"id":"2193761136","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640041206,"share":"https://www.laohu8.com/m/news/2193761136?lang=&edition=full","pubTime":"2021-12-21 07:00","market":"us","language":"en","title":"Wall Street skids on Omicron worry, obstacle to Biden social-spending package","url":"https://stock-news.laohu8.com/highlight/detail?id=2193761136","media":"Reuters","summary":"* Financials, materials lead declines among sectors\n* S&P 500 falls below 50-day moving average\n* Or","content":"<p>* Financials, materials lead declines among sectors</p>\n<p>* S&amp;P 500 falls below 50-day moving average</p>\n<p>* Oracle drops after deal to buy Cerner for $28 bln</p>\n<p>* Indexes down: Dow 1.23%, S&amp;P 1.14%, Nasdaq 1.24%</p>\n<p>Dec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.</p>\n<p>The financials&nbsp;and materials&nbsp;sectors fell most among S&amp;P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.</p>\n<p>Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.</p>\n<p>\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 433.28 points, or 1.23%, to 34,932.16, the S&amp;P 500&nbsp;lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite&nbsp;dropped 188.74 points, or 1.24%, to 14,980.94.</p>\n<p>Financials fell 1.9% and materials dropped 1.8%. Microsoft&nbsp;and Tesla&nbsp;were the biggest individual weights on the S&amp;P 500, falling 1.2% and 3.5% respectively.</p>\n<p>The indexes finished above their session lows, but the benchmark S&amp;P 500 ended below its 50-day moving average, a key technical level.</p>\n<p>In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.</p>\n<p>After Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.</p>\n<p>The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>Investors have taken a more defensive stance this month, with sectors such as consumer staples&nbsp;and utilities&nbsp;rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.</p>\n<p>The S&amp;P 500 remains up 21.6% so far in 2021.</p>\n<p>“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.</p>\n<p>In company news, Oracle Corp&nbsp;shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp&nbsp;for $28.3 billion.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.</p>\n<p>About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street skids on Omicron worry, obstacle to Biden social-spending package</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street skids on Omicron worry, obstacle to Biden social-spending package\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 07:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Financials, materials lead declines among sectors</p>\n<p>* S&amp;P 500 falls below 50-day moving average</p>\n<p>* Oracle drops after deal to buy Cerner for $28 bln</p>\n<p>* Indexes down: Dow 1.23%, S&amp;P 1.14%, Nasdaq 1.24%</p>\n<p>Dec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.</p>\n<p>The financials&nbsp;and materials&nbsp;sectors fell most among S&amp;P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.</p>\n<p>Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.</p>\n<p>\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 433.28 points, or 1.23%, to 34,932.16, the S&amp;P 500&nbsp;lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite&nbsp;dropped 188.74 points, or 1.24%, to 14,980.94.</p>\n<p>Financials fell 1.9% and materials dropped 1.8%. Microsoft&nbsp;and Tesla&nbsp;were the biggest individual weights on the S&amp;P 500, falling 1.2% and 3.5% respectively.</p>\n<p>The indexes finished above their session lows, but the benchmark S&amp;P 500 ended below its 50-day moving average, a key technical level.</p>\n<p>In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.</p>\n<p>After Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.</p>\n<p>The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>Investors have taken a more defensive stance this month, with sectors such as consumer staples&nbsp;and utilities&nbsp;rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.</p>\n<p>The S&amp;P 500 remains up 21.6% so far in 2021.</p>\n<p>“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.</p>\n<p>In company news, Oracle Corp&nbsp;shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp&nbsp;for $28.3 billion.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.</p>\n<p>About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","DJX":"1/100道琼斯","BK4559":"巴菲特持仓","SPXU":"三倍做空标普500ETF","BK4550":"红杉资本持仓","DDM":"道指两倍做多ETF","QID":"纳指两倍做空ETF","UDOW":"道指三倍做多ETF-ProShares","UPRO":"三倍做多标普500ETF","DOG":"道指反向ETF","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","DXD":"道指两倍做空ETF","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","OEX":"标普100","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SDOW":"道指三倍做空ETF-ProShares","SQQQ":"纳指三倍做空ETF","SH":"标普500反向ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193761136","content_text":"* Financials, materials lead declines among sectors\n* S&P 500 falls below 50-day moving average\n* Oracle drops after deal to buy Cerner for $28 bln\n* Indexes down: Dow 1.23%, S&P 1.14%, Nasdaq 1.24%\nDec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.\nThe financials and materials sectors fell most among S&P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.\nCoronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.\n\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.\nThe Dow Jones Industrial Average fell 433.28 points, or 1.23%, to 34,932.16, the S&P 500 lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite dropped 188.74 points, or 1.24%, to 14,980.94.\nFinancials fell 1.9% and materials dropped 1.8%. Microsoft and Tesla were the biggest individual weights on the S&P 500, falling 1.2% and 3.5% respectively.\nThe indexes finished above their session lows, but the benchmark S&P 500 ended below its 50-day moving average, a key technical level.\nIn a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.\nAfter Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.\nThe developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.\nInvestors have taken a more defensive stance this month, with sectors such as consumer staples and utilities rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.\nThe S&P 500 remains up 21.6% so far in 2021.\n“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.\nIn company news, Oracle Corp shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp for $28.3 billion.\nDeclining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.\nThe S&P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.\nAbout 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693529613,"gmtCreate":1640051403730,"gmtModify":1640051403918,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693529613","repostId":"2193341971","repostType":4,"repost":{"id":"2193341971","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640049828,"share":"https://www.laohu8.com/m/news/2193341971?lang=&edition=full","pubTime":"2021-12-21 09:23","market":"us","language":"en","title":"Oil prices edge higher but investor worries on Omicron spread remain","url":"https://stock-news.laohu8.com/highlight/detail?id=2193341971","media":"Reuters","summary":"* UK says COVID surge 'extremely difficult'; Omicron grips Europe\n* OPEC+ produces below target in N","content":"<p>* UK says COVID surge 'extremely difficult'; Omicron grips Europe</p>\n<p>* OPEC+ produces below target in November as compliance rises</p>\n<p>* U.S. crude inventories expected to fall 4th straight week - poll</p>\n<p>* Coming up: API inventory data due at 2130 GMT</p>\n<p>SINGAPORE, Dec 21 (Reuters) - Oil prices edged higher on Tuesday, though investors remained worried about the rapid spread of the Omicron coronavirus variant globally, prompting countries to consider more restrictions potentially denting fuel demand.</p>\n<p>Brent crude&nbsp;futures increased by 9 cents, or 0.1%, to $71.61 a barrel by 0105 GMT, while U.S. West Texas Intermediate&nbsp;crude&nbsp;futures rose by 23 cents, or 0.3%, to $68.84 a barrel.</p>\n<p>\"It also looks increasingly likely that the UK will reimpose restrictions sometime after Boxing Day (Dec 26), with daily cases moving to record highs,\" analysts from JBC Energy wrote in a note on Tuesday.</p>\n<p>British Prime Minister Boris Johnson said on Monday he would tighten coronavirus curbs to slow the spread of the Omicron variant if needed, after the Netherlands began a fourth lockdown and other European nations considered Christmas restrictions.</p>\n<p>Omicron infections are multiplying rapidly across Europe and the United States, doubling every two or three days in London and elsewhere and taking a heavy toll on financial markets, which fear the impact on the global economic recovery.</p>\n<p>Still, Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant of the coronavirus in laboratory testing, providing some hope to investors.</p>\n<p>On the supply front, OPEC+ compliance with oil production cuts rose to 117% in November from 116% a month earlier, two sources from the group told Reuters, indicating production levels remain well below agreed targets.</p>\n<p>In the United States, crude oil inventories were expected to have fallen for a fourth consecutive week, while distillate and gasoline stockpiles likely rose last week, a preliminary Reuters poll showed on Monday.</p>\n<p>The poll was conducted ahead of reports from the American Petroleum Institute, an industry group, due on Tuesday, and the EIA, the statistical arm of the U.S. Department of Energy, due on Wednesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil prices edge higher but investor worries on Omicron spread remain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil prices edge higher but investor worries on Omicron spread remain\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 09:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* UK says COVID surge 'extremely difficult'; Omicron grips Europe</p>\n<p>* OPEC+ produces below target in November as compliance rises</p>\n<p>* U.S. crude inventories expected to fall 4th straight week - poll</p>\n<p>* Coming up: API inventory data due at 2130 GMT</p>\n<p>SINGAPORE, Dec 21 (Reuters) - Oil prices edged higher on Tuesday, though investors remained worried about the rapid spread of the Omicron coronavirus variant globally, prompting countries to consider more restrictions potentially denting fuel demand.</p>\n<p>Brent crude&nbsp;futures increased by 9 cents, or 0.1%, to $71.61 a barrel by 0105 GMT, while U.S. West Texas Intermediate&nbsp;crude&nbsp;futures rose by 23 cents, or 0.3%, to $68.84 a barrel.</p>\n<p>\"It also looks increasingly likely that the UK will reimpose restrictions sometime after Boxing Day (Dec 26), with daily cases moving to record highs,\" analysts from JBC Energy wrote in a note on Tuesday.</p>\n<p>British Prime Minister Boris Johnson said on Monday he would tighten coronavirus curbs to slow the spread of the Omicron variant if needed, after the Netherlands began a fourth lockdown and other European nations considered Christmas restrictions.</p>\n<p>Omicron infections are multiplying rapidly across Europe and the United States, doubling every two or three days in London and elsewhere and taking a heavy toll on financial markets, which fear the impact on the global economic recovery.</p>\n<p>Still, Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant of the coronavirus in laboratory testing, providing some hope to investors.</p>\n<p>On the supply front, OPEC+ compliance with oil production cuts rose to 117% in November from 116% a month earlier, two sources from the group told Reuters, indicating production levels remain well below agreed targets.</p>\n<p>In the United States, crude oil inventories were expected to have fallen for a fourth consecutive week, while distillate and gasoline stockpiles likely rose last week, a preliminary Reuters poll showed on Monday.</p>\n<p>The poll was conducted ahead of reports from the American Petroleum Institute, an industry group, due on Tuesday, and the EIA, the statistical arm of the U.S. Department of Energy, due on Wednesday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4213":"石油与天然气的勘探与生产","DUG":"二倍做空石油与天然气ETF(ProShares)","BK4532":"文艺复兴科技持仓","UCO":"二倍做多彭博原油ETF","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","DDG":"ProShares做空石油与天然气ETF","SCO":"二倍做空彭博原油指数ETF","BK4568":"美国抗疫概念","USO":"美国原油ETF","DWT":"三倍做空原油ETN","WTI":"W&T海底钻探","MRNA":"Moderna, Inc.","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193341971","content_text":"* UK says COVID surge 'extremely difficult'; Omicron grips Europe\n* OPEC+ produces below target in November as compliance rises\n* U.S. crude inventories expected to fall 4th straight week - poll\n* Coming up: API inventory data due at 2130 GMT\nSINGAPORE, Dec 21 (Reuters) - Oil prices edged higher on Tuesday, though investors remained worried about the rapid spread of the Omicron coronavirus variant globally, prompting countries to consider more restrictions potentially denting fuel demand.\nBrent crude futures increased by 9 cents, or 0.1%, to $71.61 a barrel by 0105 GMT, while U.S. West Texas Intermediate crude futures rose by 23 cents, or 0.3%, to $68.84 a barrel.\n\"It also looks increasingly likely that the UK will reimpose restrictions sometime after Boxing Day (Dec 26), with daily cases moving to record highs,\" analysts from JBC Energy wrote in a note on Tuesday.\nBritish Prime Minister Boris Johnson said on Monday he would tighten coronavirus curbs to slow the spread of the Omicron variant if needed, after the Netherlands began a fourth lockdown and other European nations considered Christmas restrictions.\nOmicron infections are multiplying rapidly across Europe and the United States, doubling every two or three days in London and elsewhere and taking a heavy toll on financial markets, which fear the impact on the global economic recovery.\nStill, Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant of the coronavirus in laboratory testing, providing some hope to investors.\nOn the supply front, OPEC+ compliance with oil production cuts rose to 117% in November from 116% a month earlier, two sources from the group told Reuters, indicating production levels remain well below agreed targets.\nIn the United States, crude oil inventories were expected to have fallen for a fourth consecutive week, while distillate and gasoline stockpiles likely rose last week, a preliminary Reuters poll showed on Monday.\nThe poll was conducted ahead of reports from the American Petroleum Institute, an industry group, due on Tuesday, and the EIA, the statistical arm of the U.S. Department of Energy, due on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693955597,"gmtCreate":1639963987876,"gmtModify":1639963988061,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693955597","repostId":"1146401633","repostType":4,"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699462679,"gmtCreate":1639878358412,"gmtModify":1639878358595,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699462679","repostId":"1156922518","repostType":4,"repost":{"id":"1156922518","pubTimestamp":1639871838,"share":"https://www.laohu8.com/m/news/1156922518?lang=&edition=full","pubTime":"2021-12-19 07:57","market":"us","language":"en","title":"Watch these five electric vehicle models in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1156922518","media":"Seeking Alpha","summary":"The electrification push in the auto industry became even more mainstream last week when Toyota Moto","content":"<p>The electrification push in the auto industry became even more mainstream last week when Toyota Motor (NYSE:TM) made its 30 by 30 announcement. The Japanese automaker says it will introduce 30 new all-electric cars by 2030, which places it on the same all-electric trajectory of Ford (NYSE:F), General Motors (NYSE:GM) and Volkswagen (OTCPK:VLKAF).</p>\n<p>Analysts say the rubber will meet the road next year for some of the major players as all-electric models battle for market share with demand tailwinds in place. Five EV models to watch for are listed below.</p>\n<p>(1) <a href=\"https://laohu8.com/S/TSLA\">Tesla </a> is promising to deliver the Cybertruck to customers by the end of 2022. The all-electric truck features range of up to 500 miles and is expected to price at around $40K. The 0-to-60 mph speed is listed at 2.5 seconds.</p>\n<p>(2) The Lucid Air Pure is expected to come to the market by the end of the year with a range of up to 520 miles and price tag of $77,400. <a href=\"https://laohu8.com/S/LCID\">Lucid Group </a> hauled in the Motor Trend 2022 Car of the Year award for the highly-watched model.</p>\n<p>(3) <a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive </a> is expected to start delivering R1S SUVs during the early part of the year. The quad-motor will have a 0-to-60 mph time of around 3 seconds and be able to tow up to 7,700 pounds. The model will list at $70K.</p>\n<p>(4) <a href=\"https://laohu8.com/S/F\">Ford </a> is set to introduce the all-electric F-150 Lightning by the middle of the year. The F-150 Lightning will have a range of 300 miles with an extended-range battery. The truck can also be used to power a house for three days, or up to ten days if the power is rationed slowly. A 0-to-60 mph speed of four seconds is being advertised. The electric truck will list at a base price of $39,974</p>\n<p>(5) <a href=\"https://laohu8.com/S/FSR\">Fisker </a> is scheduled to start production on the Ocean SUV in November and could make a delivery soon after. Early reviews could be critical in supporting Fisker's share price.</p>\n<p>By the end of 2022, expect plenty of talk about the arrival of the all-electric Chevy Silverado in 2023. Production timeline updates from Nikola (NASDAQ:NKLA) and Lordstown Motors (NASDAQ:RIDE) will also be critical in supporting bull cases.</p>\n<p>Looking for some sleeper EV stocks that could emerge from the pack in 2022? Proterra (NASDAQ:PTRA) has been singled out as a possible EV beneficiary that is flying below the radar. Meanwhile, Hyundai (OTCPK:HYMTF) is considered a possible partner for Apple (NASDAQ:AAPL) on EVs. On a Seeking Alpha Quant Rating basis - ON Semi (NASDAQ:ON), Qualcomm (NASDAQ:QCOM) and Microchip Technology (NASDAQ:MCHP) are the EV semiconductor stocks to watch.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Watch these five electric vehicle models in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWatch these five electric vehicle models in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 07:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3781486-watch-these-five-electric-vehicle-models-in-2022-and-these-five-sleeper-ev-stocks><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The electrification push in the auto industry became even more mainstream last week when Toyota Motor (NYSE:TM) made its 30 by 30 announcement. The Japanese automaker says it will introduce 30 new all...</p>\n\n<a href=\"https://seekingalpha.com/news/3781486-watch-these-five-electric-vehicle-models-in-2022-and-these-five-sleeper-ev-stocks\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","LCID":"Lucid Group Inc","FSR":"菲斯克","TSLA":"特斯拉","F":"福特汽车"},"source_url":"https://seekingalpha.com/news/3781486-watch-these-five-electric-vehicle-models-in-2022-and-these-five-sleeper-ev-stocks","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156922518","content_text":"The electrification push in the auto industry became even more mainstream last week when Toyota Motor (NYSE:TM) made its 30 by 30 announcement. The Japanese automaker says it will introduce 30 new all-electric cars by 2030, which places it on the same all-electric trajectory of Ford (NYSE:F), General Motors (NYSE:GM) and Volkswagen (OTCPK:VLKAF).\nAnalysts say the rubber will meet the road next year for some of the major players as all-electric models battle for market share with demand tailwinds in place. Five EV models to watch for are listed below.\n(1) Tesla  is promising to deliver the Cybertruck to customers by the end of 2022. The all-electric truck features range of up to 500 miles and is expected to price at around $40K. The 0-to-60 mph speed is listed at 2.5 seconds.\n(2) The Lucid Air Pure is expected to come to the market by the end of the year with a range of up to 520 miles and price tag of $77,400. Lucid Group  hauled in the Motor Trend 2022 Car of the Year award for the highly-watched model.\n(3) Rivian Automotive  is expected to start delivering R1S SUVs during the early part of the year. The quad-motor will have a 0-to-60 mph time of around 3 seconds and be able to tow up to 7,700 pounds. The model will list at $70K.\n(4) Ford  is set to introduce the all-electric F-150 Lightning by the middle of the year. The F-150 Lightning will have a range of 300 miles with an extended-range battery. The truck can also be used to power a house for three days, or up to ten days if the power is rationed slowly. A 0-to-60 mph speed of four seconds is being advertised. The electric truck will list at a base price of $39,974\n(5) Fisker  is scheduled to start production on the Ocean SUV in November and could make a delivery soon after. Early reviews could be critical in supporting Fisker's share price.\nBy the end of 2022, expect plenty of talk about the arrival of the all-electric Chevy Silverado in 2023. Production timeline updates from Nikola (NASDAQ:NKLA) and Lordstown Motors (NASDAQ:RIDE) will also be critical in supporting bull cases.\nLooking for some sleeper EV stocks that could emerge from the pack in 2022? Proterra (NASDAQ:PTRA) has been singled out as a possible EV beneficiary that is flying below the radar. Meanwhile, Hyundai (OTCPK:HYMTF) is considered a possible partner for Apple (NASDAQ:AAPL) on EVs. On a Seeking Alpha Quant Rating basis - ON Semi (NASDAQ:ON), Qualcomm (NASDAQ:QCOM) and Microchip Technology (NASDAQ:MCHP) are the EV semiconductor stocks to watch.","news_type":1},"isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699612765,"gmtCreate":1639791269292,"gmtModify":1639791309359,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699612765","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690610849,"gmtCreate":1639662758694,"gmtModify":1639662758873,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690610849","repostId":"1194981368","repostType":4,"repost":{"id":"1194981368","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639660244,"share":"https://www.laohu8.com/m/news/1194981368?lang=&edition=full","pubTime":"2021-12-16 21:10","market":"us","language":"en","title":"Adobe tumbled over 7% in premarket trading as its financial report missed estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=1194981368","media":"Tiger Newspress","summary":"Adobe tumbled over 7% in premarket trading as its financial report missed estimate.It reported quart","content":"<p>Adobe tumbled over 7% in premarket trading as its financial report missed estimate.<img src=\"https://static.tigerbbs.com/42e7a1b918851f0c0996155afe429f7d\" tg-width=\"767\" tg-height=\"567\" referrerpolicy=\"no-referrer\">It&nbsp;reported quarterly earnings of $3.20 per share which met the analyst consensus estimate. This is a 13.88 percent increase over earnings of $2.81 per share from the same period last year. The company reported quarterly sales of $4.11 billion which beat the analyst consensus estimate of $4.09 billion by 0.49 percent. This is a 20.04 percent increase over sales of $3.42 billion the same period last year.</p>\n<p>It&nbsp;now sees FY22 adj. EPS $13.70; FactSet consensus is&nbsp;$14.26;FY22 revenue will&nbsp;be $17.9 bln; FactSet consensus is&nbsp;$18.2 bln.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adobe tumbled over 7% in premarket trading as its financial report missed estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdobe tumbled over 7% in premarket trading as its financial report missed estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 21:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adobe tumbled over 7% in premarket trading as its financial report missed estimate.<img src=\"https://static.tigerbbs.com/42e7a1b918851f0c0996155afe429f7d\" tg-width=\"767\" tg-height=\"567\" referrerpolicy=\"no-referrer\">It&nbsp;reported quarterly earnings of $3.20 per share which met the analyst consensus estimate. This is a 13.88 percent increase over earnings of $2.81 per share from the same period last year. The company reported quarterly sales of $4.11 billion which beat the analyst consensus estimate of $4.09 billion by 0.49 percent. This is a 20.04 percent increase over sales of $3.42 billion the same period last year.</p>\n<p>It&nbsp;now sees FY22 adj. EPS $13.70; FactSet consensus is&nbsp;$14.26;FY22 revenue will&nbsp;be $17.9 bln; FactSet consensus is&nbsp;$18.2 bln.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADBE":"Adobe"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194981368","content_text":"Adobe tumbled over 7% in premarket trading as its financial report missed estimate.It reported quarterly earnings of $3.20 per share which met the analyst consensus estimate. This is a 13.88 percent increase over earnings of $2.81 per share from the same period last year. The company reported quarterly sales of $4.11 billion which beat the analyst consensus estimate of $4.09 billion by 0.49 percent. This is a 20.04 percent increase over sales of $3.42 billion the same period last year.\nIt now sees FY22 adj. EPS $13.70; FactSet consensus is $14.26;FY22 revenue will be $17.9 bln; FactSet consensus is $18.2 bln.","news_type":1},"isVote":1,"tweetType":1,"viewCount":188,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607491890,"gmtCreate":1639575373548,"gmtModify":1639575409529,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607491890","repostId":"1144636661","repostType":4,"repost":{"id":"1144636661","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639573288,"share":"https://www.laohu8.com/m/news/1144636661?lang=&edition=full","pubTime":"2021-12-15 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1144636661","media":"Tiger Newspress","summary":"U.S. Stock futures traded flat Wednesday morning as investors looked ahead to the Federal Reserve's ","content":"<p>U.S.&nbsp;Stock futures traded flat Wednesday morning as investors&nbsp;looked ahead to the Federal Reserve's final monetary policy decision of 2021&nbsp;and weighed the central bank's potential response to persistent inflationary pressures.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 16 points, or 0.05%, S&amp;P 500 e-minis were up 0.75 point, or 0.02%, and Nasdaq 100 e-minis were down 9.25 points, or 0.06%.</p>\n<p><img src=\"https://static.tigerbbs.com/34286b7e4b17094339c3a583ba0a4e13\" tg-width=\"1080\" tg-height=\"379\" width=\"100%\" height=\"auto\"></p>\n<p>All eyes on Wednesday will be on the Federal Reserve's monetary policy statement and press conference by Federal Reserve Chair Jerome Powell. Many market participants expect these will set the stage for the Fed to speed the withdrawal of its crisis-era stimulus programs, with the firming economic recovery and soaring inflation suggesting the central bank has room for a more hawkish tilt to policy. </p>\n<p>Last week's Consumer Price Index showed the&nbsp;fastest surge in U.S. consumer prices since 1982&nbsp;on a year-over-year basis in November. And on Tuesday, the U.S. Producer Price Index jumped by the most on record at a 9.6% year-over-year increase for last month.</p>\n<p>Specifically, many investors anticipate the Fed will ramp up the rate of tapering of its asset-purchasing program, which took place at a rate of $120 billion per month in combined Treasuries and agency mortgage-backed securities from the start of the pandemic through November. Last month, the Fed began dialing back these purchases by $15 billion, and announced another $15 billion reduction for December.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/TM\">Toyota</a> </b>– <a href=\"https://laohu8.com/S/TM\">Toyota</a> gained 2.2% in premarket trading, after announcing it would produce a record 800,000 vehicles in January. Toyota is ramping up output to make up for prior production lost to parts shortages.</p>\n<p><b><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a></b> – <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a> is rallying 4.3% in the premarket, putting it in position to rise for a fifth straight day. The drugmaker announced further data showing that its Covid-19 antibody therapy – developed in partnership with&nbsp;GlaxoSmithKline(GSK) – was effective against the omicron variant.</p>\n<p><b><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a></b> – The drugmaker raised its 2022 profit and revenue forecast ahead of today’s meeting with the investment community, noting that it is on track to meet its goal of delivering 20 new treatments in the 10-year period through 2023. Lilly moved higher by 4.7% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a></b> – <a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a> agreed to be acquired by Chatham Asset Management – the printing company’s top shareholder – for about $897 million. Donnelley terminated an earlier buyout deal it reached with private equity firm Atlas Holdings after determining that Chatham’s bid was a “superior proposal.” The stock fell 2.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/DPZ\">Domino's Pizza</a></b> – Domino’s fell 2.1% in premarket trading after Barclays downgraded the stock to “underweight” from “equal weight.” Barclays said solid fundamentals and Covid headwinds in the industry as a whole helped Domino’s outperform during the pandemic, but noted that those headwinds for its competitors are now fading.</p>\n<p><b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – Regeneron was downgraded to “market perform” from “outperform” at Bernstein, which cites the risk to Regeneron’s best-selling eye drug Eylea from the future release of biosimilars. Regeneron slid 1.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/SIX\">Six Flags Entertainment</a></b> – The theme park operator’s stock rose 2.2% in the premarket after Goldman Sachs upgraded it to “buy” from “neutral,” noting resilient ticket pricing as well as guidance from Six Flags that Goldman considers conservative.</p>\n<p><b><a href=\"https://laohu8.com/S/TWNK\">Hostess Brands Inc</a></b> – The maker of Twinkies and other snack foods was rated “buy” in new coverage at Citi, which said Hostess is exiting the pandemic in a strong position with innovation driving market share gains. Hostess was up 1.1% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/UPS\">United Parcel Service Inc</a></b> – UBS named the delivery service’s stock as a “top pick,” saying UPS should benefit from increased consumer spending and that it has a greater chance of margin expansion than its rivals. UPS rose 1.1% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/CCMP\">Cabot Microelectronics</a></b> – The advanced materials supplier agreed to be acquired by rivalEntegris(ENTG) in a cash-and-stock deal. Based on Tuesday’s closing prices, the transaction is worth $197.53 per CMC share, compared with CMC’s Tuesday close of $145.97. Entegris fell 3% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/BLMN\">Bloomin</a></b> – The Outback Steakhouse parent surged 5.3% in premarket trading after Jefferies added the stock to its “franchise picks” list, saying the company was positioned to benefit from positive structural changes in the casual dining category.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.&nbsp;Stock futures traded flat Wednesday morning as investors&nbsp;looked ahead to the Federal Reserve's final monetary policy decision of 2021&nbsp;and weighed the central bank's potential response to persistent inflationary pressures.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 16 points, or 0.05%, S&amp;P 500 e-minis were up 0.75 point, or 0.02%, and Nasdaq 100 e-minis were down 9.25 points, or 0.06%.</p>\n<p><img src=\"https://static.tigerbbs.com/34286b7e4b17094339c3a583ba0a4e13\" tg-width=\"1080\" tg-height=\"379\" width=\"100%\" height=\"auto\"></p>\n<p>All eyes on Wednesday will be on the Federal Reserve's monetary policy statement and press conference by Federal Reserve Chair Jerome Powell. Many market participants expect these will set the stage for the Fed to speed the withdrawal of its crisis-era stimulus programs, with the firming economic recovery and soaring inflation suggesting the central bank has room for a more hawkish tilt to policy. </p>\n<p>Last week's Consumer Price Index showed the&nbsp;fastest surge in U.S. consumer prices since 1982&nbsp;on a year-over-year basis in November. And on Tuesday, the U.S. Producer Price Index jumped by the most on record at a 9.6% year-over-year increase for last month.</p>\n<p>Specifically, many investors anticipate the Fed will ramp up the rate of tapering of its asset-purchasing program, which took place at a rate of $120 billion per month in combined Treasuries and agency mortgage-backed securities from the start of the pandemic through November. Last month, the Fed began dialing back these purchases by $15 billion, and announced another $15 billion reduction for December.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/TM\">Toyota</a> </b>– <a href=\"https://laohu8.com/S/TM\">Toyota</a> gained 2.2% in premarket trading, after announcing it would produce a record 800,000 vehicles in January. Toyota is ramping up output to make up for prior production lost to parts shortages.</p>\n<p><b><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a></b> – <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a> is rallying 4.3% in the premarket, putting it in position to rise for a fifth straight day. The drugmaker announced further data showing that its Covid-19 antibody therapy – developed in partnership with&nbsp;GlaxoSmithKline(GSK) – was effective against the omicron variant.</p>\n<p><b><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a></b> – The drugmaker raised its 2022 profit and revenue forecast ahead of today’s meeting with the investment community, noting that it is on track to meet its goal of delivering 20 new treatments in the 10-year period through 2023. Lilly moved higher by 4.7% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a></b> – <a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a> agreed to be acquired by Chatham Asset Management – the printing company’s top shareholder – for about $897 million. Donnelley terminated an earlier buyout deal it reached with private equity firm Atlas Holdings after determining that Chatham’s bid was a “superior proposal.” The stock fell 2.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/DPZ\">Domino's Pizza</a></b> – Domino’s fell 2.1% in premarket trading after Barclays downgraded the stock to “underweight” from “equal weight.” Barclays said solid fundamentals and Covid headwinds in the industry as a whole helped Domino’s outperform during the pandemic, but noted that those headwinds for its competitors are now fading.</p>\n<p><b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – Regeneron was downgraded to “market perform” from “outperform” at Bernstein, which cites the risk to Regeneron’s best-selling eye drug Eylea from the future release of biosimilars. Regeneron slid 1.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/SIX\">Six Flags Entertainment</a></b> – The theme park operator’s stock rose 2.2% in the premarket after Goldman Sachs upgraded it to “buy” from “neutral,” noting resilient ticket pricing as well as guidance from Six Flags that Goldman considers conservative.</p>\n<p><b><a href=\"https://laohu8.com/S/TWNK\">Hostess Brands Inc</a></b> – The maker of Twinkies and other snack foods was rated “buy” in new coverage at Citi, which said Hostess is exiting the pandemic in a strong position with innovation driving market share gains. Hostess was up 1.1% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/UPS\">United Parcel Service Inc</a></b> – UBS named the delivery service’s stock as a “top pick,” saying UPS should benefit from increased consumer spending and that it has a greater chance of margin expansion than its rivals. UPS rose 1.1% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/CCMP\">Cabot Microelectronics</a></b> – The advanced materials supplier agreed to be acquired by rivalEntegris(ENTG) in a cash-and-stock deal. Based on Tuesday’s closing prices, the transaction is worth $197.53 per CMC share, compared with CMC’s Tuesday close of $145.97. Entegris fell 3% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/BLMN\">Bloomin</a></b> – The Outback Steakhouse parent surged 5.3% in premarket trading after Jefferies added the stock to its “franchise picks” list, saying the company was positioned to benefit from positive structural changes in the casual dining category.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144636661","content_text":"U.S. Stock futures traded flat Wednesday morning as investors looked ahead to the Federal Reserve's final monetary policy decision of 2021 and weighed the central bank's potential response to persistent inflationary pressures.\nAt 8:00 a.m. ET, Dow e-minis were up 16 points, or 0.05%, S&P 500 e-minis were up 0.75 point, or 0.02%, and Nasdaq 100 e-minis were down 9.25 points, or 0.06%.\n\nAll eyes on Wednesday will be on the Federal Reserve's monetary policy statement and press conference by Federal Reserve Chair Jerome Powell. Many market participants expect these will set the stage for the Fed to speed the withdrawal of its crisis-era stimulus programs, with the firming economic recovery and soaring inflation suggesting the central bank has room for a more hawkish tilt to policy. \nLast week's Consumer Price Index showed the fastest surge in U.S. consumer prices since 1982 on a year-over-year basis in November. And on Tuesday, the U.S. Producer Price Index jumped by the most on record at a 9.6% year-over-year increase for last month.\nSpecifically, many investors anticipate the Fed will ramp up the rate of tapering of its asset-purchasing program, which took place at a rate of $120 billion per month in combined Treasuries and agency mortgage-backed securities from the start of the pandemic through November. Last month, the Fed began dialing back these purchases by $15 billion, and announced another $15 billion reduction for December.\nStocks making the biggest moves premarket: \nToyota – Toyota gained 2.2% in premarket trading, after announcing it would produce a record 800,000 vehicles in January. Toyota is ramping up output to make up for prior production lost to parts shortages.\nVir Biotechnology, Inc. – Vir Biotechnology, Inc. is rallying 4.3% in the premarket, putting it in position to rise for a fifth straight day. The drugmaker announced further data showing that its Covid-19 antibody therapy – developed in partnership with GlaxoSmithKline(GSK) – was effective against the omicron variant.\nEli Lilly and – The drugmaker raised its 2022 profit and revenue forecast ahead of today’s meeting with the investment community, noting that it is on track to meet its goal of delivering 20 new treatments in the 10-year period through 2023. Lilly moved higher by 4.7% in the premarket.\nR.R.Donnelley – R.R.Donnelley agreed to be acquired by Chatham Asset Management – the printing company’s top shareholder – for about $897 million. Donnelley terminated an earlier buyout deal it reached with private equity firm Atlas Holdings after determining that Chatham’s bid was a “superior proposal.” The stock fell 2.8% in the premarket.\nDomino's Pizza – Domino’s fell 2.1% in premarket trading after Barclays downgraded the stock to “underweight” from “equal weight.” Barclays said solid fundamentals and Covid headwinds in the industry as a whole helped Domino’s outperform during the pandemic, but noted that those headwinds for its competitors are now fading.\nRegeneron Pharmaceuticals – Regeneron was downgraded to “market perform” from “outperform” at Bernstein, which cites the risk to Regeneron’s best-selling eye drug Eylea from the future release of biosimilars. Regeneron slid 1.8% in the premarket.\nSix Flags Entertainment – The theme park operator’s stock rose 2.2% in the premarket after Goldman Sachs upgraded it to “buy” from “neutral,” noting resilient ticket pricing as well as guidance from Six Flags that Goldman considers conservative.\nHostess Brands Inc – The maker of Twinkies and other snack foods was rated “buy” in new coverage at Citi, which said Hostess is exiting the pandemic in a strong position with innovation driving market share gains. Hostess was up 1.1% in the premarket.\nUnited Parcel Service Inc – UBS named the delivery service’s stock as a “top pick,” saying UPS should benefit from increased consumer spending and that it has a greater chance of margin expansion than its rivals. UPS rose 1.1% in premarket trading.\nCabot Microelectronics – The advanced materials supplier agreed to be acquired by rivalEntegris(ENTG) in a cash-and-stock deal. Based on Tuesday’s closing prices, the transaction is worth $197.53 per CMC share, compared with CMC’s Tuesday close of $145.97. Entegris fell 3% in the premarket.\nBloomin – The Outback Steakhouse parent surged 5.3% in premarket trading after Jefferies added the stock to its “franchise picks” list, saying the company was positioned to benefit from positive structural changes in the casual dining category.","news_type":1},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607380390,"gmtCreate":1639489578610,"gmtModify":1639489578778,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607380390","repostId":"1192557604","repostType":4,"repost":{"id":"1192557604","pubTimestamp":1639488210,"share":"https://www.laohu8.com/m/news/1192557604?lang=&edition=full","pubTime":"2021-12-14 21:23","market":"us","language":"en","title":"4 Stocks Insiders Are Selling","url":"https://stock-news.laohu8.com/highlight/detail?id=1192557604","media":"Benzinga","summary":"Tesla\n\nThe Trade:Tesla, Inc. CEO Elon Musk disposed a total of 169111 shares at an average price of ","content":"<p><b>Tesla</b></p>\n<ul>\n <li><b>The Trade:Tesla, Inc.</b>&nbsp;CEO Elon Musk&nbsp;<i>disposed a total of 169111 shares</i>&nbsp;at an average price of $992.27. The insider received $167,804,267.54 as a result of the transaction.</li>\n <li><b>What’s Happening:</b>Tesla CEO Elon Musk-owned SpaceX has a plan to draw carbon dioxide from the earth’s atmosphere and use it as rocket fuel.</li>\n <li><b>What Tesla Does:</b>Founded in 2003 and based in Palo Alto, California, Tesla is a vertically integrated sustainable energy company that also aims to transition the world to electric mobility by making electric vehicles.</li>\n</ul>\n<p><b>Box</b></p>\n<ul>\n <li><b>The Trade:Box, Inc.</b>&nbsp;Director Daniel Levin<i>sold a total of 128600 shares</i>&nbsp;at an average price of $26.04. The insider received $3,348,245.17 from selling those shares.</li>\n <li><b>What’s Happening:</b>Box recently reported better-than-expected Q3 EPS and sales results.</li>\n <li><b>What Box Does:</b>Box was founded in 2005 as a natively built cloud file sync and sharing provider for enterprises. Box is headquartered in Redwood City, California.</li>\n</ul>\n<p><b>QUALCOMM</b></p>\n<ul>\n <li><b>The Trade:QUALCOMM Incorporated</b>&nbsp;Chief Technology Officer James H Thompson&nbsp;<i>sold a total of 10000 shares</i>&nbsp;at an average price of $183.39. The insider received $1,815,526.35 as a result of the transaction.</li>\n <li><b>What’s Happening:</b>JPMorgan added Qualcomm to the firm's Analyst Focus List.</li>\n <li><b>What QUALCOMM Does:</b>Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks.</li>\n</ul>\n<p><b>Southwest Airlines</b></p>\n<ul>\n <li><b>The Trade:Southwest Airlines Co.</b>&nbsp;Director John T Montford<i>sold a total of 3230 shares</i>&nbsp;at an average price of $43.88. The insider received $23,697.36 from selling those shares.</li>\n <li><b>What’s Happening:</b>Goldman Sachs recently downgraded the stock from Neutral to Sell and lowered its price target from $59 to $36.</li>\n <li><b>What Southwest Airlines Does:</b>Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Insiders Are Selling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Insiders Are Selling\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24589297/4-stocks-insiders-are-selling><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla\n\nThe Trade:Tesla, Inc. CEO Elon Musk disposed a total of 169111 shares at an average price of $992.27. The insider received $167,804,267.54 as a result of the transaction.\nWhat’s Happening:Tesla...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24589297/4-stocks-insiders-are-selling\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","BOX":"Box Inc","QCOM":"高通"},"source_url":"https://www.benzinga.com/news/21/12/24589297/4-stocks-insiders-are-selling","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192557604","content_text":"Tesla\n\nThe Trade:Tesla, Inc. CEO Elon Musk disposed a total of 169111 shares at an average price of $992.27. The insider received $167,804,267.54 as a result of the transaction.\nWhat’s Happening:Tesla CEO Elon Musk-owned SpaceX has a plan to draw carbon dioxide from the earth’s atmosphere and use it as rocket fuel.\nWhat Tesla Does:Founded in 2003 and based in Palo Alto, California, Tesla is a vertically integrated sustainable energy company that also aims to transition the world to electric mobility by making electric vehicles.\n\nBox\n\nThe Trade:Box, Inc. Director Daniel Levinsold a total of 128600 shares at an average price of $26.04. The insider received $3,348,245.17 from selling those shares.\nWhat’s Happening:Box recently reported better-than-expected Q3 EPS and sales results.\nWhat Box Does:Box was founded in 2005 as a natively built cloud file sync and sharing provider for enterprises. Box is headquartered in Redwood City, California.\n\nQUALCOMM\n\nThe Trade:QUALCOMM Incorporated Chief Technology Officer James H Thompson sold a total of 10000 shares at an average price of $183.39. The insider received $1,815,526.35 as a result of the transaction.\nWhat’s Happening:JPMorgan added Qualcomm to the firm's Analyst Focus List.\nWhat QUALCOMM Does:Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks.\n\nSouthwest Airlines\n\nThe Trade:Southwest Airlines Co. Director John T Montfordsold a total of 3230 shares at an average price of $43.88. The insider received $23,697.36 from selling those shares.\nWhat’s Happening:Goldman Sachs recently downgraded the stock from Neutral to Sell and lowered its price target from $59 to $36.\nWhat Southwest Airlines Does:Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded.","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604811187,"gmtCreate":1639368580477,"gmtModify":1639368580693,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604811187","repostId":"2191708046","repostType":4,"repost":{"id":"2191708046","pubTimestamp":1639366317,"share":"https://www.laohu8.com/m/news/2191708046?lang=&edition=full","pubTime":"2021-12-13 11:31","market":"us","language":"en","title":"Charlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd","url":"https://stock-news.laohu8.com/highlight/detail?id=2191708046","media":"MoneyWise","summary":"Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and c","content":"<p><img src=\"https://static.tigerbbs.com/5664762597a5b9b6b53168b267173a39\" tg-width=\"1800\" tg-height=\"800\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and criticisms than his business partner, Warren Buffett.</p>\n<p>Munger didn’t mince words when he said earlier this month that he considers today’s stock market environment “even crazier than the dot-com era.”</p>\n<p>\"I just can't stand participating in these insane booms,” Munger said at the Sohn Hearts &amp; Minds Investment Leaders Conference. “There's no great company that can't be turned into a bad investment just by raising the price.\"</p>\n<p>Munger, as usual, had harsh words for cryptocurrencies. He praised China’s crackdown on crypto and said he wished the technology “had never been invented.”</p>\n<p>One way to avoid both crypto and getting burned by an overvalued market is to look at companies with stock that has dropped but seems poised for a rebound.</p>\n<p>Here are three stocks with some bruises that fit that category. You might even be able to include some undervalued stocks in your portfolio with a little spare change.</p>\n<h2>Walt Disney Co. (DIS)</h2>\n<p><img src=\"https://static.tigerbbs.com/1eb7ad7f596bcaa16827853ace850b05\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">AFM Visuals/Shutterstock</p>\n<p>Disney’s stock got hammered in the pandemic’s early days, shedding about 38% of its value in the month ending March 20, 2020. After rallying for much of last year, it’s down almost 15% since the beginning of 2021. Disney’s earnings in the fiscal fourth quarter, which ended Oct. 2, came in about $200 million short of expectations. Its theme parks are still operating at reduced capacity, so Q4’s results could have been much worse.</p>\n<p>Streaming platform Disney+ is up to 118.1 million subscribers, and the company projects that figure will grow to more than 230 million by 2024. While the company says Disney+ subscriber growth slowed, revenue from subscriptions across Disney+, ESPN+ and Hulu was $4.6 billion in Q4 — 38% higher than a year before.</p>\n<p>Disney remains a beloved global brand and says it expects international visitors to parks to pick up later in 2022 as restrictions ease. JPMorgan Chase predicts a full economic rebound from COVID-19 in 2022, and if that’s true, Disney’s theme parks could once again be packed.</p>\n<h2>Mastercard (MA)</h2>\n<p><img src=\"https://static.tigerbbs.com/aed78bfcce51f38789bf91a87e4815ed\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">garmoncheg/Shutterstock</p>\n<p>Mastercard’s stock has been mostly trending downward since July, and it recently hit the skids, shrinking by 17% from Nov. 16 through Dec. 1. However, it’s trending upward over the last week or so, recovering most of that recent loss.</p>\n<p>The sell-off of Mastercard’s stock doesn’t appear to have anything to do with the company’s performance. Q3 net revenue was $5 billion, a year-over-year increase of 30%. Purchase volume was up 23% over the same period.</p>\n<p>Mastercard’s in a tricky position. Buy now, pay later apps are doing their best to disrupt the credit card space, and the company doesn’t currently seem to have an answer that will help increase the company’s cache with younger users.</p>\n<p>But that could be more of a long-term issue. In the short-term, inflation-jacked prices mean customers are paying more, and a rebound in tourism and credit card spending should have the company’s users — there’s almost a billion of them — ringing up purchases left and right.</p>\n<h2>AT&amp;T (T)</h2>\n<p><img src=\"https://static.tigerbbs.com/2584b9217af4e8f8876958e9a7bf34a2\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">Jonathan Weiss/Shutterstock</p>\n<p>AT&amp;T’s stock has been on a downward tumble for a while now. Its share price is 45% lower than it was five years ago, and is down more than 22% this year alone.</p>\n<p>AT&amp;T has taken some big swings that haven’t paid off. Its purchase of DirecTV and Time Warner in 2015 and 2018, respectively, added more than $130 billion in debt to the company’s balance sheet. Last year, T-Mobile replaced AT&amp;T as America’s second-largest wireless carrier.</p>\n<p>None of that sounds particularly enticing, but the company knows changes need to be made. It divested a number of its smaller businesses and some of its real estate holdings and sold 30% of DirecTV to streamline operations and free up capital for the expansion of its 5G network, which could be huge.</p>\n<p>AT&amp;T is still a risky buy with its stumbles this year, but if you believe in the turnaround plan, the anxiety might be worthwhile. Big picture, AT&amp;T continues to boast the scale advantages required to compete in the high-growth wireless space long term.</p>\n<h2>If your faith in the market is flagging …</h2>\n<p><img src=\"https://static.tigerbbs.com/eedd4d7004b766d5dc2e8fe34b4c1922\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">MartinLueke/Shutterstock</p>\n<p>With elite investors like Charlie Munger, Michael Burry and Jeremy Grantham all saying the market is due for a correction, it might be worth looking into investments other than stocks.</p>\n<p>There’s no shortage of unique alternative assets you can invest in that have little correlation with the stock market, including luxury vehicles, commercial real estate, blue-chip artworks or even marine finance.</p>\n<p>Traditionally, many alternative asset classes have only been available to millionaires because of the enormous costs involved. But a new platform is making these opportunities available to retail investors too.</p>\n<p><i>This article provides information only and should not be construed as advice. It is provided without warranty of any kind.</i></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 11:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/charlie-munger-market-even-crazier-164000236.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and criticisms than his business partner, Warren Buffett.\nMunger didn’t mince words when he said earlier ...</p>\n\n<a href=\"https://finance.yahoo.com/news/charlie-munger-market-even-crazier-164000236.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4524":"宅经济概念","BK4535":"淡马锡持仓","DIS":"迪士尼","BK4559":"巴菲特持仓","MA":"万事达","BK4527":"明星科技股","BK4550":"红杉资本持仓","BK4115":"综合电信业务","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓","BK4106":"数据处理与外包服务","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4554":"元宇宙及AR概念","T":"美国电话电报","BK4108":"电影和娱乐","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团"},"source_url":"https://finance.yahoo.com/news/charlie-munger-market-even-crazier-164000236.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2191708046","content_text":"Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and criticisms than his business partner, Warren Buffett.\nMunger didn’t mince words when he said earlier this month that he considers today’s stock market environment “even crazier than the dot-com era.”\n\"I just can't stand participating in these insane booms,” Munger said at the Sohn Hearts & Minds Investment Leaders Conference. “There's no great company that can't be turned into a bad investment just by raising the price.\"\nMunger, as usual, had harsh words for cryptocurrencies. He praised China’s crackdown on crypto and said he wished the technology “had never been invented.”\nOne way to avoid both crypto and getting burned by an overvalued market is to look at companies with stock that has dropped but seems poised for a rebound.\nHere are three stocks with some bruises that fit that category. You might even be able to include some undervalued stocks in your portfolio with a little spare change.\nWalt Disney Co. (DIS)\nAFM Visuals/Shutterstock\nDisney’s stock got hammered in the pandemic’s early days, shedding about 38% of its value in the month ending March 20, 2020. After rallying for much of last year, it’s down almost 15% since the beginning of 2021. Disney’s earnings in the fiscal fourth quarter, which ended Oct. 2, came in about $200 million short of expectations. Its theme parks are still operating at reduced capacity, so Q4’s results could have been much worse.\nStreaming platform Disney+ is up to 118.1 million subscribers, and the company projects that figure will grow to more than 230 million by 2024. While the company says Disney+ subscriber growth slowed, revenue from subscriptions across Disney+, ESPN+ and Hulu was $4.6 billion in Q4 — 38% higher than a year before.\nDisney remains a beloved global brand and says it expects international visitors to parks to pick up later in 2022 as restrictions ease. JPMorgan Chase predicts a full economic rebound from COVID-19 in 2022, and if that’s true, Disney’s theme parks could once again be packed.\nMastercard (MA)\ngarmoncheg/Shutterstock\nMastercard’s stock has been mostly trending downward since July, and it recently hit the skids, shrinking by 17% from Nov. 16 through Dec. 1. However, it’s trending upward over the last week or so, recovering most of that recent loss.\nThe sell-off of Mastercard’s stock doesn’t appear to have anything to do with the company’s performance. Q3 net revenue was $5 billion, a year-over-year increase of 30%. Purchase volume was up 23% over the same period.\nMastercard’s in a tricky position. Buy now, pay later apps are doing their best to disrupt the credit card space, and the company doesn’t currently seem to have an answer that will help increase the company’s cache with younger users.\nBut that could be more of a long-term issue. In the short-term, inflation-jacked prices mean customers are paying more, and a rebound in tourism and credit card spending should have the company’s users — there’s almost a billion of them — ringing up purchases left and right.\nAT&T (T)\nJonathan Weiss/Shutterstock\nAT&T’s stock has been on a downward tumble for a while now. Its share price is 45% lower than it was five years ago, and is down more than 22% this year alone.\nAT&T has taken some big swings that haven’t paid off. Its purchase of DirecTV and Time Warner in 2015 and 2018, respectively, added more than $130 billion in debt to the company’s balance sheet. Last year, T-Mobile replaced AT&T as America’s second-largest wireless carrier.\nNone of that sounds particularly enticing, but the company knows changes need to be made. It divested a number of its smaller businesses and some of its real estate holdings and sold 30% of DirecTV to streamline operations and free up capital for the expansion of its 5G network, which could be huge.\nAT&T is still a risky buy with its stumbles this year, but if you believe in the turnaround plan, the anxiety might be worthwhile. Big picture, AT&T continues to boast the scale advantages required to compete in the high-growth wireless space long term.\nIf your faith in the market is flagging …\nMartinLueke/Shutterstock\nWith elite investors like Charlie Munger, Michael Burry and Jeremy Grantham all saying the market is due for a correction, it might be worth looking into investments other than stocks.\nThere’s no shortage of unique alternative assets you can invest in that have little correlation with the stock market, including luxury vehicles, commercial real estate, blue-chip artworks or even marine finance.\nTraditionally, many alternative asset classes have only been available to millionaires because of the enormous costs involved. But a new platform is making these opportunities available to retail investors too.\nThis article provides information only and should not be construed as advice. It is provided without warranty of any kind.","news_type":1},"isVote":1,"tweetType":1,"viewCount":300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605758892,"gmtCreate":1639270553116,"gmtModify":1639270553336,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605758892","repostId":"2190484675","repostType":4,"repost":{"id":"2190484675","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639186463,"share":"https://www.laohu8.com/m/news/2190484675?lang=&edition=full","pubTime":"2021-12-11 09:34","market":"us","language":"en","title":"Ford expects to triple electric Mustang output by 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2190484675","media":"Reuters","summary":"Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV","content":"<p>Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV to over 200,000 units per year by 2023 for North America and Europe, its Chief Executive Officer Jim Farley said in a tweet on Friday.</p>\n<p>\"It's hard to produce Mustang Mach-Es fast enough to meet the incredible demand, but we are sure going to try.\" Farley added</p>\n<p>In a hot electrical vehicle market, Ford is pitting itself against the likes of century-old rival General Motors Co and European carmaker Stellantis , while chasing Volkswagen and global EV leader Tesla Inc .</p>\n<p>Last week, a top Ford executive said that the company was aiming for annual EV production capacity of nearly 600,000 within the next two years, which would also include its Lightning pickup and E-Transit van.</p>\n<p>Lisa Drake, the chief operating officer of Ford North America, said that the company's optimism stemmed from increasing demand for its F-150 Lightning pickup, with retail reservations approaching 200,000.</p>\n<p>Automotive News reported earlier on Friday that Ford was postponing the production of electric versions of the Explorer and Lincoln Aviator crossovers by about <a href=\"https://laohu8.com/S/AONE.U\">one</a> and a half years to increase manufacturing of its Mustang Mach-E SUVs.</p>\n<p>Ford told its suppliers that production of these new EVs is now scheduled to start in December 2024, according to the report.</p>\n<p>Ford did not immediately respond to a request for comment on the Automotive News report.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford expects to triple electric Mustang output by 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord expects to triple electric Mustang output by 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV to over 200,000 units per year by 2023 for North America and Europe, its Chief Executive Officer Jim Farley said in a tweet on Friday.</p>\n<p>\"It's hard to produce Mustang Mach-Es fast enough to meet the incredible demand, but we are sure going to try.\" Farley added</p>\n<p>In a hot electrical vehicle market, Ford is pitting itself against the likes of century-old rival General Motors Co and European carmaker Stellantis , while chasing Volkswagen and global EV leader Tesla Inc .</p>\n<p>Last week, a top Ford executive said that the company was aiming for annual EV production capacity of nearly 600,000 within the next two years, which would also include its Lightning pickup and E-Transit van.</p>\n<p>Lisa Drake, the chief operating officer of Ford North America, said that the company's optimism stemmed from increasing demand for its F-150 Lightning pickup, with retail reservations approaching 200,000.</p>\n<p>Automotive News reported earlier on Friday that Ford was postponing the production of electric versions of the Explorer and Lincoln Aviator crossovers by about <a href=\"https://laohu8.com/S/AONE.U\">one</a> and a half years to increase manufacturing of its Mustang Mach-E SUVs.</p>\n<p>Ford told its suppliers that production of these new EVs is now scheduled to start in December 2024, according to the report.</p>\n<p>Ford did not immediately respond to a request for comment on the Automotive News report.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","BK4555":"新能源车","TSLA":"特斯拉","BK4099":"汽车制造商","F":"福特汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190484675","content_text":"Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV to over 200,000 units per year by 2023 for North America and Europe, its Chief Executive Officer Jim Farley said in a tweet on Friday.\n\"It's hard to produce Mustang Mach-Es fast enough to meet the incredible demand, but we are sure going to try.\" Farley added\nIn a hot electrical vehicle market, Ford is pitting itself against the likes of century-old rival General Motors Co and European carmaker Stellantis , while chasing Volkswagen and global EV leader Tesla Inc .\nLast week, a top Ford executive said that the company was aiming for annual EV production capacity of nearly 600,000 within the next two years, which would also include its Lightning pickup and E-Transit van.\nLisa Drake, the chief operating officer of Ford North America, said that the company's optimism stemmed from increasing demand for its F-150 Lightning pickup, with retail reservations approaching 200,000.\nAutomotive News reported earlier on Friday that Ford was postponing the production of electric versions of the Explorer and Lincoln Aviator crossovers by about one and a half years to increase manufacturing of its Mustang Mach-E SUVs.\nFord told its suppliers that production of these new EVs is now scheduled to start in December 2024, according to the report.\nFord did not immediately respond to a request for comment on the Automotive News report.","news_type":1},"isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":698422321,"gmtCreate":1640502303877,"gmtModify":1640502591533,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698422321","repostId":"1144001147","repostType":4,"repost":{"id":"1144001147","pubTimestamp":1640485026,"share":"https://www.laohu8.com/m/news/1144001147?lang=&edition=full","pubTime":"2021-12-26 10:17","market":"us","language":"en","title":"A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State","url":"https://stock-news.laohu8.com/highlight/detail?id=1144001147","media":"InvestorPlace","summary":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, t","content":"<p>In the last year,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.</p>\n<p>However, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with&nbsp;<b>Bharat Biotech</b>. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.</p>\n<p>Beyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.</p>\n<p>Ocugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.</p>\n<p>Let’s talk about the reasons to be bearish.</p>\n<p>FDA Approval Remains Elusive</p>\n<p><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>) and&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.</p>\n<p>Back in June, the biotech company’s&nbsp;application for emergency use authorization&nbsp;was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.</p>\n<p>In November, Ocugen announced that the FDA has “issued a clinical hold&nbsp;on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.</p>\n<p>The key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.</p>\n<p>In July, Ocugen had also initiated a&nbsp;rolling submission to Health Canada&nbsp;for the vaccine. There is no positive news on that front either.</p>\n<p>Let’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.</p>\n<p>Can Omicron Provide a Lifeline for OCGN Stock?</p>\n<p>The omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are&nbsp;currently studying the effectiveness&nbsp;of the vaccine against the variant.</p>\n<p>If the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.</p>\n<p>First and foremost, Moderna has announced that its Covid-19 booster&nbsp;increases neutralizing antibodies 37-fold&nbsp;against Omicron variant.</p>\n<p>Furthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold&nbsp;compared to two doses against the Omicron variant.”</p>\n<p>Clearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.</p>\n<p>People who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.</p>\n<p>It’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.</p>\n<p>OCGN Stock Will Trend Lower</p>\n<p>OCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.</p>\n<p>The company is&nbsp;building a pipeline of drugs&nbsp;for various indications. However, the pipeline for various indications is still at a pre-clinical stage.</p>\n<p>The stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.</p>\n<p>It also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Year After Announcing a Big Partnership, Ocugen Is in a Sorry State\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there...</p>\n\n<a href=\"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144001147","content_text":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.\nHowever, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with Bharat Biotech. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.\nBeyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.\nOcugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.\nLet’s talk about the reasons to be bearish.\nFDA Approval Remains Elusive\nPfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.\nBack in June, the biotech company’s application for emergency use authorization was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.\nIn November, Ocugen announced that the FDA has “issued a clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.\nThe key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.\nIn July, Ocugen had also initiated a rolling submission to Health Canada for the vaccine. There is no positive news on that front either.\nLet’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.\nCan Omicron Provide a Lifeline for OCGN Stock?\nThe omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are currently studying the effectiveness of the vaccine against the variant.\nIf the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.\nFirst and foremost, Moderna has announced that its Covid-19 booster increases neutralizing antibodies 37-fold against Omicron variant.\nFurthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold compared to two doses against the Omicron variant.”\nClearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.\nPeople who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.\nIt’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.\nOCGN Stock Will Trend Lower\nOCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.\nThe company is building a pipeline of drugs for various indications. However, the pipeline for various indications is still at a pre-clinical stage.\nThe stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.\nIt also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852017447,"gmtCreate":1635222457066,"gmtModify":1635222457336,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/852017447","repostId":"2178456478","repostType":4,"repost":{"id":"2178456478","pubTimestamp":1635220382,"share":"https://www.laohu8.com/m/news/2178456478?lang=&edition=full","pubTime":"2021-10-26 11:53","market":"us","language":"en","title":"Cathie Wood's ARKK Wagers Overshadow Tesla's 45% Surge This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2178456478","media":"Bloomberg","summary":"ARKK nursing 2021 losses as EV maker soars to all-time high\nBiotech, stay-at-home holdings pressurin","content":"<ul>\n <li>ARKK nursing 2021 losses as EV maker soars to all-time high</li>\n <li>Biotech, stay-at-home holdings pressuring Wood’s flagship fund</li>\n</ul>\n<p>Cathie Wood’s flagship fund is still underwater for the year, even as its top holding soars to an all-time high.</p>\n<p>Tesla Inc., which comprises about 10% of the $21 billion <a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> (ARKK), surged to another record. The Elon Musk-led carmaker has been on a tear amid a global shift to electric vehicles, with its stock surging more&nbsp;than 45% in 2021. While the rally helped lift ARKK on Monday, the exchange-traded fund is still lower by about 2% in 2021 as some big names in the portfolio struggle.</p>\n<p>Since early August, 34 of ARKK’s 46 holdings have fallen, with losses in <a href=\"https://laohu8.com/S/ROKU\">Roku Inc</a>. and <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc. weighing heavily on the ETF’s performance, according to Bloomberg data. To make matters worse, Wood’s funds have also been offloading shares of the electric-vehicle maker over the past few months.</p>\n<p>“Teladoc, Roku, Zoom, <a href=\"https://laohu8.com/S/Z\">Zillow</a>, etc -- they’ve all performed quite poorly” and Wood has been cutting back on her Tesla position as well, said Matt Maley, chief market strategist for Miller Tabak + Co. “It shows that the continued rally in the big innovation stocks is really starting to narrow quite a bit.”</p>\n<p>Ark’s performance in 2021 means essentially nothing to anyone who has held on for its 500% rally since 2016, of course, though it does highlight the perils of investing in cutting edge technology. Very few of Wood’s picks sit still over periods of months or quarters, and a couple big drops in relatively heavily weighted companies can easily torpedo returns.</p>\n<p><img src=\"https://static.tigerbbs.com/aa22eb6acc222e424a34851a0453d4ee\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>ARKK was one of 2020’s highest fliers, propelled by its tech-heavy holdings as Treasury yields cratered. Building inflation expectations and climbing rates have dented performance since, with the fund set to fall for the first year since 2016.</p>\n<p>The ETF has staged a comeback this month, rising 10% in October after September’s 9.4% slide. However, the Federal Reserve’s tapering of its bond-buying program -- expected to kick off in November or December -- should continue to weigh on the disruptive growth stocks that Wood tends to gravitate towards, according to Maley.</p>\n<p>“A lot of these innovative stocks got an extra boost from the Fed’s massive stimulus program,” Maley said. “Investors realize that the Fed is going to pare back.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood's ARKK Wagers Overshadow Tesla's 45% Surge This Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood's ARKK Wagers Overshadow Tesla's 45% Surge This Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-26 11:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-10-25/misfired-ark-wagers-overshadow-tesla-s-45-surge-this-year><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARKK nursing 2021 losses as EV maker soars to all-time high\nBiotech, stay-at-home holdings pressuring Wood’s flagship fund\n\nCathie Wood’s flagship fund is still underwater for the year, even as its ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-10-25/misfired-ark-wagers-overshadow-tesla-s-45-surge-this-year\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","ARKK":"ARK Innovation ETF"},"source_url":"https://www.bloomberg.com/news/articles/2021-10-25/misfired-ark-wagers-overshadow-tesla-s-45-surge-this-year","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178456478","content_text":"ARKK nursing 2021 losses as EV maker soars to all-time high\nBiotech, stay-at-home holdings pressuring Wood’s flagship fund\n\nCathie Wood’s flagship fund is still underwater for the year, even as its top holding soars to an all-time high.\nTesla Inc., which comprises about 10% of the $21 billion ARK Innovation ETF (ARKK), surged to another record. The Elon Musk-led carmaker has been on a tear amid a global shift to electric vehicles, with its stock surging more than 45% in 2021. While the rally helped lift ARKK on Monday, the exchange-traded fund is still lower by about 2% in 2021 as some big names in the portfolio struggle.\nSince early August, 34 of ARKK’s 46 holdings have fallen, with losses in Roku Inc. and Zoom Video Communications Inc. weighing heavily on the ETF’s performance, according to Bloomberg data. To make matters worse, Wood’s funds have also been offloading shares of the electric-vehicle maker over the past few months.\n“Teladoc, Roku, Zoom, Zillow, etc -- they’ve all performed quite poorly” and Wood has been cutting back on her Tesla position as well, said Matt Maley, chief market strategist for Miller Tabak + Co. “It shows that the continued rally in the big innovation stocks is really starting to narrow quite a bit.”\nArk’s performance in 2021 means essentially nothing to anyone who has held on for its 500% rally since 2016, of course, though it does highlight the perils of investing in cutting edge technology. Very few of Wood’s picks sit still over periods of months or quarters, and a couple big drops in relatively heavily weighted companies can easily torpedo returns.\n\nARKK was one of 2020’s highest fliers, propelled by its tech-heavy holdings as Treasury yields cratered. Building inflation expectations and climbing rates have dented performance since, with the fund set to fall for the first year since 2016.\nThe ETF has staged a comeback this month, rising 10% in October after September’s 9.4% slide. However, the Federal Reserve’s tapering of its bond-buying program -- expected to kick off in November or December -- should continue to weigh on the disruptive growth stocks that Wood tends to gravitate towards, according to Maley.\n“A lot of these innovative stocks got an extra boost from the Fed’s massive stimulus program,” Maley said. “Investors realize that the Fed is going to pare back.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828086519,"gmtCreate":1633823254789,"gmtModify":1633823254902,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828086519","repostId":"2174892254","repostType":4,"repost":{"id":"2174892254","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633762920,"share":"https://www.laohu8.com/m/news/2174892254?lang=&edition=full","pubTime":"2021-10-09 15:02","market":"us","language":"en","title":"China's Zijin Mining to acquire Neo Lithium in $737 mln deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2174892254","media":"Reuters","summary":"Oct 8 (Reuters) - China's Zijin Mining Group Co Ltd will buy Canada's Neo Lithium Corp for C$918.7 m","content":"<p>Oct 8 (Reuters) - China's Zijin Mining Group Co Ltd&nbsp;will buy Canada's Neo Lithium Corp&nbsp;for C$918.7 million ($737.14 million)the companies said on Friday.</p>\n<p>Zijin has agreed to buy Argentina-focused lithium company, Neo Lithium at a price of C$6.50 per share in cash, the companies said in a joint statement.</p>\n<p>The offer represents a premium of over 18% to Neo Lithium's last close of C$5.49 on Friday.</p>\n<p>Neo Lithium said that the deal has been unanimously approved by the board.</p>\n<p>In August, Chinese gold and copper miner Zijin said its plan on lithium and other new energy minerals were in a preliminary strategic planning stage with no detailed time frame or specific projects yet.</p>\n<p>The deal comes after Chinese battery maker Contemporary Amperex Technology Co Ltd <a href=\"https://laohu8.com/S/CATL.UK\">$(CATL.UK)$</a> last month agreed to acquire Canada's Millennial Lithium Corp in all stock cash deal worth C$376.8 million ($302.33 million).</p>\n<p>Last year, CATL also purchased more than 10 million shares of Neo Lithium Corp and became the company's third largest shareholder.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's Zijin Mining to acquire Neo Lithium in $737 mln deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's Zijin Mining to acquire Neo Lithium in $737 mln deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-09 15:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oct 8 (Reuters) - China's Zijin Mining Group Co Ltd&nbsp;will buy Canada's Neo Lithium Corp&nbsp;for C$918.7 million ($737.14 million)the companies said on Friday.</p>\n<p>Zijin has agreed to buy Argentina-focused lithium company, Neo Lithium at a price of C$6.50 per share in cash, the companies said in a joint statement.</p>\n<p>The offer represents a premium of over 18% to Neo Lithium's last close of C$5.49 on Friday.</p>\n<p>Neo Lithium said that the deal has been unanimously approved by the board.</p>\n<p>In August, Chinese gold and copper miner Zijin said its plan on lithium and other new energy minerals were in a preliminary strategic planning stage with no detailed time frame or specific projects yet.</p>\n<p>The deal comes after Chinese battery maker Contemporary Amperex Technology Co Ltd <a href=\"https://laohu8.com/S/CATL.UK\">$(CATL.UK)$</a> last month agreed to acquire Canada's Millennial Lithium Corp in all stock cash deal worth C$376.8 million ($302.33 million).</p>\n<p>Last year, CATL also purchased more than 10 million shares of Neo Lithium Corp and became the company's third largest shareholder.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NTTHF":"Neo Lithium Corp.","02899":"紫金矿业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2174892254","content_text":"Oct 8 (Reuters) - China's Zijin Mining Group Co Ltd will buy Canada's Neo Lithium Corp for C$918.7 million ($737.14 million)the companies said on Friday.\nZijin has agreed to buy Argentina-focused lithium company, Neo Lithium at a price of C$6.50 per share in cash, the companies said in a joint statement.\nThe offer represents a premium of over 18% to Neo Lithium's last close of C$5.49 on Friday.\nNeo Lithium said that the deal has been unanimously approved by the board.\nIn August, Chinese gold and copper miner Zijin said its plan on lithium and other new energy minerals were in a preliminary strategic planning stage with no detailed time frame or specific projects yet.\nThe deal comes after Chinese battery maker Contemporary Amperex Technology Co Ltd $(CATL.UK)$ last month agreed to acquire Canada's Millennial Lithium Corp in all stock cash deal worth C$376.8 million ($302.33 million).\nLast year, CATL also purchased more than 10 million shares of Neo Lithium Corp and became the company's third largest shareholder.","news_type":1},"isVote":1,"tweetType":1,"viewCount":75,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607491890,"gmtCreate":1639575373548,"gmtModify":1639575409529,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607491890","repostId":"1144636661","repostType":4,"repost":{"id":"1144636661","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639573288,"share":"https://www.laohu8.com/m/news/1144636661?lang=&edition=full","pubTime":"2021-12-15 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1144636661","media":"Tiger Newspress","summary":"U.S. Stock futures traded flat Wednesday morning as investors looked ahead to the Federal Reserve's ","content":"<p>U.S.&nbsp;Stock futures traded flat Wednesday morning as investors&nbsp;looked ahead to the Federal Reserve's final monetary policy decision of 2021&nbsp;and weighed the central bank's potential response to persistent inflationary pressures.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 16 points, or 0.05%, S&amp;P 500 e-minis were up 0.75 point, or 0.02%, and Nasdaq 100 e-minis were down 9.25 points, or 0.06%.</p>\n<p><img src=\"https://static.tigerbbs.com/34286b7e4b17094339c3a583ba0a4e13\" tg-width=\"1080\" tg-height=\"379\" width=\"100%\" height=\"auto\"></p>\n<p>All eyes on Wednesday will be on the Federal Reserve's monetary policy statement and press conference by Federal Reserve Chair Jerome Powell. Many market participants expect these will set the stage for the Fed to speed the withdrawal of its crisis-era stimulus programs, with the firming economic recovery and soaring inflation suggesting the central bank has room for a more hawkish tilt to policy. </p>\n<p>Last week's Consumer Price Index showed the&nbsp;fastest surge in U.S. consumer prices since 1982&nbsp;on a year-over-year basis in November. And on Tuesday, the U.S. Producer Price Index jumped by the most on record at a 9.6% year-over-year increase for last month.</p>\n<p>Specifically, many investors anticipate the Fed will ramp up the rate of tapering of its asset-purchasing program, which took place at a rate of $120 billion per month in combined Treasuries and agency mortgage-backed securities from the start of the pandemic through November. Last month, the Fed began dialing back these purchases by $15 billion, and announced another $15 billion reduction for December.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/TM\">Toyota</a> </b>– <a href=\"https://laohu8.com/S/TM\">Toyota</a> gained 2.2% in premarket trading, after announcing it would produce a record 800,000 vehicles in January. Toyota is ramping up output to make up for prior production lost to parts shortages.</p>\n<p><b><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a></b> – <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a> is rallying 4.3% in the premarket, putting it in position to rise for a fifth straight day. The drugmaker announced further data showing that its Covid-19 antibody therapy – developed in partnership with&nbsp;GlaxoSmithKline(GSK) – was effective against the omicron variant.</p>\n<p><b><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a></b> – The drugmaker raised its 2022 profit and revenue forecast ahead of today’s meeting with the investment community, noting that it is on track to meet its goal of delivering 20 new treatments in the 10-year period through 2023. Lilly moved higher by 4.7% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a></b> – <a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a> agreed to be acquired by Chatham Asset Management – the printing company’s top shareholder – for about $897 million. Donnelley terminated an earlier buyout deal it reached with private equity firm Atlas Holdings after determining that Chatham’s bid was a “superior proposal.” The stock fell 2.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/DPZ\">Domino's Pizza</a></b> – Domino’s fell 2.1% in premarket trading after Barclays downgraded the stock to “underweight” from “equal weight.” Barclays said solid fundamentals and Covid headwinds in the industry as a whole helped Domino’s outperform during the pandemic, but noted that those headwinds for its competitors are now fading.</p>\n<p><b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – Regeneron was downgraded to “market perform” from “outperform” at Bernstein, which cites the risk to Regeneron’s best-selling eye drug Eylea from the future release of biosimilars. Regeneron slid 1.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/SIX\">Six Flags Entertainment</a></b> – The theme park operator’s stock rose 2.2% in the premarket after Goldman Sachs upgraded it to “buy” from “neutral,” noting resilient ticket pricing as well as guidance from Six Flags that Goldman considers conservative.</p>\n<p><b><a href=\"https://laohu8.com/S/TWNK\">Hostess Brands Inc</a></b> – The maker of Twinkies and other snack foods was rated “buy” in new coverage at Citi, which said Hostess is exiting the pandemic in a strong position with innovation driving market share gains. Hostess was up 1.1% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/UPS\">United Parcel Service Inc</a></b> – UBS named the delivery service’s stock as a “top pick,” saying UPS should benefit from increased consumer spending and that it has a greater chance of margin expansion than its rivals. UPS rose 1.1% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/CCMP\">Cabot Microelectronics</a></b> – The advanced materials supplier agreed to be acquired by rivalEntegris(ENTG) in a cash-and-stock deal. Based on Tuesday’s closing prices, the transaction is worth $197.53 per CMC share, compared with CMC’s Tuesday close of $145.97. Entegris fell 3% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/BLMN\">Bloomin</a></b> – The Outback Steakhouse parent surged 5.3% in premarket trading after Jefferies added the stock to its “franchise picks” list, saying the company was positioned to benefit from positive structural changes in the casual dining category.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.&nbsp;Stock futures traded flat Wednesday morning as investors&nbsp;looked ahead to the Federal Reserve's final monetary policy decision of 2021&nbsp;and weighed the central bank's potential response to persistent inflationary pressures.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 16 points, or 0.05%, S&amp;P 500 e-minis were up 0.75 point, or 0.02%, and Nasdaq 100 e-minis were down 9.25 points, or 0.06%.</p>\n<p><img src=\"https://static.tigerbbs.com/34286b7e4b17094339c3a583ba0a4e13\" tg-width=\"1080\" tg-height=\"379\" width=\"100%\" height=\"auto\"></p>\n<p>All eyes on Wednesday will be on the Federal Reserve's monetary policy statement and press conference by Federal Reserve Chair Jerome Powell. Many market participants expect these will set the stage for the Fed to speed the withdrawal of its crisis-era stimulus programs, with the firming economic recovery and soaring inflation suggesting the central bank has room for a more hawkish tilt to policy. </p>\n<p>Last week's Consumer Price Index showed the&nbsp;fastest surge in U.S. consumer prices since 1982&nbsp;on a year-over-year basis in November. And on Tuesday, the U.S. Producer Price Index jumped by the most on record at a 9.6% year-over-year increase for last month.</p>\n<p>Specifically, many investors anticipate the Fed will ramp up the rate of tapering of its asset-purchasing program, which took place at a rate of $120 billion per month in combined Treasuries and agency mortgage-backed securities from the start of the pandemic through November. Last month, the Fed began dialing back these purchases by $15 billion, and announced another $15 billion reduction for December.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/TM\">Toyota</a> </b>– <a href=\"https://laohu8.com/S/TM\">Toyota</a> gained 2.2% in premarket trading, after announcing it would produce a record 800,000 vehicles in January. Toyota is ramping up output to make up for prior production lost to parts shortages.</p>\n<p><b><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a></b> – <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology, Inc.</a> is rallying 4.3% in the premarket, putting it in position to rise for a fifth straight day. The drugmaker announced further data showing that its Covid-19 antibody therapy – developed in partnership with&nbsp;GlaxoSmithKline(GSK) – was effective against the omicron variant.</p>\n<p><b><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a></b> – The drugmaker raised its 2022 profit and revenue forecast ahead of today’s meeting with the investment community, noting that it is on track to meet its goal of delivering 20 new treatments in the 10-year period through 2023. Lilly moved higher by 4.7% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a></b> – <a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a> agreed to be acquired by Chatham Asset Management – the printing company’s top shareholder – for about $897 million. Donnelley terminated an earlier buyout deal it reached with private equity firm Atlas Holdings after determining that Chatham’s bid was a “superior proposal.” The stock fell 2.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/DPZ\">Domino's Pizza</a></b> – Domino’s fell 2.1% in premarket trading after Barclays downgraded the stock to “underweight” from “equal weight.” Barclays said solid fundamentals and Covid headwinds in the industry as a whole helped Domino’s outperform during the pandemic, but noted that those headwinds for its competitors are now fading.</p>\n<p><b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – Regeneron was downgraded to “market perform” from “outperform” at Bernstein, which cites the risk to Regeneron’s best-selling eye drug Eylea from the future release of biosimilars. Regeneron slid 1.8% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/SIX\">Six Flags Entertainment</a></b> – The theme park operator’s stock rose 2.2% in the premarket after Goldman Sachs upgraded it to “buy” from “neutral,” noting resilient ticket pricing as well as guidance from Six Flags that Goldman considers conservative.</p>\n<p><b><a href=\"https://laohu8.com/S/TWNK\">Hostess Brands Inc</a></b> – The maker of Twinkies and other snack foods was rated “buy” in new coverage at Citi, which said Hostess is exiting the pandemic in a strong position with innovation driving market share gains. Hostess was up 1.1% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/UPS\">United Parcel Service Inc</a></b> – UBS named the delivery service’s stock as a “top pick,” saying UPS should benefit from increased consumer spending and that it has a greater chance of margin expansion than its rivals. UPS rose 1.1% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/CCMP\">Cabot Microelectronics</a></b> – The advanced materials supplier agreed to be acquired by rivalEntegris(ENTG) in a cash-and-stock deal. Based on Tuesday’s closing prices, the transaction is worth $197.53 per CMC share, compared with CMC’s Tuesday close of $145.97. Entegris fell 3% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/BLMN\">Bloomin</a></b> – The Outback Steakhouse parent surged 5.3% in premarket trading after Jefferies added the stock to its “franchise picks” list, saying the company was positioned to benefit from positive structural changes in the casual dining category.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144636661","content_text":"U.S. Stock futures traded flat Wednesday morning as investors looked ahead to the Federal Reserve's final monetary policy decision of 2021 and weighed the central bank's potential response to persistent inflationary pressures.\nAt 8:00 a.m. ET, Dow e-minis were up 16 points, or 0.05%, S&P 500 e-minis were up 0.75 point, or 0.02%, and Nasdaq 100 e-minis were down 9.25 points, or 0.06%.\n\nAll eyes on Wednesday will be on the Federal Reserve's monetary policy statement and press conference by Federal Reserve Chair Jerome Powell. Many market participants expect these will set the stage for the Fed to speed the withdrawal of its crisis-era stimulus programs, with the firming economic recovery and soaring inflation suggesting the central bank has room for a more hawkish tilt to policy. \nLast week's Consumer Price Index showed the fastest surge in U.S. consumer prices since 1982 on a year-over-year basis in November. And on Tuesday, the U.S. Producer Price Index jumped by the most on record at a 9.6% year-over-year increase for last month.\nSpecifically, many investors anticipate the Fed will ramp up the rate of tapering of its asset-purchasing program, which took place at a rate of $120 billion per month in combined Treasuries and agency mortgage-backed securities from the start of the pandemic through November. Last month, the Fed began dialing back these purchases by $15 billion, and announced another $15 billion reduction for December.\nStocks making the biggest moves premarket: \nToyota – Toyota gained 2.2% in premarket trading, after announcing it would produce a record 800,000 vehicles in January. Toyota is ramping up output to make up for prior production lost to parts shortages.\nVir Biotechnology, Inc. – Vir Biotechnology, Inc. is rallying 4.3% in the premarket, putting it in position to rise for a fifth straight day. The drugmaker announced further data showing that its Covid-19 antibody therapy – developed in partnership with GlaxoSmithKline(GSK) – was effective against the omicron variant.\nEli Lilly and – The drugmaker raised its 2022 profit and revenue forecast ahead of today’s meeting with the investment community, noting that it is on track to meet its goal of delivering 20 new treatments in the 10-year period through 2023. Lilly moved higher by 4.7% in the premarket.\nR.R.Donnelley – R.R.Donnelley agreed to be acquired by Chatham Asset Management – the printing company’s top shareholder – for about $897 million. Donnelley terminated an earlier buyout deal it reached with private equity firm Atlas Holdings after determining that Chatham’s bid was a “superior proposal.” The stock fell 2.8% in the premarket.\nDomino's Pizza – Domino’s fell 2.1% in premarket trading after Barclays downgraded the stock to “underweight” from “equal weight.” Barclays said solid fundamentals and Covid headwinds in the industry as a whole helped Domino’s outperform during the pandemic, but noted that those headwinds for its competitors are now fading.\nRegeneron Pharmaceuticals – Regeneron was downgraded to “market perform” from “outperform” at Bernstein, which cites the risk to Regeneron’s best-selling eye drug Eylea from the future release of biosimilars. Regeneron slid 1.8% in the premarket.\nSix Flags Entertainment – The theme park operator’s stock rose 2.2% in the premarket after Goldman Sachs upgraded it to “buy” from “neutral,” noting resilient ticket pricing as well as guidance from Six Flags that Goldman considers conservative.\nHostess Brands Inc – The maker of Twinkies and other snack foods was rated “buy” in new coverage at Citi, which said Hostess is exiting the pandemic in a strong position with innovation driving market share gains. Hostess was up 1.1% in the premarket.\nUnited Parcel Service Inc – UBS named the delivery service’s stock as a “top pick,” saying UPS should benefit from increased consumer spending and that it has a greater chance of margin expansion than its rivals. UPS rose 1.1% in premarket trading.\nCabot Microelectronics – The advanced materials supplier agreed to be acquired by rivalEntegris(ENTG) in a cash-and-stock deal. Based on Tuesday’s closing prices, the transaction is worth $197.53 per CMC share, compared with CMC’s Tuesday close of $145.97. Entegris fell 3% in the premarket.\nBloomin – The Outback Steakhouse parent surged 5.3% in premarket trading after Jefferies added the stock to its “franchise picks” list, saying the company was positioned to benefit from positive structural changes in the casual dining category.","news_type":1},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698594888,"gmtCreate":1640439041190,"gmtModify":1640439041417,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698594888","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692285036,"gmtCreate":1640993498730,"gmtModify":1640993498922,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692285036","repostId":"1150283067","repostType":4,"repost":{"id":"1150283067","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640962811,"share":"https://www.laohu8.com/m/news/1150283067?lang=&edition=full","pubTime":"2021-12-31 23:00","market":"us","language":"en","title":"4 Biggest Price Target Changes For Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1150283067","media":"Benzinga","summary":"SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. X","content":"<html><head></head><body><p>SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.</p><p>Rosenblatt lifted Synaptics Incorporated SYNA +0.75%  price target from $290 to $345. Synaptics shares fell 1.6% to close at $287.70 on Thursday.</p><p>HC Wainwright &amp; Co. raised the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $4.25 to $5.4. Xeris Biopharma shares gained 18.9% to $2.89 in pre-market trading.</p><p>Barclays raised Constellation Brands, Inc. STZ +0.19% price target from $268 to $271. Constellation shares fell 0.2% to $249.00 in pre-market trading.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Biggest Price Target Changes For Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Biggest Price Target Changes For Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-31 23:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.</p><p>Rosenblatt lifted Synaptics Incorporated SYNA +0.75%  price target from $290 to $345. Synaptics shares fell 1.6% to close at $287.70 on Thursday.</p><p>HC Wainwright &amp; Co. raised the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $4.25 to $5.4. Xeris Biopharma shares gained 18.9% to $2.89 in pre-market trading.</p><p>Barclays raised Constellation Brands, Inc. STZ +0.19% price target from $268 to $271. Constellation shares fell 0.2% to $249.00 in pre-market trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STZ":"星座品牌","SYNA":"Synaptics Incorporated","XERS":"Xeris制药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150283067","content_text":"SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.Rosenblatt lifted Synaptics Incorporated SYNA +0.75%  price target from $290 to $345. Synaptics shares fell 1.6% to close at $287.70 on Thursday.HC Wainwright & Co. raised the price target on Xeris Biopharma Holdings, Inc. XERS +24.21% from $4.25 to $5.4. Xeris Biopharma shares gained 18.9% to $2.89 in pre-market trading.Barclays raised Constellation Brands, Inc. STZ +0.19% price target from $268 to $271. Constellation shares fell 0.2% to $249.00 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":760,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696976213,"gmtCreate":1640612015110,"gmtModify":1640612015319,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696976213","repostId":"1122290660","repostType":4,"repost":{"id":"1122290660","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640608857,"share":"https://www.laohu8.com/m/news/1122290660?lang=&edition=full","pubTime":"2021-12-27 20:40","market":"us","language":"en","title":"Grab stock climbed more than 3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1122290660","media":"Tiger Newspress","summary":"Grab stock climbed more than 3% in premarket trading as Wall Street saw massive upside for Asian tec","content":"<p>Grab stock climbed more than 3% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p><img src=\"https://static.tigerbbs.com/722d12abbd9fc66fd8ccd5576d98e63c\" tg-width=\"841\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock climbed more than 3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock climbed more than 3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 20:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab stock climbed more than 3% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p><img src=\"https://static.tigerbbs.com/722d12abbd9fc66fd8ccd5576d98e63c\" tg-width=\"841\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Grab debuted on the Nasdaq following a deal with blank-check company&nbsp;Altimeter Growth Corp., which&nbsp;valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.</p>\n<p>But shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.</p>\n<p>Still, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.</p>\n<p>“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”</p>\n<p>Here are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:</p>\n<p><b>JPMorgan</b></p>\n<p>JPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.</p>\n<p>Based on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.</p>\n<p>The analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”</p>\n<p>GMV is a metric&nbsp;often used in e-commerce&nbsp;to measure the total dollar value of goods sold&nbsp;over a certain period of time.</p>\n<p>The investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.</p>\n<p>While the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.</p>\n<p>The analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.</p>\n<p><b>Citi</b></p>\n<p>Citi initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.</p>\n<p>Compared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.</p>\n<p>The analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.</p>\n<p>Citi said, however, spending per transaction and per user is lower for Grab than other regional players like&nbsp;Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.</p>\n<p>“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.</p>\n<p><b>Evercore</b></p>\n<p>Evercore initiated coverage with an outperform rating and a price target of $10.</p>\n<p>The firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.</p>\n<p>“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.</p>\n<p>“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.</p>\n<p>In the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.</p>\n<p>Still, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122290660","content_text":"Grab stock climbed more than 3% in premarket trading as Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.\n\nGrab debuted on the Nasdaq following a deal with blank-check company Altimeter Growth Corp., which valued the company at nearly $40 billion. It became the largest-ever company to close a SPAC merger and go public.\nBut shares fell more than 20% from $13.06 to $8.75 a piece in the first day of trading. Since then, the stock has fallen another 16%.\nStill, JPMorgan likes the stock and said the company has a “superior regional superapp” and multiple opportunities for “multi-year growth.” The investment bank said that Grab’s regional leadership in Southeast Asia is driven by a highly scalable and localized platform that is underpinned by its proprietary technology.\n“The platform enables Grab to offer its services at a structurally lower cost base vs peers, with higher retention rates,” JPMorgan analysts wrote in their initiation coverage note earlier this month. “Grab’s platform gives it further advantages over its peers with limited geographical presence and/or fewer services, as Grab can allocate cash flows across countries and services to deliver on growth.”\nHere are JPMorgan, Citi and Evercore’s ratings and price targets for Grab, and why they like the stock:\nJPMorgan\nJPMorgan initiated coverage on Grab with an overweight rating and a price target of $12.50 over the next 12 months — that represents over 70% upside from the Dec. 23 closing price of $7.35.\nBased on the investment bank’s rating system, an overweight rating implies JPMorgan expects Grab’s stock to outperform over the next six to 12 months.\nThe analysts said Grab’s superior regional app, comprising multiple services including ride-hailing and food delivery, is “best geared to rising online consumption” in Southeast Asia. They said they identified gross merchandize value and revenue growth as key catalysts for the company and they see “multiple opportunities for multi-year growth.”\nGMV is a metric often used in e-commerce to measure the total dollar value of goods sold over a certain period of time.\nThe investment bank said Grab is a leader in ride-hailing across the region and that could lead to a highly profitable mobility business, where lifting Covid restrictions and broader economic reopening could drive growth.\nWhile the company’s delivery business is at an earlier stage of development, JPMorgan said there’s growth potential due to the relatively fragmented, but large total addressable market for food delivery and groceries. But the bank said that Grab is likely to see losses in the near-to-mid term due to investments and competition for market share.\nThe analysts warned, however, that Grab’s stock price could be volatile over the next six months as the free float expands due to staggered expiration of lock-ups that will release additional shares. Potential inclusion in MSCI indexes could also contribute to the volatility, JPMorgan said.\nCiti\nCiti initiated coverage of Grab with a buy rating and a price target of $12 a share, but also flagged the stock as high risk.\nCompared with regional peers, Citi analysts said Grab benefits from its ability to capture larger volumes of consumer data given higher frequency of delivery and mobility demand compared to services like e-commerce. That gives the company an easier way to cross-sell its financial services products, they added.\nThe analysts pointed out that Grab has a “broader geographic footprint with more equal strength in the ... Southeast Asia countries in which it operates,” compared with Indonesian rival GoTo Group.\nCiti said, however, spending per transaction and per user is lower for Grab than other regional players like Sea, which operates e-commerce platform Shopee. That implies Grab would face more headwinds if Covid cases in the region surge again, forcing countries to impose lockdowns and other mobility restrictions.\n“Grab also lacks a high-margin gaming business and global exposure given its Southeast Asia focus,” Citi analysts said.\nEvercore\nEvercore initiated coverage with an outperform rating and a price target of $10.\nThe firm said Grab will likely face more local competition in each market for its delivery business compared to ridesharing, where the only other international incumbent is GoTo Group’s Gojek — particularly, in Indonesia.\n“Within its Delivery segment, Grab faces a bit more competition across its core geographies,” Evercore analysts said in a recent note. They flagged the likes of Foodpanda, Gojek and Deliveroo in Singapore, LineMan in Thailand as well as Now and Baemin in Vietnam as competitors.\n“Lastly, Grab competes with last-mile logistics providers such as Gojek and Lalamove, and more local last-mile players such as AhaMove (Vietnam),” the analysts said.\nIn the financial services business, Grab faces competition from traditional players including credit card companies, banks as well as cash, which is still the predominant mode of payment in Southeast Asia.\nStill, the Evercore analysts said that most of Grab’s core business segments including delivery, mobility and financial services remain underpenetrated, which grants the Singapore-headquartered company “a probable long runway for growth.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605279533,"gmtCreate":1639185235150,"gmtModify":1639185235353,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605279533","repostId":"2190673267","repostType":4,"repost":{"id":"2190673267","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639176815,"share":"https://www.laohu8.com/m/news/2190673267?lang=&edition=full","pubTime":"2021-12-11 06:53","market":"hk","language":"en","title":"Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2190673267","media":"Reuters","summary":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year,","content":"<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Week Ahead-Investors await faster taper, inflation view at Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 06:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190673267","content_text":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.\nStocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.\nThere is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.\nMarkets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.\n“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.\nHigher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.\nThe S&P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.\nThe yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.\nSome stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.\nThe broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.\nThe Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.\nBets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.\nInvestors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.\nOne possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.\nMona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.\n“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601192121,"gmtCreate":1638496140168,"gmtModify":1638496141337,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601192121","repostId":"1119529609","repostType":4,"isVote":1,"tweetType":1,"viewCount":13,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877969164,"gmtCreate":1637877949550,"gmtModify":1637877949632,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877969164","repostId":"1143924299","repostType":4,"repost":{"id":"1143924299","pubTimestamp":1637846658,"share":"https://www.laohu8.com/m/news/1143924299?lang=&edition=full","pubTime":"2021-11-25 21:24","market":"us","language":"en","title":"What Inflation? Small Investors Keep Piling Into Flashy Growth Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1143924299","media":"WSJ","summary":"Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small i","content":"<p>Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small investors don’t care.</p>\n<p>Individual investors continue to stampede into shares of growth companies, the types of buzzy stocks that have enjoyed explosive price gains this year. Advanced Micro Devices Inc.,&nbsp;Nvidia Corp. and Apple Inc. are the three stocks most purchased this month by individual investors, according to VandaTrack, a Vanda Research flow tracker that measures net purchases.</p>\n<p>Growth stocks are typically companies—often tech firms—that are expected to deliver faster-than-average profit growth in the future. They tend to flourish in a low-rate environment, including over the past year and a half. Investors are typically willing to pay higher prices for such companies when they don’t see many alternatives for making sizable profits.</p>\n<p>For example, 18 of the stocks that are most favored by individual investors, including the chip makers AMD and Nvidia, trade on average at nearly 13 times their trailing 12-month sales, according to an analysis by Dow Jones Market Data. Stocks in the S&amp;P 500 trade at an average of three times their sales.</p>\n<p>But mounting inflation can be troublesome for growth stocks. That is because inflation brings the prospect of higher interest rates and higher bond yields, making the future cash flows of growth stocks less attractive. Traders, in turn, typically shuffle their portfolios to include other investments that stand to benefit from rising rates.</p>\n<p>A government report this month showed that the consumer-price index jumped 6.2% in October from a year earlier, climbing atthe fastest pace in three decades. Fund-flow tracker EPFR, whose data captures mostly institutional investor behavior, estimates that investors responded by yanking more than $2 billion out of U.S. tech-focused mutual and exchange-traded funds in the two weeks ended Nov. 17. That marks the worst stretch since a two-week period ended in early January 2019.</p>\n<p>At the same time, institutional investors are pumping money into more value-oriented sectors, such as consumer goods, healthcare and utilities, EPFR data show. Those industries tend to trade at lower valuations and tend to be more defensive moves for investors during times of heightened uncertainty.</p>\n<p>Greg Hahn, chief investment officer of Indianapolis-based Winthrop Capital Management, said his team has been paring back exposure to large-cap technology stocks.</p>\n<p>“We’re shifting out of growth,” Mr. Hahn said. Instead, the firm is focused on finding quality companies that have reasonable valuations and strong balance sheets—ones that are “sustainable in a potentially rough next market cycle,” he said.</p>\n<p>Recently, Mr. Hahn said, he has added exposure to a company that manufactures engines and generators and a pharmaceutical company that produces medicines and other products for animals.</p>\n<p>To be sure, U.S. stocks are still hovering near records, bond yields remain historically low and&nbsp;an earlier rally in gold prices&nbsp;has subsided. That suggests that inflation fears haven’t yet spurred many professional investors to entirely upend their playbooks. Some 61% of fund managers surveyed this month believe inflation is transitory, according to Bank of America Global Research.</p>\n<p>Still, the recent divergence in strategy between professional and individual investors is the latest example of&nbsp;the unusual dynamics that have played out in financial markets&nbsp;this year. Repeatedly, small investors&nbsp;have upended longstanding trading strategies&nbsp;by sending stocks such asGameStopCorp.andHertz Global HoldingsInc.HTZ11.06%soaring, with little regard for the companies’ underlying value. Some rely on classic momentum investing—a strategy of buying assets simply because they are rising.</p>\n<p>It isn’t uncommon for stocks favored by individual investors to be volatile. But those stocks can pay off too: AMD and Nvidia are each up 28% or more month-to-date, while Apple has climbed 8.1%. That compares with a 2.1% rise for the S&amp;P 500.</p>\n<p>“The lesson we’ve learned over the past 12 to 18 months…is that IPOs, fiscal stimulus and other micro [events] are much bigger drivers for retail investor behavior” than inflation readings, said Viraj Patel, global macro strategist at Vanda Research. “We’ve never woken up the day after the CPI and seen huge selling from retail investors.”</p>\n<p>Matt Delao, a 28-year-old individual investor from California, said he has followed data on inflation and supply-chain snarls this year. But he said his trading strategy has focused mostly on screening for stocks that appear priced for a significant move. Recently, he has traded options for AMD and bitcoin-mining companyRiot Blockchain&nbsp;Inc.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Inflation? Small Investors Keep Piling Into Flashy Growth Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Inflation? Small Investors Keep Piling Into Flashy Growth Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/what-inflation-small-investors-keep-piling-into-flashy-growth-stocks-11637836200?siteid=yhoof2><strong>WSJ</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small investors don’t care.\nIndividual investors continue to stampede into shares of growth companies, the ...</p>\n\n<a href=\"https://www.wsj.com/articles/what-inflation-small-investors-keep-piling-into-flashy-growth-stocks-11637836200?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","AAPL":"苹果","AMD":"美国超微公司"},"source_url":"https://www.wsj.com/articles/what-inflation-small-investors-keep-piling-into-flashy-growth-stocks-11637836200?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143924299","content_text":"Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small investors don’t care.\nIndividual investors continue to stampede into shares of growth companies, the types of buzzy stocks that have enjoyed explosive price gains this year. Advanced Micro Devices Inc., Nvidia Corp. and Apple Inc. are the three stocks most purchased this month by individual investors, according to VandaTrack, a Vanda Research flow tracker that measures net purchases.\nGrowth stocks are typically companies—often tech firms—that are expected to deliver faster-than-average profit growth in the future. They tend to flourish in a low-rate environment, including over the past year and a half. Investors are typically willing to pay higher prices for such companies when they don’t see many alternatives for making sizable profits.\nFor example, 18 of the stocks that are most favored by individual investors, including the chip makers AMD and Nvidia, trade on average at nearly 13 times their trailing 12-month sales, according to an analysis by Dow Jones Market Data. Stocks in the S&P 500 trade at an average of three times their sales.\nBut mounting inflation can be troublesome for growth stocks. That is because inflation brings the prospect of higher interest rates and higher bond yields, making the future cash flows of growth stocks less attractive. Traders, in turn, typically shuffle their portfolios to include other investments that stand to benefit from rising rates.\nA government report this month showed that the consumer-price index jumped 6.2% in October from a year earlier, climbing atthe fastest pace in three decades. Fund-flow tracker EPFR, whose data captures mostly institutional investor behavior, estimates that investors responded by yanking more than $2 billion out of U.S. tech-focused mutual and exchange-traded funds in the two weeks ended Nov. 17. That marks the worst stretch since a two-week period ended in early January 2019.\nAt the same time, institutional investors are pumping money into more value-oriented sectors, such as consumer goods, healthcare and utilities, EPFR data show. Those industries tend to trade at lower valuations and tend to be more defensive moves for investors during times of heightened uncertainty.\nGreg Hahn, chief investment officer of Indianapolis-based Winthrop Capital Management, said his team has been paring back exposure to large-cap technology stocks.\n“We’re shifting out of growth,” Mr. Hahn said. Instead, the firm is focused on finding quality companies that have reasonable valuations and strong balance sheets—ones that are “sustainable in a potentially rough next market cycle,” he said.\nRecently, Mr. Hahn said, he has added exposure to a company that manufactures engines and generators and a pharmaceutical company that produces medicines and other products for animals.\nTo be sure, U.S. stocks are still hovering near records, bond yields remain historically low and an earlier rally in gold prices has subsided. That suggests that inflation fears haven’t yet spurred many professional investors to entirely upend their playbooks. Some 61% of fund managers surveyed this month believe inflation is transitory, according to Bank of America Global Research.\nStill, the recent divergence in strategy between professional and individual investors is the latest example of the unusual dynamics that have played out in financial markets this year. Repeatedly, small investors have upended longstanding trading strategies by sending stocks such asGameStopCorp.andHertz Global HoldingsInc.HTZ11.06%soaring, with little regard for the companies’ underlying value. Some rely on classic momentum investing—a strategy of buying assets simply because they are rising.\nIt isn’t uncommon for stocks favored by individual investors to be volatile. But those stocks can pay off too: AMD and Nvidia are each up 28% or more month-to-date, while Apple has climbed 8.1%. That compares with a 2.1% rise for the S&P 500.\n“The lesson we’ve learned over the past 12 to 18 months…is that IPOs, fiscal stimulus and other micro [events] are much bigger drivers for retail investor behavior” than inflation readings, said Viraj Patel, global macro strategist at Vanda Research. “We’ve never woken up the day after the CPI and seen huge selling from retail investors.”\nMatt Delao, a 28-year-old individual investor from California, said he has followed data on inflation and supply-chain snarls this year. But he said his trading strategy has focused mostly on screening for stocks that appear priced for a significant move. Recently, he has traded options for AMD and bitcoin-mining companyRiot Blockchain Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854103039,"gmtCreate":1635425007173,"gmtModify":1635425021981,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854103039","repostId":"2178250012","repostType":4,"repost":{"id":"2178250012","pubTimestamp":1635423721,"share":"https://www.laohu8.com/m/news/2178250012?lang=&edition=full","pubTime":"2021-10-28 20:22","market":"us","language":"en","title":"3 Hypergrowth Stocks Expected to Increase Sales 21,551% to 948,737% by 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2178250012","media":"Motley Fool","summary":"Since the Great Recession ended in 2009, growth stocks have been virtually unstoppable. The combinat","content":"<p>Since the Great Recession ended in 2009, growth stocks have been virtually unstoppable. The combination of historically low lending rates and an accommodative central bank has rolled out the red carpet for fast-paced businesses to borrow at attractive rates.</p>\n<p>But for some companies, their hypergrowth period is just getting started. Based on Wall Street's consensus sales estimates, the following supercharged growth stocks are expected to see their sales rise 21,551% to as much as 948,737% by 2023.</p>\n<h2>Marathon Digital Holdings: 21,551% implied sales growth by 2023</h2>\n<p>Easily one of the fastest-growing stocks on the planet over the next three years is cryptocurrency mining company <b>Marathon Digital Holdings</b> (NASDAQ:MARA). Marathon reported $4.36 million in sales last year, but is projected by Wall Street to generate $944 million in full-year sales in 2023. That's your run-of-the-mill 21,551% increase in sales in just three years, if Wall Street's estimates prove accurate.</p>\n<p>Cryptocurrency miners are people or businesses using high-powered computers to solve complex mathematical equations that validate groups of transactions (known as a block) on a blockchain as true. Being the first to validate a block on a proof-of-work blockchain network results in the miner receiving a reward. In Marathon's case, it's specifically targeting the largest cryptocurrency in the world, <b>Bitcoin</b> (CRYPTO:BTC), which pays out 6.25 bitcoin per block reward. This means each block reward is worth close to $380,000.</p>\n<p>Marathon Digital's hypergrowth is the result of the company quickly growing its miner farm. In this instance, the more miners at work, the greater the likelihood of Marathon beating other miners to the punch and earning Bitcoin block rewards. When October began, the company had 25,272 active miners.&nbsp; But based on the company's existing orders, it has more than 107,000 additional miners on the way. When fully deployed, Marathon will have 133,120 miners up and running by mid-2022.</p>\n<p>While this might sound like a no-brainer way to play the cryptocurrency/Bitcoin buzz, crypto mining stocks might be the absolute worst choice for your investment dollars.</p>\n<p>To begin with, Bitcoin's block rewards halve every four years, and the barrier to entry for cryptocurrency mining is pretty much nonexistent. This means Marathon's competition will continue to increase as the long-term block reward profile for Bitcoin declines.</p>\n<p>What's more, Marathon Digital Holdings is entirely reliant on external factors for its growth, rather than innovation. It needs the hype and use case for Bitcoin to grow, otherwise its block rewards and balance sheet, which is held in Bitcoin, will shrink. As a reminder, Bitcoin has undergone three separate retracements of at least 80% over the past decade.</p>\n<p>If investors want to ride on Bitcoin's coattails, buying Marathon Digital isn't the way to do it.</p>\n<h2>Nikola: 788,321% implied sales growth by 2023</h2>\n<p>Another hypergrowth stock expected to deliver a jaw-dropping sales increase by the end of 2023 is electric vehicle (EV) and fuel cell electric vehicle (FCEV) manufacturer <b>Nikola</b> (NASDAQ:NKLA). Last year, Nikola recognized only $95,000 in total sales. But by the time 2023 rolls around, Wall Street expects the green-energy automaker to produce $749 million in sales. That's an increase of more than 788,000%!</p>\n<p>The opportunity on Nikola's doorstep is massive. Virtually all developed markets are focusing on ways to fight climate change, and replacing fossil fuel-burning vehicles with EVs and other alternative energy-powered vehicles is one of the easiest ways to reduce long-term carbon emissions. This consumer and enterprise vehicle replacement cycle could take decades to complete, meaning there's room for a dozen or more major automakers to thrive in developed and emerging markets.</p>\n<p>Over just the past three weeks, Nikola has secured two agreements. On Oct. 7, it and <b>TC Energy</b>&nbsp;announced a collaboration to develop large-scale hydrogen hubs for hydrogen-fueled heavy-duty trucks.&nbsp; Exactly one week later, Nikola announced a collaboration with PGT Trucking. This collaboration includes a letter of intent for 100 Nikola Tre heavy-duty FCEVs.</p>\n<p>While it's great to see Nikola fielding orders and collaborations, the company is a long way from shaking off the gray clouds hovering over it. Last year, short-selling firm Hindenburg Research alleged Nikola was a fraud. While an independent review found that many of Hindenburg's statements weren't accurate, some claims about Nikola's pre-sells were shown to be true. This admission, along with a Securities and Exchange Commission probe, has cost investors' trust in management.</p>\n<p>To make matters worse, it's pretty clear that Nikola doesn't have anywhere near enough capital to adequately ramp up production and build up its brand. This need for capital is likely to weigh on shareholders for the foreseeable future.</p>\n<h2>Ocugen: 948,737% implied sales growth by 2023</h2>\n<p>However, the kingpin of supercharged growth on this list is clinical-stage biotech stock <b>Ocugen</b> (NASDAQ:OCGN). Sales for the company totaled a mere $43,000 in 2020. By the end of 2023, Wall Street will be looking for $408 million in revenue. That's nearing a 950,000% increase in just three years.</p>\n<p>This hyperbolic sales growth for Ocugen is expected to come on the back of Covaxin, an as-of-now experimental COVID-19 vaccine. Covaxin was developed by India's Bharat Biotech, with Ocugen holding co-commercialization rights in the U.S. and Canada. In a large-scale clinical study in India, Covaxin demonstrated a nearly 78% vaccine efficacy (VE). While not on par with the top-notch initial VE's from <b>Moderna</b>&nbsp;and <b>Pfizer</b>/<b>BioNTech</b>&nbsp;in the U.S., a 78% VE would seemingly be strong enough to gain momentum in emerging markets where billions of vaccines still need to be administered.</p>\n<p>The mutability of the SARS-CoV-2 virus that causes COVID-19 has also worked in Ocugen's favor. The idea here being that different strains of the disease could coerce the need for booster shots and/or additional vaccine purchases.</p>\n<p>But there's a very serious flaw in the Ocugen bull thesis: the aforementioned co-commercialization rights being tied to only the U.S. and Canada. It really doesn't matter if Bharat Biotech is successful or fails to gain emergency-use approval in any other countries worldwide, because it won't influence U.S. or Canadian regulators to approve Covaxin any faster.</p>\n<p>To boot, the U.S. and Canada invested heavily in their respective vaccine stockpiles over the past year and likely have no need for another vaccine that's failed to stand out. That's bad news for Ocugen and its hopes to generate meaningful revenue anytime soon.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Hypergrowth Stocks Expected to Increase Sales 21,551% to 948,737% by 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Hypergrowth Stocks Expected to Increase Sales 21,551% to 948,737% by 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-28 20:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/28/3-hypergrowth-stock-increase-sales-21551-to-948737/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since the Great Recession ended in 2009, growth stocks have been virtually unstoppable. The combination of historically low lending rates and an accommodative central bank has rolled out the red ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/28/3-hypergrowth-stock-increase-sales-21551-to-948737/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MARA":"Marathon Digital Holdings Inc","NKLA":"Nikola Corporation","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2021/10/28/3-hypergrowth-stock-increase-sales-21551-to-948737/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178250012","content_text":"Since the Great Recession ended in 2009, growth stocks have been virtually unstoppable. The combination of historically low lending rates and an accommodative central bank has rolled out the red carpet for fast-paced businesses to borrow at attractive rates.\nBut for some companies, their hypergrowth period is just getting started. Based on Wall Street's consensus sales estimates, the following supercharged growth stocks are expected to see their sales rise 21,551% to as much as 948,737% by 2023.\nMarathon Digital Holdings: 21,551% implied sales growth by 2023\nEasily one of the fastest-growing stocks on the planet over the next three years is cryptocurrency mining company Marathon Digital Holdings (NASDAQ:MARA). Marathon reported $4.36 million in sales last year, but is projected by Wall Street to generate $944 million in full-year sales in 2023. That's your run-of-the-mill 21,551% increase in sales in just three years, if Wall Street's estimates prove accurate.\nCryptocurrency miners are people or businesses using high-powered computers to solve complex mathematical equations that validate groups of transactions (known as a block) on a blockchain as true. Being the first to validate a block on a proof-of-work blockchain network results in the miner receiving a reward. In Marathon's case, it's specifically targeting the largest cryptocurrency in the world, Bitcoin (CRYPTO:BTC), which pays out 6.25 bitcoin per block reward. This means each block reward is worth close to $380,000.\nMarathon Digital's hypergrowth is the result of the company quickly growing its miner farm. In this instance, the more miners at work, the greater the likelihood of Marathon beating other miners to the punch and earning Bitcoin block rewards. When October began, the company had 25,272 active miners.  But based on the company's existing orders, it has more than 107,000 additional miners on the way. When fully deployed, Marathon will have 133,120 miners up and running by mid-2022.\nWhile this might sound like a no-brainer way to play the cryptocurrency/Bitcoin buzz, crypto mining stocks might be the absolute worst choice for your investment dollars.\nTo begin with, Bitcoin's block rewards halve every four years, and the barrier to entry for cryptocurrency mining is pretty much nonexistent. This means Marathon's competition will continue to increase as the long-term block reward profile for Bitcoin declines.\nWhat's more, Marathon Digital Holdings is entirely reliant on external factors for its growth, rather than innovation. It needs the hype and use case for Bitcoin to grow, otherwise its block rewards and balance sheet, which is held in Bitcoin, will shrink. As a reminder, Bitcoin has undergone three separate retracements of at least 80% over the past decade.\nIf investors want to ride on Bitcoin's coattails, buying Marathon Digital isn't the way to do it.\nNikola: 788,321% implied sales growth by 2023\nAnother hypergrowth stock expected to deliver a jaw-dropping sales increase by the end of 2023 is electric vehicle (EV) and fuel cell electric vehicle (FCEV) manufacturer Nikola (NASDAQ:NKLA). Last year, Nikola recognized only $95,000 in total sales. But by the time 2023 rolls around, Wall Street expects the green-energy automaker to produce $749 million in sales. That's an increase of more than 788,000%!\nThe opportunity on Nikola's doorstep is massive. Virtually all developed markets are focusing on ways to fight climate change, and replacing fossil fuel-burning vehicles with EVs and other alternative energy-powered vehicles is one of the easiest ways to reduce long-term carbon emissions. This consumer and enterprise vehicle replacement cycle could take decades to complete, meaning there's room for a dozen or more major automakers to thrive in developed and emerging markets.\nOver just the past three weeks, Nikola has secured two agreements. On Oct. 7, it and TC Energy announced a collaboration to develop large-scale hydrogen hubs for hydrogen-fueled heavy-duty trucks.  Exactly one week later, Nikola announced a collaboration with PGT Trucking. This collaboration includes a letter of intent for 100 Nikola Tre heavy-duty FCEVs.\nWhile it's great to see Nikola fielding orders and collaborations, the company is a long way from shaking off the gray clouds hovering over it. Last year, short-selling firm Hindenburg Research alleged Nikola was a fraud. While an independent review found that many of Hindenburg's statements weren't accurate, some claims about Nikola's pre-sells were shown to be true. This admission, along with a Securities and Exchange Commission probe, has cost investors' trust in management.\nTo make matters worse, it's pretty clear that Nikola doesn't have anywhere near enough capital to adequately ramp up production and build up its brand. This need for capital is likely to weigh on shareholders for the foreseeable future.\nOcugen: 948,737% implied sales growth by 2023\nHowever, the kingpin of supercharged growth on this list is clinical-stage biotech stock Ocugen (NASDAQ:OCGN). Sales for the company totaled a mere $43,000 in 2020. By the end of 2023, Wall Street will be looking for $408 million in revenue. That's nearing a 950,000% increase in just three years.\nThis hyperbolic sales growth for Ocugen is expected to come on the back of Covaxin, an as-of-now experimental COVID-19 vaccine. Covaxin was developed by India's Bharat Biotech, with Ocugen holding co-commercialization rights in the U.S. and Canada. In a large-scale clinical study in India, Covaxin demonstrated a nearly 78% vaccine efficacy (VE). While not on par with the top-notch initial VE's from Moderna and Pfizer/BioNTech in the U.S., a 78% VE would seemingly be strong enough to gain momentum in emerging markets where billions of vaccines still need to be administered.\nThe mutability of the SARS-CoV-2 virus that causes COVID-19 has also worked in Ocugen's favor. The idea here being that different strains of the disease could coerce the need for booster shots and/or additional vaccine purchases.\nBut there's a very serious flaw in the Ocugen bull thesis: the aforementioned co-commercialization rights being tied to only the U.S. and Canada. It really doesn't matter if Bharat Biotech is successful or fails to gain emergency-use approval in any other countries worldwide, because it won't influence U.S. or Canadian regulators to approve Covaxin any faster.\nTo boot, the U.S. and Canada invested heavily in their respective vaccine stockpiles over the past year and likely have no need for another vaccine that's failed to stand out. That's bad news for Ocugen and its hopes to generate meaningful revenue anytime soon.","news_type":1},"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858088098,"gmtCreate":1634953278914,"gmtModify":1634954240091,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/858088098","repostId":"2177412634","repostType":4,"repost":{"id":"2177412634","pubTimestamp":1634950352,"share":"https://www.laohu8.com/m/news/2177412634?lang=&edition=full","pubTime":"2021-10-23 08:52","market":"us","language":"en","title":"Apple faces supply-chain issues, but can its buying power keep earnings on track?","url":"https://stock-news.laohu8.com/highlight/detail?id=2177412634","media":"MarketWatch","summary":"Apple earnings preview: Most valuable U.S. company faces same issues as other hardware makers, but i","content":"<p>Apple earnings preview: Most valuable U.S. company faces same issues as other hardware makers, but its status could help it withstand better than others</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a08f140d530f27e3d8519546232232f8\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Apple Inc. is scheduled to release its quarterly earnings report on Thursday afternoon.</span></p>\n<p>As supply constraints hit nearly every market, how much does the buying power of a $2.5 trillion electronics giant help?</p>\n<p>Investors are about to find out as Apple Inc.&nbsp;gears up for its Thursday afternoon earnings report. The company warned three months back that it expected greater impacts from supply-chain issues in the September quarter than it saw in the June quarter, but the global crunch appears to have intensified since Apple last faced investors -- a recent Bloomberg News report indicated that Apple was planning to cut its iPhone 13 production targets for the year due to component shortages.</p>\n<p>In perhaps a sign of its confidence, Apple plowed ahead with numerous device launches in the past two months. The company held its traditional September iPhone launch event, which also featured Apple Watch and iPad introductions, and then it unveiled new MacBook Pros and AirPods a month later.</p>\n<p>Potential supply constraints threaten to muddy an already uneventful iPhone launch and come at a crucial time for Apple as it heads into the holiday season. Even in less dramatic times for the global consumer-electronics industry, Apple has sometimes struggled to meet holiday-quarter demand for popular gift-giving items like its AirPods.</p>\n<p>Still, one analyst saw a potential positive for Apple amid the global disruption. If the company indeed faces component shortages that will impact its ability to get devices to consumers, its rivals could be feeling the crunch even more deeply, according to <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>'s Katy Huberty. Apple gets \"preferential treatment\" from its suppliers in tight situations, she argued, positioning it potentially to win market share during this stretch.</p>\n<p>D.A. Davidson analyst Tom Forte wrote that he was \"heartened\" to see relatively quick lead times for the products Apple announced in October. He'll be monitoring for the revenue and profit impacts of supply issues on Apple's earnings call.</p>\n<p>HP Inc., one of those Apple rivals, painted a mixed picture recently as executives called out continued strong demand for the company's personal computers but noted that they expect shortages to persist into next year. The company faces a growing backlog.</p>\n<p>It has been more than a year since Apple last issued a traditional financial outlook along with its earnings report, and it's unlikely that the company will go back to its old guidance-giving ways amid uncertainty about supply dynamics. Still, investors will be looking for some signals of how the latest iPhone line has performed in its first few weeks of availability as well as for broader indications of Apple's ability to manage supply-chain disruptions in the months ahead.</p>\n<p><b>What to watch for</b></p>\n<p><b>Earnings: </b>Analysts tracked by FactSet expect that Apple earned $1.24 a share in its fiscal fourth quarter, up from 73 cents a share in the year-earlier period. According to Estimize, which crowdsources projections from hedge funds, academics and others, the average earnings estimate calls for $1.33 a share.</p>\n<p><b>Revenue:</b> The FactSet consensus calls for September-quarter revenue of $84.99 billion, up from $64.7 billion a year prior. The average projection on Estimize is for $87.09 billion.</p>\n<p>Analysts tracked by FactSet are looking for $41.16 billion in iPhone sales; $7.25 billion in iPad sales; $9.15 billion in Mac sales; $9.40 billion in wearables, home and accessories sales; and $17.70 billion in services revenue.</p>\n<p><b>Stock movement:</b> Apple shares have fallen the day after each of the company's last four earnings reports. Shares have added 12.2% so far this year as the Dow Jones Industrial Average , which counts Apple as a component, has risen 16.6%.</p>\n<p>Analysts remain generally upbeat about Apple's prospects: Of the 43 tracked by FactSet who cover Apple's stock, 32 have buy ratings, nine have hold ratings, and two have sell ratings. The average price target listed is $167.32, which is 12.5% above recent levels.</p>\n<p><b>What analysts are saying</b></p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>.'s (SNAP) pain could be Apple's gain.</p>\n<p>The smartphone giant has been orienting itself as a champion of privacy, which is hurting social-media companies on Snap that have relied on the ability to track user activity and target advertisements accordingly.</p>\n<p>Users have gradually been upgrading their device operating systems to newer versions of Apple's iOS that allow for the ability to opt out of third-party tracking, and Snap expects a significant impact from the changes. Its shares suffered a record fall after its September-quarter report, suggesting to at least one analyst that Apple may be poised to benefit by appealing to advertisers itself.</p>\n<p>While Apple has clamped down on the ability for third parties to track user activity for marketing purposes, the company is also trying to build out its own advertising business, and Evercore ISI analyst Amit Daryanani wrote that the disruptions felt by Snap could help \"newer players in the market like Apple at the expense of more established competitors,\" though admittedly Apple's measurement tools may not be ideal for some in the ad market.</p>\n<p>\"Apple's recent actions may be focused on privacy, but it also creates a very favorable environment as they look to build an advertising business that we think could eventually generate $20 billion in annual revenue,\" he wrote.</p>\n<p>Advertising sits within Apple's services business, along with the App Store, which has increasingly become an area of contention. Apple takes up to 30% of in-app purchases made through its payment system, and some high-profile developers have asked for an alternate payment option. Following a lawsuit from Epic Games, a federal judge recently ruled that Apple had to allow app developers to link to other payment options, but the company is appealing that decision.</p>\n<p>App Store fees are a lucrative part of Apple's business, and the company may face questions during its earnings call about its growing antitrust pressures as well as the financial impacts of possible App Store payment changes.</p>\n<p>\"The injunction could equal a 1% revenue and 4% EPS impact for Apple in 2023 and beyond,\" Jefferies analyst Kyle McNealy wrote last month. \"Any impact will take time and won't be seen until the Jun'22 Q at the earliest,\" he continued, calling the judge's ruling \"largely a win\" for Apple since the judge declined to call the company an illegal monopolist.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple faces supply-chain issues, but can its buying power keep earnings on track?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple faces supply-chain issues, but can its buying power keep earnings on track?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-23 08:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/apple-faces-supply-chain-issues-but-can-its-buying-power-keep-earnings-on-track-11634938762?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple earnings preview: Most valuable U.S. company faces same issues as other hardware makers, but its status could help it withstand better than others\nApple Inc. is scheduled to release its ...</p>\n\n<a href=\"https://www.marketwatch.com/story/apple-faces-supply-chain-issues-but-can-its-buying-power-keep-earnings-on-track-11634938762?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.marketwatch.com/story/apple-faces-supply-chain-issues-but-can-its-buying-power-keep-earnings-on-track-11634938762?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177412634","content_text":"Apple earnings preview: Most valuable U.S. company faces same issues as other hardware makers, but its status could help it withstand better than others\nApple Inc. is scheduled to release its quarterly earnings report on Thursday afternoon.\nAs supply constraints hit nearly every market, how much does the buying power of a $2.5 trillion electronics giant help?\nInvestors are about to find out as Apple Inc. gears up for its Thursday afternoon earnings report. The company warned three months back that it expected greater impacts from supply-chain issues in the September quarter than it saw in the June quarter, but the global crunch appears to have intensified since Apple last faced investors -- a recent Bloomberg News report indicated that Apple was planning to cut its iPhone 13 production targets for the year due to component shortages.\nIn perhaps a sign of its confidence, Apple plowed ahead with numerous device launches in the past two months. The company held its traditional September iPhone launch event, which also featured Apple Watch and iPad introductions, and then it unveiled new MacBook Pros and AirPods a month later.\nPotential supply constraints threaten to muddy an already uneventful iPhone launch and come at a crucial time for Apple as it heads into the holiday season. Even in less dramatic times for the global consumer-electronics industry, Apple has sometimes struggled to meet holiday-quarter demand for popular gift-giving items like its AirPods.\nStill, one analyst saw a potential positive for Apple amid the global disruption. If the company indeed faces component shortages that will impact its ability to get devices to consumers, its rivals could be feeling the crunch even more deeply, according to Morgan Stanley's Katy Huberty. Apple gets \"preferential treatment\" from its suppliers in tight situations, she argued, positioning it potentially to win market share during this stretch.\nD.A. Davidson analyst Tom Forte wrote that he was \"heartened\" to see relatively quick lead times for the products Apple announced in October. He'll be monitoring for the revenue and profit impacts of supply issues on Apple's earnings call.\nHP Inc., one of those Apple rivals, painted a mixed picture recently as executives called out continued strong demand for the company's personal computers but noted that they expect shortages to persist into next year. The company faces a growing backlog.\nIt has been more than a year since Apple last issued a traditional financial outlook along with its earnings report, and it's unlikely that the company will go back to its old guidance-giving ways amid uncertainty about supply dynamics. Still, investors will be looking for some signals of how the latest iPhone line has performed in its first few weeks of availability as well as for broader indications of Apple's ability to manage supply-chain disruptions in the months ahead.\nWhat to watch for\nEarnings: Analysts tracked by FactSet expect that Apple earned $1.24 a share in its fiscal fourth quarter, up from 73 cents a share in the year-earlier period. According to Estimize, which crowdsources projections from hedge funds, academics and others, the average earnings estimate calls for $1.33 a share.\nRevenue: The FactSet consensus calls for September-quarter revenue of $84.99 billion, up from $64.7 billion a year prior. The average projection on Estimize is for $87.09 billion.\nAnalysts tracked by FactSet are looking for $41.16 billion in iPhone sales; $7.25 billion in iPad sales; $9.15 billion in Mac sales; $9.40 billion in wearables, home and accessories sales; and $17.70 billion in services revenue.\nStock movement: Apple shares have fallen the day after each of the company's last four earnings reports. Shares have added 12.2% so far this year as the Dow Jones Industrial Average , which counts Apple as a component, has risen 16.6%.\nAnalysts remain generally upbeat about Apple's prospects: Of the 43 tracked by FactSet who cover Apple's stock, 32 have buy ratings, nine have hold ratings, and two have sell ratings. The average price target listed is $167.32, which is 12.5% above recent levels.\nWhat analysts are saying\nSnap Inc.'s (SNAP) pain could be Apple's gain.\nThe smartphone giant has been orienting itself as a champion of privacy, which is hurting social-media companies on Snap that have relied on the ability to track user activity and target advertisements accordingly.\nUsers have gradually been upgrading their device operating systems to newer versions of Apple's iOS that allow for the ability to opt out of third-party tracking, and Snap expects a significant impact from the changes. Its shares suffered a record fall after its September-quarter report, suggesting to at least one analyst that Apple may be poised to benefit by appealing to advertisers itself.\nWhile Apple has clamped down on the ability for third parties to track user activity for marketing purposes, the company is also trying to build out its own advertising business, and Evercore ISI analyst Amit Daryanani wrote that the disruptions felt by Snap could help \"newer players in the market like Apple at the expense of more established competitors,\" though admittedly Apple's measurement tools may not be ideal for some in the ad market.\n\"Apple's recent actions may be focused on privacy, but it also creates a very favorable environment as they look to build an advertising business that we think could eventually generate $20 billion in annual revenue,\" he wrote.\nAdvertising sits within Apple's services business, along with the App Store, which has increasingly become an area of contention. Apple takes up to 30% of in-app purchases made through its payment system, and some high-profile developers have asked for an alternate payment option. Following a lawsuit from Epic Games, a federal judge recently ruled that Apple had to allow app developers to link to other payment options, but the company is appealing that decision.\nApp Store fees are a lucrative part of Apple's business, and the company may face questions during its earnings call about its growing antitrust pressures as well as the financial impacts of possible App Store payment changes.\n\"The injunction could equal a 1% revenue and 4% EPS impact for Apple in 2023 and beyond,\" Jefferies analyst Kyle McNealy wrote last month. \"Any impact will take time and won't be seen until the Jun'22 Q at the earliest,\" he continued, calling the judge's ruling \"largely a win\" for Apple since the judge declined to call the company an illegal monopolist.","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":892938311,"gmtCreate":1628631833833,"gmtModify":1633745671649,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"&nbsp; &nbsp;[开心]&nbsp;","listText":"&nbsp; &nbsp;[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/892938311","repostId":"2158477242","repostType":4,"repost":{"id":"2158477242","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1628608200,"share":"https://www.laohu8.com/m/news/2158477242?lang=&edition=full","pubTime":"2021-08-10 23:10","market":"us","language":"en","title":"DoorDash is trying to plan for the end of the pandemic while benefiting from it","url":"https://stock-news.laohu8.com/highlight/detail?id=2158477242","media":"Dow Jones","summary":"DoorDash earnings preview: Delivery company is seeking to expand business beyond prepared foods while experiencing huge gains from Americans staying home. DoorDash Inc. has benefited from the pandemic, but the delivery company hopes it can branch out beyond prepared-food delivery for greater sustainability.Restaurants have reopened along with the rest of the economy, but with the delta variant of COVID-19 surging in many states, delivery platform DoorDash is still expected to show strong results","content":"<p>DoorDash earnings preview: Delivery company is seeking to expand business beyond prepared foods while experiencing huge gains from Americans staying home</p>\n<p>DoorDash Inc. has benefited from the pandemic, but the delivery company hopes it can branch out beyond prepared-food delivery for greater sustainability.</p>\n<p>Restaurants have reopened along with the rest of the economy, but with the delta variant of COVID-19 surging in many states, delivery platform DoorDash is still expected to show strong results when it reports earnings Thursday afternoon, some analysts say.</p>\n<p>DoorDash <a href=\"https://laohu8.com/S/DASH\">$(DASH)$</a>, which handily beat expectations in the previous quarter , likely had a strong second quarter, too, Truist Securities analysts say. They expect the company to benefit from \"continued momentum in food delivery even as the economy reopens, and from early traction in the non-restaurant segments,\" the analysts wrote in a note to investors.</p>\n<p>DoorDash now also offers convenience-store and grocery deliveries, including partnerships with big grocers like Albertsons Cos. Inc.<a href=\"https://laohu8.com/S/ACI.UK\">$(ACI.UK)$</a> And this month, the company announced DoubleDash, which offers customers the ability to combine their restaurant orders with orders from a nearby store in a single transaction.</p>\n<p>Already the U.S. market leader in food delivery, DoorDash is doing what competitor and ride-hailing giant Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> has done by rivaling DoorDash: hedge its bets. To underscore that point, data from research firm M Science shows that even if customer growth may now be slowing compared with the big boost in customers DoorDash saw because of the pandemic-related lockdowns, there is still quarter-over-quarter \"growth in share of [gross order volume] attributable to non-restaurant categories.\"</p>\n<p>See: The rise of the gig economy spells the end for these workers</p>\n<p>In addition, a new wave of coronavirus cases could \"prevent the economy from fully reopening and benefit DoorDash short term,\" Truist analysts wrote. But they said the \"very tough\" second-half, year-over-year comparisons could cause the company to issue conservative guidance.</p>\n<p>What to expect</p>\n<p>Earnings: Analysts surveyed by FactSet on average expect DoorDash to post a loss of $75 million, or 6 cents a share. The average expectation of analysts, hedge-fund managers, executives and more, as gathered by Estimize, is a loss of 7 cents a share.</p>\n<p>Revenue: Analysts on average expect revenue of $1.1 billion, according to FactSet. Estimize is guiding for $1.09 billion.</p>\n<p>Stock movement: DoorDash shares are up about 28% this year through Monday's session, while the S&amp;P 500 index has gained 18%.</p>\n<p>What analysts are saying</p>\n<p>According to Truist's data, DoorDash's marketplace gross order volume, or GOV, may have grown 60% or more in the quarter. Analyst Youssef Squali wrote that would be in line with Truist's June survey, which found that even after vaccination, consumers showed \"little change\" in using food delivery.</p>\n<p>Analysts surveyed by FactSet on average expect GOV of $9.78 billion. That's about a 59% increase year over year. By comparison, GOV rose 227% from $1.88 billion in the second quarter of 2019 to $6.15 billion in the second quarter of 2020.</p>\n<p>Another key issue for DoorDash is fee caps that were instituted by cities and counties during the pandemic. Those have expired in many places, but this summer San Francisco made 15% fee commissions -- what delivery platforms charge restaurants -- permanent, prompting a lawsuit from DoorDash and competitor Grubhub.</p>\n<p>Despite possible complications for DoorDash's business over fee caps, Truist analysts wrote that they \"view the easing of fee caps as a positive for DoorDash take rate\" in the second half of 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DoorDash is trying to plan for the end of the pandemic while benefiting from it</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoorDash is trying to plan for the end of the pandemic while benefiting from it\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-10 23:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>DoorDash earnings preview: Delivery company is seeking to expand business beyond prepared foods while experiencing huge gains from Americans staying home</p>\n<p>DoorDash Inc. has benefited from the pandemic, but the delivery company hopes it can branch out beyond prepared-food delivery for greater sustainability.</p>\n<p>Restaurants have reopened along with the rest of the economy, but with the delta variant of COVID-19 surging in many states, delivery platform DoorDash is still expected to show strong results when it reports earnings Thursday afternoon, some analysts say.</p>\n<p>DoorDash <a href=\"https://laohu8.com/S/DASH\">$(DASH)$</a>, which handily beat expectations in the previous quarter , likely had a strong second quarter, too, Truist Securities analysts say. They expect the company to benefit from \"continued momentum in food delivery even as the economy reopens, and from early traction in the non-restaurant segments,\" the analysts wrote in a note to investors.</p>\n<p>DoorDash now also offers convenience-store and grocery deliveries, including partnerships with big grocers like Albertsons Cos. Inc.<a href=\"https://laohu8.com/S/ACI.UK\">$(ACI.UK)$</a> And this month, the company announced DoubleDash, which offers customers the ability to combine their restaurant orders with orders from a nearby store in a single transaction.</p>\n<p>Already the U.S. market leader in food delivery, DoorDash is doing what competitor and ride-hailing giant Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> has done by rivaling DoorDash: hedge its bets. To underscore that point, data from research firm M Science shows that even if customer growth may now be slowing compared with the big boost in customers DoorDash saw because of the pandemic-related lockdowns, there is still quarter-over-quarter \"growth in share of [gross order volume] attributable to non-restaurant categories.\"</p>\n<p>See: The rise of the gig economy spells the end for these workers</p>\n<p>In addition, a new wave of coronavirus cases could \"prevent the economy from fully reopening and benefit DoorDash short term,\" Truist analysts wrote. But they said the \"very tough\" second-half, year-over-year comparisons could cause the company to issue conservative guidance.</p>\n<p>What to expect</p>\n<p>Earnings: Analysts surveyed by FactSet on average expect DoorDash to post a loss of $75 million, or 6 cents a share. The average expectation of analysts, hedge-fund managers, executives and more, as gathered by Estimize, is a loss of 7 cents a share.</p>\n<p>Revenue: Analysts on average expect revenue of $1.1 billion, according to FactSet. Estimize is guiding for $1.09 billion.</p>\n<p>Stock movement: DoorDash shares are up about 28% this year through Monday's session, while the S&amp;P 500 index has gained 18%.</p>\n<p>What analysts are saying</p>\n<p>According to Truist's data, DoorDash's marketplace gross order volume, or GOV, may have grown 60% or more in the quarter. Analyst Youssef Squali wrote that would be in line with Truist's June survey, which found that even after vaccination, consumers showed \"little change\" in using food delivery.</p>\n<p>Analysts surveyed by FactSet on average expect GOV of $9.78 billion. That's about a 59% increase year over year. By comparison, GOV rose 227% from $1.88 billion in the second quarter of 2019 to $6.15 billion in the second quarter of 2020.</p>\n<p>Another key issue for DoorDash is fee caps that were instituted by cities and counties during the pandemic. Those have expired in many places, but this summer San Francisco made 15% fee commissions -- what delivery platforms charge restaurants -- permanent, prompting a lawsuit from DoorDash and competitor Grubhub.</p>\n<p>Despite possible complications for DoorDash's business over fee caps, Truist analysts wrote that they \"view the easing of fee caps as a positive for DoorDash take rate\" in the second half of 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UBER":"优步","ACI":"艾伯森","DASH":"DoorDash, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158477242","content_text":"DoorDash earnings preview: Delivery company is seeking to expand business beyond prepared foods while experiencing huge gains from Americans staying home\nDoorDash Inc. has benefited from the pandemic, but the delivery company hopes it can branch out beyond prepared-food delivery for greater sustainability.\nRestaurants have reopened along with the rest of the economy, but with the delta variant of COVID-19 surging in many states, delivery platform DoorDash is still expected to show strong results when it reports earnings Thursday afternoon, some analysts say.\nDoorDash $(DASH)$, which handily beat expectations in the previous quarter , likely had a strong second quarter, too, Truist Securities analysts say. They expect the company to benefit from \"continued momentum in food delivery even as the economy reopens, and from early traction in the non-restaurant segments,\" the analysts wrote in a note to investors.\nDoorDash now also offers convenience-store and grocery deliveries, including partnerships with big grocers like Albertsons Cos. Inc.$(ACI.UK)$ And this month, the company announced DoubleDash, which offers customers the ability to combine their restaurant orders with orders from a nearby store in a single transaction.\nAlready the U.S. market leader in food delivery, DoorDash is doing what competitor and ride-hailing giant Uber Technologies Inc. $(UBER)$ has done by rivaling DoorDash: hedge its bets. To underscore that point, data from research firm M Science shows that even if customer growth may now be slowing compared with the big boost in customers DoorDash saw because of the pandemic-related lockdowns, there is still quarter-over-quarter \"growth in share of [gross order volume] attributable to non-restaurant categories.\"\nSee: The rise of the gig economy spells the end for these workers\nIn addition, a new wave of coronavirus cases could \"prevent the economy from fully reopening and benefit DoorDash short term,\" Truist analysts wrote. But they said the \"very tough\" second-half, year-over-year comparisons could cause the company to issue conservative guidance.\nWhat to expect\nEarnings: Analysts surveyed by FactSet on average expect DoorDash to post a loss of $75 million, or 6 cents a share. The average expectation of analysts, hedge-fund managers, executives and more, as gathered by Estimize, is a loss of 7 cents a share.\nRevenue: Analysts on average expect revenue of $1.1 billion, according to FactSet. Estimize is guiding for $1.09 billion.\nStock movement: DoorDash shares are up about 28% this year through Monday's session, while the S&P 500 index has gained 18%.\nWhat analysts are saying\nAccording to Truist's data, DoorDash's marketplace gross order volume, or GOV, may have grown 60% or more in the quarter. Analyst Youssef Squali wrote that would be in line with Truist's June survey, which found that even after vaccination, consumers showed \"little change\" in using food delivery.\nAnalysts surveyed by FactSet on average expect GOV of $9.78 billion. That's about a 59% increase year over year. By comparison, GOV rose 227% from $1.88 billion in the second quarter of 2019 to $6.15 billion in the second quarter of 2020.\nAnother key issue for DoorDash is fee caps that were instituted by cities and counties during the pandemic. Those have expired in many places, but this summer San Francisco made 15% fee commissions -- what delivery platforms charge restaurants -- permanent, prompting a lawsuit from DoorDash and competitor Grubhub.\nDespite possible complications for DoorDash's business over fee caps, Truist analysts wrote that they \"view the easing of fee caps as a positive for DoorDash take rate\" in the second half of 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693955597,"gmtCreate":1639963987876,"gmtModify":1639963988061,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693955597","repostId":"1146401633","repostType":4,"repost":{"id":"1146401633","pubTimestamp":1639960833,"share":"https://www.laohu8.com/m/news/1146401633?lang=&edition=full","pubTime":"2021-12-20 08:40","market":"sg","language":"en","title":"Singapore’s Economy Faces Multiple Threats as Growth Slows","url":"https://stock-news.laohu8.com/highlight/detail?id=1146401633","media":"Bloomberg","summary":"A year ago, Singapore welcomed 2021 hoping the worst of the pandemic was over, with Prime Minister L","content":"<p>A year ago, Singapore welcomed 2021 hoping the worst of the pandemic was over, with Prime Minister Lee Hsien Loong&nbsp;hailing&nbsp;“the light at the end of the tunnel” as the city-state&nbsp;launched&nbsp;its vaccination drive.</p>\n<p>Since then, new virus variants and Singapore’s worst Covid surge have tempered expectations of a quick reopening, even as the island nation boasts one of the world’s highest vaccination rates. Now, on the cusp of 2022, the global spread of the omicron variant has&nbsp;rekindled concern&nbsp;over setbacks and a reimposition of social curbs -- though so far the government is&nbsp;staying the course&nbsp;on reopening.</p>\n<p>New challenges like the persistent rise of inflation and a slowing economic recovery will keep eyes focused on how Singapore policy makers react. Investors also are watching how economic policies addressing long-term challenges like climate change and income inequality impact the island’s business-friendly reputation.</p>\n<p>Here are some themes and events to look out for in 2022:</p>\n<p><b>Reopening Bumps</b></p>\n<p>Singapore’s pivot to a strategy of “living with the virus” was already facing hiccups when a surge in cases this fall led authorities to reimpose local restrictions. In recent weeks, the emergence of omicron has forced authorities to&nbsp;hold off&nbsp;on expanding vaccinated travel lanes to other hubs like Dubai.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/16771ae17de905540087682bf9b9da66\" tg-width=\"1000\" tg-height=\"665\" width=\"100%\" height=\"auto\"><span>Travellers outside the transit area of the departure hall at Changi International Airport in Singapore on Dec. 2.Photographer: Roslan Rahman/AFP/Getty Images</span></p>\n<p>The rise of omicron “has definitely put a damper on reopening plans and may exacerbate imported inflation, as border controls and heightened hygiene measures also contribute to global supply-chain bottlenecks,” said Selena Ling, head of treasury research and strategy at&nbsp;Oversea-Chinese Banking Corp.</p>\n<p><img src=\"https://static.tigerbbs.com/5b2a215d7bf90bf7bfa23b3be11473e2\" tg-width=\"953\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p>\n<p>Singapore’s economic recovery was already&nbsp;expected to slowto 3%-5% growth next year, from about 7% this year, according to the trade ministry. Still, most economists remain optimistic about the city-state’s growth prospects as local infections&nbsp;subside.</p>\n<p>“We see significant room for catch-up” of vulnerable sectors like tourism and aviation,Nomura Holdings Inc.&nbsp;economis&nbsp;ts including Euben Paracuelles wrote in a December report.</p>\n<p>Electronics&nbsp;and pharmaceuticals production, which are relatively insulated from slower global growth, can continue lifting Singapore’s economy, they said. A rise in vacancies paints a strong outlook for jobs, with the unemployment rate seen dropping to 1.9% next year, below its pre-pandemic level of 2.2%.</p>\n<p><b>Inflation Bites</b></p>\n<p>Singapore has avoided the worst of the price rises seen in countries from the U.S. to Brazil, even as supply-chain bottlenecks and a&nbsp;global energy crisis&nbsp;drive up local food and electricity bills.</p>\n<p>Most observers expect the central bank to tighten monetary policy again at its April review after core inflation hit its&nbsp;highest level&nbsp;in more than two years last month.</p>\n<p><img src=\"https://static.tigerbbs.com/2dd1c0ddc4eea1ea56d5df7a15d8dad3\" tg-width=\"959\" tg-height=\"576\" width=\"100%\" height=\"auto\"></p>\n<p>Headline inflation also is expected to continue rising into next year, before moderating. As a trade hub, Singapore could be more sensitive than most to further snarls in global supply chains that could drive up prices around the world.</p>\n<p>How aggressive the&nbsp;Monetary Authority of Singapore&nbsp;will be remains an open question. It surprised markets in October when it&nbsp;tightened&nbsp;monetary policy, and has&nbsp;indicated&nbsp;it is “ready to act” against further inflation risks.</p>\n<p>Faiz Nagutha, Asean economist at Bank of America Securities, expects MAS to steepen the slope of its currency band to 1% appreciation per year, from the current 0.5% pace. He’s not ruling out a&nbsp;sharper hike&nbsp;to 1.5% appreciation -- already the baseline forecast at&nbsp;Goldman Sachs Group Inc.-- if inflation accelerates further.</p>\n<p><b>Property</b></p>\n<p>Long a topic of concern among Singapore residents, the property market’s&nbsp;strong performance&nbsp;this year prompted&nbsp;mid-December curbsfrom the government, the first new measures since 2018.</p>\n<p>Amid signs that the U.S. Federal Reserve may&nbsp;accelerate interest-rate hikes&nbsp;next year -- something that could drive rates higher globally -- concerns have risen that Singapore borrowers may be vulnerable. New requirements such as additional stamp duties for second homes could be targeted at buyers that have overstretched their finances to purchase private property, said&nbsp;Christine Sun, senior vice president of research and analytics at&nbsp;OrangeTee &amp; Tie Pte.&nbsp;in Singapore.</p>\n<p>Market watchers are divided on how much the new policies might dampen market momentum. Sun projects private-home prices to rise “at a much slower pace” in 2022, in the range of 0%-3%.</p>\n<p>Alan Cheong, executive director of research at&nbsp;Savills Plc, said the new measures may limit foreign buying of private residential properties, but are “unlikely to have any significant impact” on local demand.</p>\n<p>Cheong still expects Singapore private residential prices to rise by 7% next year, as “the belief that real estate is a hedge against inflation” means that elevated inflation could actually be a driver of demand. He does not believe any significant government intervention is likely next year.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4308e0de57dd5ce4ee5bb1f994d65b01\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"><span>The lounge of an apartment for sale in Singapore earlier in August. Photographer: Wei Leng Tay/Bloomberg</span></p>\n<p><b>Taxes</b></p>\n<p>Singapore’s 2022 budget in February will be closely watched for any moves targeting the wealthy and raising revenue to consolidate the city’s finances after two years of pandemic-driven deficits.</p>\n<p>“Fiscal policy in particular will prioritize a return to balanced budget over the current term of government, which may require a range of tax increases,”Citigroup Inc.&nbsp;economists Kit Wei Zheng and Ang Kai Wei wrote in a December note.</p>\n<p>Bloomberg News previously&nbsp;reported&nbsp;that city officials have been consulting business elites about possible changes, but Prime Minister Lee said in November that finding effective ways to tax wealth was“not so easy.”Finance Minister Lawrence Wong has committed to announcing a&nbsp;carbon-tax hike&nbsp;for 2024 in next year’s budget, as the city takes additional steps against climate change.</p>\n<p>Citigroup’s economists say a hike in the goods and services tax -- which the government has said will happen by 2025 -- will likely be implemented next July, along with a wealth tax on existing property assets to “cushion the political impact.”</p>\n<p>Such an approach will avoid hurting “the important wealth management industry” and Singapore’s competitiveness, while targeting “relatively immobile forms of wealth” Citi said.</p>\n<p>Policy makers will be under pressure to maintain current spending levels, with Singapore’s top business federation recently calling for the&nbsp;further extension&nbsp;of wage and loan support into next year.</p>\n<p>Trinh Nguyen, senior economist for emerging Asia at&nbsp;Natixis SA&nbsp;believes the government will “act rather cautiously” on taxes while it shores up the recovery. The rise in GST may be delayed, she said, as it would “push inflation higher and is regressive.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore’s Economy Faces Multiple Threats as Growth Slows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore’s Economy Faces Multiple Threats as Growth Slows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 08:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-19/singapore-s-economy-faces-multiple-threats-as-growth-slows><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A year ago, Singapore welcomed 2021 hoping the worst of the pandemic was over, with Prime Minister Lee Hsien Loong hailing “the light at the end of the tunnel” as the city-state launched its ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-19/singapore-s-economy-faces-multiple-threats-as-growth-slows\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-19/singapore-s-economy-faces-multiple-threats-as-growth-slows","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146401633","content_text":"A year ago, Singapore welcomed 2021 hoping the worst of the pandemic was over, with Prime Minister Lee Hsien Loong hailing “the light at the end of the tunnel” as the city-state launched its vaccination drive.\nSince then, new virus variants and Singapore’s worst Covid surge have tempered expectations of a quick reopening, even as the island nation boasts one of the world’s highest vaccination rates. Now, on the cusp of 2022, the global spread of the omicron variant has rekindled concern over setbacks and a reimposition of social curbs -- though so far the government is staying the course on reopening.\nNew challenges like the persistent rise of inflation and a slowing economic recovery will keep eyes focused on how Singapore policy makers react. Investors also are watching how economic policies addressing long-term challenges like climate change and income inequality impact the island’s business-friendly reputation.\nHere are some themes and events to look out for in 2022:\nReopening Bumps\nSingapore’s pivot to a strategy of “living with the virus” was already facing hiccups when a surge in cases this fall led authorities to reimpose local restrictions. In recent weeks, the emergence of omicron has forced authorities to hold off on expanding vaccinated travel lanes to other hubs like Dubai.\nTravellers outside the transit area of the departure hall at Changi International Airport in Singapore on Dec. 2.Photographer: Roslan Rahman/AFP/Getty Images\nThe rise of omicron “has definitely put a damper on reopening plans and may exacerbate imported inflation, as border controls and heightened hygiene measures also contribute to global supply-chain bottlenecks,” said Selena Ling, head of treasury research and strategy at Oversea-Chinese Banking Corp.\n\nSingapore’s economic recovery was already expected to slowto 3%-5% growth next year, from about 7% this year, according to the trade ministry. Still, most economists remain optimistic about the city-state’s growth prospects as local infections subside.\n“We see significant room for catch-up” of vulnerable sectors like tourism and aviation,Nomura Holdings Inc. economis ts including Euben Paracuelles wrote in a December report.\nElectronics and pharmaceuticals production, which are relatively insulated from slower global growth, can continue lifting Singapore’s economy, they said. A rise in vacancies paints a strong outlook for jobs, with the unemployment rate seen dropping to 1.9% next year, below its pre-pandemic level of 2.2%.\nInflation Bites\nSingapore has avoided the worst of the price rises seen in countries from the U.S. to Brazil, even as supply-chain bottlenecks and a global energy crisis drive up local food and electricity bills.\nMost observers expect the central bank to tighten monetary policy again at its April review after core inflation hit its highest level in more than two years last month.\n\nHeadline inflation also is expected to continue rising into next year, before moderating. As a trade hub, Singapore could be more sensitive than most to further snarls in global supply chains that could drive up prices around the world.\nHow aggressive the Monetary Authority of Singapore will be remains an open question. It surprised markets in October when it tightened monetary policy, and has indicated it is “ready to act” against further inflation risks.\nFaiz Nagutha, Asean economist at Bank of America Securities, expects MAS to steepen the slope of its currency band to 1% appreciation per year, from the current 0.5% pace. He’s not ruling out a sharper hike to 1.5% appreciation -- already the baseline forecast at Goldman Sachs Group Inc.-- if inflation accelerates further.\nProperty\nLong a topic of concern among Singapore residents, the property market’s strong performance this year prompted mid-December curbsfrom the government, the first new measures since 2018.\nAmid signs that the U.S. Federal Reserve may accelerate interest-rate hikes next year -- something that could drive rates higher globally -- concerns have risen that Singapore borrowers may be vulnerable. New requirements such as additional stamp duties for second homes could be targeted at buyers that have overstretched their finances to purchase private property, said Christine Sun, senior vice president of research and analytics at OrangeTee & Tie Pte. in Singapore.\nMarket watchers are divided on how much the new policies might dampen market momentum. Sun projects private-home prices to rise “at a much slower pace” in 2022, in the range of 0%-3%.\nAlan Cheong, executive director of research at Savills Plc, said the new measures may limit foreign buying of private residential properties, but are “unlikely to have any significant impact” on local demand.\nCheong still expects Singapore private residential prices to rise by 7% next year, as “the belief that real estate is a hedge against inflation” means that elevated inflation could actually be a driver of demand. He does not believe any significant government intervention is likely next year.\nThe lounge of an apartment for sale in Singapore earlier in August. Photographer: Wei Leng Tay/Bloomberg\nTaxes\nSingapore’s 2022 budget in February will be closely watched for any moves targeting the wealthy and raising revenue to consolidate the city’s finances after two years of pandemic-driven deficits.\n“Fiscal policy in particular will prioritize a return to balanced budget over the current term of government, which may require a range of tax increases,”Citigroup Inc. economists Kit Wei Zheng and Ang Kai Wei wrote in a December note.\nBloomberg News previously reported that city officials have been consulting business elites about possible changes, but Prime Minister Lee said in November that finding effective ways to tax wealth was“not so easy.”Finance Minister Lawrence Wong has committed to announcing a carbon-tax hike for 2024 in next year’s budget, as the city takes additional steps against climate change.\nCitigroup’s economists say a hike in the goods and services tax -- which the government has said will happen by 2025 -- will likely be implemented next July, along with a wealth tax on existing property assets to “cushion the political impact.”\nSuch an approach will avoid hurting “the important wealth management industry” and Singapore’s competitiveness, while targeting “relatively immobile forms of wealth” Citi said.\nPolicy makers will be under pressure to maintain current spending levels, with Singapore’s top business federation recently calling for the further extension of wage and loan support into next year.\nTrinh Nguyen, senior economist for emerging Asia at Natixis SA believes the government will “act rather cautiously” on taxes while it shores up the recovery. The rise in GST may be delayed, she said, as it would “push inflation higher and is regressive.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699612765,"gmtCreate":1639791269292,"gmtModify":1639791309359,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699612765","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608376748,"gmtCreate":1638654893874,"gmtModify":1638654893965,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608376748","repostId":"2188578706","repostType":4,"repost":{"id":"2188578706","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638577500,"share":"https://www.laohu8.com/m/news/2188578706?lang=&edition=full","pubTime":"2021-12-04 08:25","market":"us","language":"en","title":"DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'","url":"https://stock-news.laohu8.com/highlight/detail?id=2188578706","media":"Dow Jones","summary":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pande","content":"<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 08:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DOCU":"Docusign","BK4023":"应用软件","BK4528":"SaaS概念"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188578706","content_text":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down\nDocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.\nShares of DocuSign $(DOCU)$ fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"\nThe stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&P 500 index has rallied 21% this year after climbing 16% last year.\nThe company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"\nCiti Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.\n\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.\nRadke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.\nEvercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"\nBut the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"\nWhile he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"\nHe cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.\nDocuSign shares are off roughly 52% from their September closing high of $310.05.","news_type":1},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609520919,"gmtCreate":1638311073672,"gmtModify":1638311073803,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609520919","repostId":"1158390889","repostType":4,"repost":{"id":"1158390889","pubTimestamp":1638285505,"share":"https://www.laohu8.com/m/news/1158390889?lang=&edition=full","pubTime":"2021-11-30 23:18","market":"us","language":"en","title":"Apple Stock: What to Expect During the Holiday Season","url":"https://stock-news.laohu8.com/highlight/detail?id=1158390889","media":"TheStreet","summary":"The 2021 holiday shopping season has officially started. Here is what Apple investors should expect of the Cupertino company and its stock in the next few weeks.Black Friday and Cyber Monday are behind us. With that, the 2021 holiday season in the US and parts of the world has officially begun. Consumer product and service companies like Apple are staring into the busiest weeks of sales in the year.Figure 1: Apple's iPhone, Apple Watch and Air Pods boxes.Today, the Apple Maven talks about what A","content":"<p>The 2021 holiday shopping season has officially started. Here is what Apple investors should expect of the Cupertino company and its stock in the next few weeks.</p>\n<p>Black Friday and Cyber Monday are behind us. With that, the 2021 holiday season in the US and parts of the world has officially begun. Consumer product and service companies like Apple are staring into the busiest weeks of sales in the year.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84c9d46c1a03b350ba81dcd1e6e39c83\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple's iPhone, Apple Watch and Air Pods boxes.</span></p>\n<p>Today, the Apple Maven talks about what Apple stock&nbsp;investors should think about as the shopping season kicks into gear.</p>\n<p><b>Apple to benefit from strong consumer</b></p>\n<p>At the highest level possible, Apple is likely to benefit from a rising tide that lifts all boats in 2021. The chart below clearly shows that consumer spending in the US has not only recovered from the 2020 flash recession, but it has been “making up for lost time”. Spending trends have even accelerated slightly compared to the pre-pandemic period.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/edfb88f466fa1cfe1c35bddbd1cf1bb7\" tg-width=\"756\" tg-height=\"357\" width=\"100%\" height=\"auto\"><span>Figure 2: Consumer spending in US.</span></p>\n<p>Regarding the holiday period, however, consumer product and service sales may look a bit atypical. Adobe has recently&nbsp;reported&nbsp;that Black Friday activity online dropped year-over-year for the first time ever. Online sales reached $8.9 billion, lower than 2020’s $9 billion.</p>\n<p>Without context, these numbers may look concerning. But once again, there is nothing typical about this COVID-19 crisis. Black Friday likely suffered from (1) consumers buying earlier than usual, to avoid delayed deliveries in late November and December, and (2) supply chain constraints causing shortages and missed sales opportunities.</p>\n<p><b>Apple could do better than average</b></p>\n<p>The demand scenario described above is at least modestly optimistic, in my view, even if not without challenges on the supply side. Even so, I think that Apple has a good chance of performing better than average in the next few weeks.</p>\n<p>For starters, the Cupertino company is&nbsp;one of the best in the world at managing inventory&nbsp;and supply chain. Consider, however, that CEO Tim Cook&nbsp;has already warned of an impact&nbsp;of $6 billion to revenues in the holiday quarter caused by the production and logistics bottlenecks.</p>\n<p>Second, the demand for Apple’s products and services seems unshaken.I have discussed a few times that the iPhone, for example, is likely to have its best years of sales ever in fiscal 2021 and 2022. Not even the tough comps introduced by the first 5G-capable model will likely be enough to steal the thunder of a well-received iPhone 13.</p>\n<p><b>But how about AAPL stock?</b></p>\n<p>Keep in mind that financial performance, especially in the short term, does not always correlate with share price movements. In fact, any impact that the holiday P&amp;L results may have on Apple stock would likely not happen until late January 2022, when the company reports fiscal Q1 earnings.</p>\n<p>For the immediate term, Apple investors should keep in mind that the stock’s&nbsp;seasonal patterns have been historically unfavorable&nbsp;around this time of the year. The chart below shows that AAPL has clearly underperformed in November through January. Will this time be any different? Only time will tell.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4c72a2f9720f472ceba32b24f4a2a78\" tg-width=\"682\" tg-height=\"357\" width=\"100%\" height=\"auto\"><span>Figure 3: AAPL average monthly return since iPhone launch.</span></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: What to Expect During the Holiday Season</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: What to Expect During the Holiday Season\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 23:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-holiday-season-starts-what-next><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The 2021 holiday shopping season has officially started. Here is what Apple investors should expect of the Cupertino company and its stock in the next few weeks.\nBlack Friday and Cyber Monday are ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-holiday-season-starts-what-next\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-holiday-season-starts-what-next","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158390889","content_text":"The 2021 holiday shopping season has officially started. Here is what Apple investors should expect of the Cupertino company and its stock in the next few weeks.\nBlack Friday and Cyber Monday are behind us. With that, the 2021 holiday season in the US and parts of the world has officially begun. Consumer product and service companies like Apple are staring into the busiest weeks of sales in the year.\nFigure 1: Apple's iPhone, Apple Watch and Air Pods boxes.\nToday, the Apple Maven talks about what Apple stock investors should think about as the shopping season kicks into gear.\nApple to benefit from strong consumer\nAt the highest level possible, Apple is likely to benefit from a rising tide that lifts all boats in 2021. The chart below clearly shows that consumer spending in the US has not only recovered from the 2020 flash recession, but it has been “making up for lost time”. Spending trends have even accelerated slightly compared to the pre-pandemic period.\nFigure 2: Consumer spending in US.\nRegarding the holiday period, however, consumer product and service sales may look a bit atypical. Adobe has recently reported that Black Friday activity online dropped year-over-year for the first time ever. Online sales reached $8.9 billion, lower than 2020’s $9 billion.\nWithout context, these numbers may look concerning. But once again, there is nothing typical about this COVID-19 crisis. Black Friday likely suffered from (1) consumers buying earlier than usual, to avoid delayed deliveries in late November and December, and (2) supply chain constraints causing shortages and missed sales opportunities.\nApple could do better than average\nThe demand scenario described above is at least modestly optimistic, in my view, even if not without challenges on the supply side. Even so, I think that Apple has a good chance of performing better than average in the next few weeks.\nFor starters, the Cupertino company is one of the best in the world at managing inventory and supply chain. Consider, however, that CEO Tim Cook has already warned of an impact of $6 billion to revenues in the holiday quarter caused by the production and logistics bottlenecks.\nSecond, the demand for Apple’s products and services seems unshaken.I have discussed a few times that the iPhone, for example, is likely to have its best years of sales ever in fiscal 2021 and 2022. Not even the tough comps introduced by the first 5G-capable model will likely be enough to steal the thunder of a well-received iPhone 13.\nBut how about AAPL stock?\nKeep in mind that financial performance, especially in the short term, does not always correlate with share price movements. In fact, any impact that the holiday P&L results may have on Apple stock would likely not happen until late January 2022, when the company reports fiscal Q1 earnings.\nFor the immediate term, Apple investors should keep in mind that the stock’s seasonal patterns have been historically unfavorable around this time of the year. The chart below shows that AAPL has clearly underperformed in November through January. Will this time be any different? Only time will tell.\nFigure 3: AAPL average monthly return since iPhone launch.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874212203,"gmtCreate":1637791334683,"gmtModify":1637791334769,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874212203","repostId":"1151417653","repostType":4,"repost":{"id":"1151417653","pubTimestamp":1637765751,"share":"https://www.laohu8.com/m/news/1151417653?lang=&edition=full","pubTime":"2021-11-24 22:55","market":"us","language":"en","title":"Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1151417653","media":"Benzinga","summary":"Gilead Sciences Inc and Merck & Co Inc have temporarily paused enrollment in the Phase 2 study evalu","content":"<p><b>Gilead Sciences Inc</b>&nbsp;and&nbsp;<b>Merck &amp; Co Inc</b>&nbsp;have&nbsp;temporarily paused enrollment&nbsp;in the Phase 2 study evaluating the combination regimen of islatravir and lenacapavir in HIV infection.</p>\n<ul>\n <li>The temporary pause has been implemented out of an abundance of caution to allow the companies to consider potential protocol adjustments to the trial after&nbsp;Merck decided to stop the MK-8507 combination HIV trial.</li>\n <li>Participants enrolled in this trial will continue to receive the study drug and be monitored per the current protocol.</li>\n <li>The Phase 2 study is designed to evaluate the safety and antiviral effect of an oral weekly regimen of islatravir in combination with lenacapavir in virologically suppressed people aged 18 years and older with HIV.</li>\n <li>Lenacapavir is Gilead’s investigational long-acting HIV-1 capsid inhibitor.</li>\n <li>Islatravir (MK-8591) is Merck’s investigational nucleoside reverse transcriptase translocation inhibitor under evaluation in more than ten clinical trials.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-24 22:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/24270813/gilead-merck-stop-enrollment-in-mid-stage-hiv-combination-therapy-trial><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gilead Sciences Inc and Merck & Co Inc have temporarily paused enrollment in the Phase 2 study evaluating the combination regimen of islatravir and lenacapavir in HIV infection.\n\nThe temporary pause ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/24270813/gilead-merck-stop-enrollment-in-mid-stage-hiv-combination-therapy-trial\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GILD":"吉利德科学","MRK":"默沙东"},"source_url":"https://www.benzinga.com/general/biotech/21/11/24270813/gilead-merck-stop-enrollment-in-mid-stage-hiv-combination-therapy-trial","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151417653","content_text":"Gilead Sciences Inc and Merck & Co Inc have temporarily paused enrollment in the Phase 2 study evaluating the combination regimen of islatravir and lenacapavir in HIV infection.\n\nThe temporary pause has been implemented out of an abundance of caution to allow the companies to consider potential protocol adjustments to the trial after Merck decided to stop the MK-8507 combination HIV trial.\nParticipants enrolled in this trial will continue to receive the study drug and be monitored per the current protocol.\nThe Phase 2 study is designed to evaluate the safety and antiviral effect of an oral weekly regimen of islatravir in combination with lenacapavir in virologically suppressed people aged 18 years and older with HIV.\nLenacapavir is Gilead’s investigational long-acting HIV-1 capsid inhibitor.\nIslatravir (MK-8591) is Merck’s investigational nucleoside reverse transcriptase translocation inhibitor under evaluation in more than ten clinical trials.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872378577,"gmtCreate":1637452428767,"gmtModify":1637452428841,"author":{"id":"3583487187442003","authorId":"3583487187442003","name":"419eae9a","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872378577","repostId":"2184984959","repostType":4,"repost":{"id":"2184984959","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637376795,"share":"https://www.laohu8.com/m/news/2184984959?lang=&edition=full","pubTime":"2021-11-20 10:53","market":"hk","language":"en","title":"House approves Biden's $2 trillion social-spending bill, but big changes loom in Senate","url":"https://stock-news.laohu8.com/highlight/detail?id=2184984959","media":"Dow Jones","summary":"Legislation would boost deficits by $367 billion, congressional scorekeepers say\nThe House of Repres","content":"<p>Legislation would boost deficits by $367 billion, congressional scorekeepers say</p>\n<p>The House of Representatives on Friday approved a roughly $2 trillion social-spending and climate-change bill backed by President Joe Biden, sending the measure to the Senate, where it is expected to face significant changes.</p>\n<p>Lawmakers in the Democratic-controlled House passed what's known as the Build Back Better plan on a vote of 220 to 213. The sprawling package would create universal preschool, extend more-expansive Affordable Care Act subsidies, fund clean-energy programs and provide tax credits for electric vehicles <a href=\"https://laohu8.com/S/F\">$(F)$</a><a href=\"https://laohu8.com/S/GM\">$(GM)$</a> of as much as $12,500.</p>\n<p>\"Too many Americans are just barely getting by in our economy,\" House Majority Leader Steny Hoyer, a Maryland Democrat, said before the vote. \"And we simply can't go back to the way things were before the pandemic.\" Speaking to reporters after lawmakers voted, House Speaker Nancy Pelosi, a California Democrat, said \"we'll be telling our children and grandchildren we were here this day.\"</p>\n<p>Final passage was delayed to Friday morning from late Thursday as House Minority Leader Kevin McCarthy, a California Republican, spoke for over three hours criticizing the legislation, Biden and Democrats, drawing sporadic boos and groans from Democratic lawmakers. McCarthy is in line to become House speaker if the GOP takes back control of the chamber in next year's midterm elections.</p>\n<p>Some major portions of the legislation -- such as paid leave and immigration policy -- are expected to undergo removal or changes in the Senate, where Democrats have no votes to spare. West Virginia Sen. Joe Manchin, a moderate Democrat, has raised concerns about the paid leave program, as well as the cost of the overall package. In the 50-50 Senate, the bill will need the backing of every Democrat to pass, since no Republicans support it.</p>\n<p>Another controversial provision: the $10,000 cap on the state and local tax deduction would be raised to $80,000 beginning in tax year 2021. That higher cap would be extended over nine years. Sen. Bernie Sanders, the Vermont independent who leads the Senate Budget Committee, on Thursday called that provision \"wrong,\" and said it amounts to a tax break for the wealthy.</p>\n<p>Rep. Jared Golden of Maine, a critic of raising the SALT cap, was the sole House Democrat to vote against the bill on Friday. All House Republicans voted against the package.</p>\n<p>Biden, fresh off a victory from the $1 trillion bipartisan infrastructure <a href=\"https://laohu8.com/S/PAVE.UK\">$(PAVE.UK)$</a> bill's enactment, has talked up the bigger package in public appearances this week, and touted reports that showed his agenda will not worsen inflation pressures. Republicans have pointed to the highest inflation in three decades and charge that Biden's plans will add to it.</p>\n<p>Read more:Housing inflation is getting worse. Will Biden's 'Build Back Better' program help renters and buyers?</p>\n<p>Biden has said the 10-year legislation would pay for itself, including by raising taxes on high-income Americans and a new corporate minimum tax.</p>\n<p>Late Thursday, however, the nonpartisan Congressional Budget Office said the legislation would increase the deficit by $367 billion over a decade. That estimate doesn't include revenue that could be generated from increasing enforcement by the Internal Revenue Service.</p>\n<p>In a key area of disagreement, the CBO said beefed-up IRS enforcement would bring in $207 billion in revenues -- while the White House had estimated $400 billion over a decade.</p>\n<p>Democrats are looking to deliver another legislative win as Biden is struggling with falling approval ratings, and with the party facing potentially tough midterm elections next year.</p>\n<p>Senate Majority Chuck Schumer, a New York Democrat, told reporters earlier this week that his chamber is aiming to pass the Build Back Better Act before Christmas.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>House approves Biden's $2 trillion social-spending bill, but big changes loom in Senate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHouse approves Biden's $2 trillion social-spending bill, but big changes loom in Senate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-20 10:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Legislation would boost deficits by $367 billion, congressional scorekeepers say</p>\n<p>The House of Representatives on Friday approved a roughly $2 trillion social-spending and climate-change bill backed by President Joe Biden, sending the measure to the Senate, where it is expected to face significant changes.</p>\n<p>Lawmakers in the Democratic-controlled House passed what's known as the Build Back Better plan on a vote of 220 to 213. The sprawling package would create universal preschool, extend more-expansive Affordable Care Act subsidies, fund clean-energy programs and provide tax credits for electric vehicles <a href=\"https://laohu8.com/S/F\">$(F)$</a><a href=\"https://laohu8.com/S/GM\">$(GM)$</a> of as much as $12,500.</p>\n<p>\"Too many Americans are just barely getting by in our economy,\" House Majority Leader Steny Hoyer, a Maryland Democrat, said before the vote. \"And we simply can't go back to the way things were before the pandemic.\" Speaking to reporters after lawmakers voted, House Speaker Nancy Pelosi, a California Democrat, said \"we'll be telling our children and grandchildren we were here this day.\"</p>\n<p>Final passage was delayed to Friday morning from late Thursday as House Minority Leader Kevin McCarthy, a California Republican, spoke for over three hours criticizing the legislation, Biden and Democrats, drawing sporadic boos and groans from Democratic lawmakers. McCarthy is in line to become House speaker if the GOP takes back control of the chamber in next year's midterm elections.</p>\n<p>Some major portions of the legislation -- such as paid leave and immigration policy -- are expected to undergo removal or changes in the Senate, where Democrats have no votes to spare. West Virginia Sen. Joe Manchin, a moderate Democrat, has raised concerns about the paid leave program, as well as the cost of the overall package. In the 50-50 Senate, the bill will need the backing of every Democrat to pass, since no Republicans support it.</p>\n<p>Another controversial provision: the $10,000 cap on the state and local tax deduction would be raised to $80,000 beginning in tax year 2021. That higher cap would be extended over nine years. Sen. Bernie Sanders, the Vermont independent who leads the Senate Budget Committee, on Thursday called that provision \"wrong,\" and said it amounts to a tax break for the wealthy.</p>\n<p>Rep. Jared Golden of Maine, a critic of raising the SALT cap, was the sole House Democrat to vote against the bill on Friday. All House Republicans voted against the package.</p>\n<p>Biden, fresh off a victory from the $1 trillion bipartisan infrastructure <a href=\"https://laohu8.com/S/PAVE.UK\">$(PAVE.UK)$</a> bill's enactment, has talked up the bigger package in public appearances this week, and touted reports that showed his agenda will not worsen inflation pressures. Republicans have pointed to the highest inflation in three decades and charge that Biden's plans will add to it.</p>\n<p>Read more:Housing inflation is getting worse. Will Biden's 'Build Back Better' program help renters and buyers?</p>\n<p>Biden has said the 10-year legislation would pay for itself, including by raising taxes on high-income Americans and a new corporate minimum tax.</p>\n<p>Late Thursday, however, the nonpartisan Congressional Budget Office said the legislation would increase the deficit by $367 billion over a decade. That estimate doesn't include revenue that could be generated from increasing enforcement by the Internal Revenue Service.</p>\n<p>In a key area of disagreement, the CBO said beefed-up IRS enforcement would bring in $207 billion in revenues -- while the White House had estimated $400 billion over a decade.</p>\n<p>Democrats are looking to deliver another legislative win as Biden is struggling with falling approval ratings, and with the party facing potentially tough midterm elections next year.</p>\n<p>Senate Majority Chuck Schumer, a New York Democrat, told reporters earlier this week that his chamber is aiming to pass the Build Back Better Act before Christmas.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","GM":"通用汽车",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184984959","content_text":"Legislation would boost deficits by $367 billion, congressional scorekeepers say\nThe House of Representatives on Friday approved a roughly $2 trillion social-spending and climate-change bill backed by President Joe Biden, sending the measure to the Senate, where it is expected to face significant changes.\nLawmakers in the Democratic-controlled House passed what's known as the Build Back Better plan on a vote of 220 to 213. The sprawling package would create universal preschool, extend more-expansive Affordable Care Act subsidies, fund clean-energy programs and provide tax credits for electric vehicles $(F)$$(GM)$ of as much as $12,500.\n\"Too many Americans are just barely getting by in our economy,\" House Majority Leader Steny Hoyer, a Maryland Democrat, said before the vote. \"And we simply can't go back to the way things were before the pandemic.\" Speaking to reporters after lawmakers voted, House Speaker Nancy Pelosi, a California Democrat, said \"we'll be telling our children and grandchildren we were here this day.\"\nFinal passage was delayed to Friday morning from late Thursday as House Minority Leader Kevin McCarthy, a California Republican, spoke for over three hours criticizing the legislation, Biden and Democrats, drawing sporadic boos and groans from Democratic lawmakers. McCarthy is in line to become House speaker if the GOP takes back control of the chamber in next year's midterm elections.\nSome major portions of the legislation -- such as paid leave and immigration policy -- are expected to undergo removal or changes in the Senate, where Democrats have no votes to spare. West Virginia Sen. Joe Manchin, a moderate Democrat, has raised concerns about the paid leave program, as well as the cost of the overall package. In the 50-50 Senate, the bill will need the backing of every Democrat to pass, since no Republicans support it.\nAnother controversial provision: the $10,000 cap on the state and local tax deduction would be raised to $80,000 beginning in tax year 2021. That higher cap would be extended over nine years. Sen. Bernie Sanders, the Vermont independent who leads the Senate Budget Committee, on Thursday called that provision \"wrong,\" and said it amounts to a tax break for the wealthy.\nRep. Jared Golden of Maine, a critic of raising the SALT cap, was the sole House Democrat to vote against the bill on Friday. All House Republicans voted against the package.\nBiden, fresh off a victory from the $1 trillion bipartisan infrastructure $(PAVE.UK)$ bill's enactment, has talked up the bigger package in public appearances this week, and touted reports that showed his agenda will not worsen inflation pressures. Republicans have pointed to the highest inflation in three decades and charge that Biden's plans will add to it.\nRead more:Housing inflation is getting worse. Will Biden's 'Build Back Better' program help renters and buyers?\nBiden has said the 10-year legislation would pay for itself, including by raising taxes on high-income Americans and a new corporate minimum tax.\nLate Thursday, however, the nonpartisan Congressional Budget Office said the legislation would increase the deficit by $367 billion over a decade. That estimate doesn't include revenue that could be generated from increasing enforcement by the Internal Revenue Service.\nIn a key area of disagreement, the CBO said beefed-up IRS enforcement would bring in $207 billion in revenues -- while the White House had estimated $400 billion over a decade.\nDemocrats are looking to deliver another legislative win as Biden is struggling with falling approval ratings, and with the party facing potentially tough midterm elections next year.\nSenate Majority Chuck Schumer, a New York Democrat, told reporters earlier this week that his chamber is aiming to pass the Build Back Better Act before Christmas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}